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 Plants are an essential resource providing the world with food, oxygen to breath, 
and animal habitats. Within each plant, there is an integrated network of pathways that 
produces phytochemicals either metabolism [1, 2]. Following the discovery of the first 
specialized metabolite in 1806, the common view has shifted from describing a collection 
of “by-products” to primary metabolism [3, 4] to the products of a value-added expansion 
of primary metabolic processes that provides an adaptive advantage to the producing 
organism.  Herein, we report the identification of metabolites for three lipid-related 
pathways and insights into their origins. The first study was initiated by the serendipitous 
discovery of unusual fatty acids in the seed oil of Orychophragmus violaceus. Structural 
analyses together with targeted syntheses of derivatives and molecular fragments 
revealed two C24 dihydroxy fatty acids identified as 7,18-(OH)2-24:1∆15 and 7,18-(OH)2-
24:2∆15,21 that account for ~50% of the seed oil. Evidence indicates that these 
hydroxylated fatty acids are made via discontinuous elongation, a novel process 
intermediate between fatty acid and polyketide syntheses. Second, 13C and 2H labeled 
precursors were used to gain insight into the biosynthetic pathway of alkamides produced 
by Echinacea. It was determined that the alkamide’s amide moiety is derived from valine 
and isoleucine, which led to the discovery of the first plant branched-chained amino acid 
decarboxylase. Separately, the involvement of these atypical acyl chains in alkamide 
biosynthesis was tested with [2H3] 2E-dodec-, tridec-, and tetradecenoic acids, and their 
isobutylamides. Analogous CoA derivatives were synthesized to characterize a ligase 
potentially responsible for the amide bond formation. Finally, to gain insight into the 
mechanism of a divergent CYP51 enzyme involved in avenacin biosynthesis, epoxy and 
hydroxylated triterpenes formed by mutant enzymes were identified. Collectively, these 
studies further the knowledge of the biosynthesis of specialized plant natural products. 
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CHAPTER 1. INTRODUCTION 
1.1 Evolution of Plant Natural Product Biosynthesis 
 It is estimated that there is almost a half million different plant species around the 
world [5]. Within each plant, there is an integrated network of enzymes that is carefully 
regulated, performing an array of chemical reactions to synthesize specific natural 
products [6]. Many of these metabolic pathways synthesize compounds that are essential 
to sustaining a living organism, while other pathways synthesize beneficial 
phytochemicals specific to the plant for genetic, physiological, or biochemical purposes 
[6].  
Plant metabolism can be divided into two categories, primary and secondary 
metabolism. Recently, there has been a push to rename “secondary metabolism” to 
“specialized metabolism,” more positively reflecting the importance of these biochemical 
pathways to their hosts [1, 2]. Common in all plants, primary metabolism synthesizes 
metabolites that are generally necessary in cells through most developmental stages [7]. 
These biosynthetic pathways produces carbohydrates, amino acids, membrane and 
common storage lipids, and nucleic acids that are essentially the same across all 
organisms [7, 8]. Pathways such as glycolysis, the pentose phosphate, and the Krebs 
cycle are all examples of primary metabolism [8].  
In contrast, secondary metabolism uses specific enzymes to produce the subset of 
sugars, waxes, lignin, starch, pigments, or alkaloids unique to each plant [9]. Specialized 
metabolism in the plant kingdom produces natural products with very diverse functions, 
including providing the means to communicate within the plant and its biome, defense 
against insects, animals, and microorganisms, and mechanisms to prevent encroachment 
by other plants [1]. Though there remains chemical variation within the categories used, 
most specialized metabolites can be classified as polyketides and fatty acids, terpenoids 
including steroids, phenylpropanoids, alkaloids or other nitrogen-containing natural 
products [10]. Nevertheless, specialized metabolism is composed of unique biosynthetic 
pathways derived from the building blocks and, frequently, variations upon the 
biosynthetic enzymes of primary metabolism (Figure 1) [3, 11]. Some natural products 
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can be classified as being derived from more than one metabolic category, such as 
capsaicin. It is derived from phenylalanine, which classifies it as a phenylpropanoid, but 
it is also derived from fatty acid biosynthesis. 
 
 
Figure 1: An example of secondary metabolites synthesized from the primary metabolic 
building blocks from photosynthesis. The orange box represents a collection of primary 
metabolic pathways including glycolysis, Calvin cycle, Krebs cycle, oxidative 
phosphorylation, pentose phosphate, and citric acid cycle and green boxes are primary 
metabolites. Red boxes denote secondary metabolic pathways and purple boxes indicate 
secondary metabolites. 
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The foundation for specialized metabolism started in 1806 with the isolation of 
morphine from opium poppy by Friedrich Willhelm Sertürner (Figure 2) [3]. After 
morphine was isolated, there was a flurry of other secondary metabolites isolated. This 
increase greatly influenced trajectory of organic chemistry especially in the synthetic, 
pharmaceutical, and analytical areas [3]. In 1882, the first total synthesis of a plant 
secondary metabolite, indigo, was completed by Johann Friedrich Wilhelm Adolf von 
Baeyer [3]. The structure of morphine was determined in 1923, and in 1950, a total 
synthesis was completed [3]. Early on, little was known about the botanical relevance of 
these products; they were categorized into different classes based on their distribution 
within plants, as nothing was known about their function [3]. The dogma was that they 
were thought of as “by-products” of primary metabolism because they were not thought 
to be crucial for the plants survival [3]. In 1888, Ernst Stahl first stated that the function 
of secondary metabolites evolves in relation to the environment, but it was mostly 
disregarded for over 60 years [3, 4]. With advancements in chemical ecology, this idea 
slowly became more accepted [3, 12, 13]. It is now known that specialized metabolism is 
unique to specific phylogenetic clades of the plant kingdom and it provides the 
physiochemical phenotypic differences among the taxonomic groups [1]. Most plants 
synthesize secondary metabolites due to an evolutionary need. For example, floral scent 
volatiles have evolved to attract pollinators and thus enhanced fertilization [14]. Some 
plants produce toxic chemicals such as terpenoids, alkaloids, and phenols to ward off 
pathogens, competitors, or herbivores [15]. 
In the early 1900s, scientists used information from analogous organic reactions 
and structures to create postulates about the formation of natural products rather than 
information from biochemical evidence [3, 16]. It wasn’t until the 1950s when tracer 
techniques using radiolabeled isotopes, particularly 14C and 3H, expanded, which 
considerably advanced mechanistic studies [3]. Further advancements occurred using 
organic chemistry to synthesize desired stable-isotope labeled precursors that benefited 
from advancements in NMR and MS techniques [3]. NMR provided the locations on 
labeled atoms and could be used under appropriate conditions for quantitative 13C NMR 
experiments, while MS techniques had increased in sensitivity and safety relative to 
NMR and radioisotopes, respectively [17, 18]. Through tracer experiments, new 
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biosynthetic pathways were discovered unexpectedly. Prior to radiolabeled isotopes, 
Ruzicka formulated the “biogenetic isoprene rule,” which stated active isoprenes such as 
isopentenyl pyrophosphate (IPP) and dimethylallyl diphosphate (DMAPP) are 
synthesized through the mevalonate pathway [3, 19]. Labeled acetate or mevalonate 
experiments confirmed this rule with the exception of the synthesis of monoterpenoids, 
diterpenoids, and carotenoids, which showed low incorporation [3, 20]. Twenty-five 
years later, Schwartz and Arigoni reported the methylerythritolphosphate (MEP) pathway 
as an alternative pathway to synthesize mono-, di-, and tetraterpenoids [21, 22]. 
 
 
 
Figure 2: Timeline of the advancements of phytochemistry from the isolation of 
morphine in 1806 [3]. 
 
Until the 1960s, little was known about the enzymes involved in secondary 
metabolism. Conn’s group was the first to purify and characterize such an enzyme, 
phenylalanine ammonia-lyase (PAL) [23]. Two developments caused a major 
breakthrough in enzymology: (1) column chromatography was introduced, which allowed 
for a rapid and selective separation of proteins [3]; and (2) plant organ and cell cultures 
were developed, which allowed for a simple way to handle plants as an in vitro system 
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[3]. Through the 1970s and 1980s, these two advancements lead to numerous 
biosynthetic pathways being characterized at an enzymatic level [3]. For example, 
Grisebach and Hahlbrock began characterizing enzymes of the phenylpropanoid pathway 
leading to flavonoids and lignins [24, 25]. Additionally, many aspects of the 
monoterpenoid indole alkaloid pathway, with over 2000 structures, have been 
characterized at the enzymatic level from tissue and root cultures [26]. Though cell 
cultures have been very successful in understanding secondary metabolism, there are still 
countless natural products that have little-to-no in vitro production [3]. For some of these 
cases, either organ cultures have been shown to help understand the biosynthetic 
pathways or, in the case of terpenoid biosynthesis, the differentiated whole plant is 
needed for effective biosynthesis [3]. 
In the 1980s, genes encoding enzymes were first cloned and functionally 
characterized, and the molecular toolbox of recombinant DNA technology has become 
easier and faster ever since [27-29]. This has allowed the expression of recombinant 
enzymes and the recovery of the protein, which can be used for kinetic and/or structural 
studies [3]. Genomic tools are being used to transfer genes or pathways between 
organisms. Specialized metabolism can naturally adapt and be modified, partially since it 
is dispensable for development and growth [3]. This gives scientists the flexibility to 
modify organisms in hopes of improving medicinal and crop plants [3]. Of significance to 
humans, today, about 25% of pharmaceuticals are plant-derived, specialized metabolites 
or their derivatives [1, 30]. For example, acetylsalicylic acid, commonly known as aspirin, 
was derived from salicin, an anti-inflammatory ingredient in willow bark [1]. Of the 
known 400,000 plant species in the world, only a small percentage have been studied for 
their specialized metabolites and, of those compounds, an even smaller percentage has 
been studied for biological or pharmacological purposes. Learning more about the origin 
of the pathways of specialized metabolites aloing with the discovery of new specialized 
products will help to understand more about the evolution of secondary pathways and the 
indispensable functions they have for each plant. Having a better understanding of plant 
natural products have the potential to increase the contribution of specialized metabolites 
in the pharmaceutical industry. 
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1.2 Research Objectives 
While specialized metabolites are distinguished by their lack of uniform 
distribution among taxa, they are typically categorized in broad classes based on the 
relatively uniform chemistry involved in their biosynthesis. Still, out of these well 
established metabolic themes variations unique to specific plants or pathways continue to 
be discovered that expand our knowledge of biological chemistry. Herein, through NMR 
experiments and the synthesis of organic probes, a novel dihydroxylated fatty acid, 
making up 50% of the seed oil in the Brassicaeae family, was identified. This is one of 
the first examples of a plant accumulating a high concentration of dihydroxy fatty acids, 
which apparently result from a new variation on fatty acid synthesis. We also describe a 
group of specialized metabolites, the alkamides, believed to derive from two biosynthetic 
pathways, fatty acid synthesis in the mitochonidria and branched-chain amino acid 
synthesis. We will look at the roles of branched-chain amino acids, the α,β-unsaturation, 
and acyl chain length in alkamide biosynthesis. Finally, we studied a CYP51 enzyme that 
mechanistically behaves differently from other members of the functionally stable 
CYP51 family. After protein expressions of site-directed mutants of CYP51, products 
were isolated and structures identified in hope of understanding the mechanism of this 
novel bifunctional enzyme. All of these projects added breadth to key biochemical 
processes, underscoring the undiscovered wealth of new chemical processes of plant 
secondary metabolism. 
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CHAPTER 2. IDENTIFICATION OF HYDROXYLATED FATTY 
ACIDS FOUND IN ORYCHOPHRAGMUS VIOLACEUS 
2.1 Introduction 
Fatty acid biosynthesis is common among all plants; it iteratively assembles 
acetate units onto an acyl chain and fully reduces the carbonyl groups prior to the 
hydrolytic termination of the chain extension.  
In this report, we describe the serendipitous discovery of novel components of the 
seed oil in the Brassicaceae Orychophragmus violaceus. This plant is native to China and 
is grown extensively as an ornamental for its late winter flower that resembles that of 
violets [31, 32]. O. violaceus has also been used in a number of interspecific crossing 
studies with Brassica napus to generate hybrids for characterization of chromosome 
stability [33, 34]. Prior reports based on GC analyses have indicated that O. violaceus 
seed oil is rich in linoleic acid (9,12-octadecadienoic acid, 18:2), but unlike most 
Brassicaceae, has relatively low VLCFA content [35, 36].  In contrast to these reports, we 
have identified two dihydroxy C24 fatty acids, not detectable by typical GC protocols that 
together account for ~ 50% of the seed oil of O. violaceus seed oil, using initially thin-
layer chromatographic, rather than GC analysis. Elucidation of the unprecedented 
chemical structures of these fatty acids was achieved using a number of analytical and 
chemical synthetic approaches. 
2.1.1 Lipids from specialized metabolism 
Plants produce the majority of the lipids found on the planet, and within lipids, 
acyl lipids form the largest group [37]. Plant fatty acids have been shown to have several 
important roles. They are the basic components of cellular membranes and of surface 
layers, such as epicuticular wax, suberin, and cutin [37]. They are an important source of 
stored energy and several metabolic derivatives have biological activity [37]. More 
recently they have been shown to have numerous industrial uses [37]. Additionally, plant-
produced ω-6, 9 polyunsaturated fatty acids are essential nutrients for humans [37].  
Within the lipid biochemistry literature, compounds typically have an abbreviated 
nomenclature. For example, the monosaturated fatty acid palmitoleic acid, shown in 
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Figure 3, is abbreviated to 16:1Δ9Z. The first number represents the length of the acyl 
chain. The number after the colon reveals the number of double bonds present. The delta 
indicates the position of the double bond, referenced to the carboxyl terminus, and 
configuration. So, in the case of 16:1Δ9Z, the acyl chain is 16 carbons in length with one 
double bond at position 9 that is in the cis (Z) configuration. If the fatty acid has an 
acetylenic functional group like crepenynic acid, the triple bond is represented with the 
letter ‘a’ (Figure 3). Crepenynic acid is abbreviated to 18:1Δ9Z, 12a with a chain length of 
18 carbons, a cis double bond starting at the 9th carbon from the carboxyl end, and an 
acetylenic bond at the 12th position. 
 
 
Figure 3: Examples of fatty acids and their abbreviated nomenclature. 
 
Plant fatty acid synthesis has been heavily researched over the past 50 years. It is 
a key example of secondary metabolism evolving from primary metabolism. All plants 
produce common fatty acids such as stearic, palmitic, oleic, and linoleic acid, which are 
components of biological membranes and are used for energy [38]. Further modification 
of these basic fatty acids produces fatty acids such as crepenynic acid and ricinoleic acid, 
which are thought of as secondary metabolites unique to certain plant species [38].  
De novo saturated fatty acid biosynthesis involves two enzyme complexes, fatty 
acid synthase (FAS) and acetyl-CoA carboxylase (ACCase) (Figure 4) [39, 40]. First 
though, CO2 and H2O must be reduced to glucose through photosynthesis [6, 40]. 
Glucose has several roles in plants; one is as a precursor to pyruvate [6]. Pyruvate is also 
central to several metabolic pathways; for fatty acid synthesis to begin, it must be 
converted to acetyl-CoA [6]. From there, ACCase catalyzes the carboxylative activation 
of acetate through the formation of malonyl-CoA, an essential substrate for FAS [6, 39]. 
FAS in plants is a multienzyme complex which generates both palmitate and stearate [6, 
37]. C16 and C18 saturated fatty acids can be further modified by elongation, desaturation, 
O
OH
Palmitoleic acid
16:1Δ9c
O
OH
crepenynic acid
18:1Δ9c,12a
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epoxidation, hydroxylation, and other functionalizations producing secondary products [6, 
40].  
 
Figure 4: Important steps of fatty acid biosynthesis. The two essential enzymes include 
acetyl-CoA carboxylase (ACCase) and fatty acid synthase (FAS) [40]. 
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FASs are structurally and functionally related to certain of the large multienzyme 
protein complexes, the polyketide synthase (PKS), a highly diversified secondary 
metabolic enzyme. These enzymatic families share a common evolutionary history [41, 
42]. They can have analogous precursors, similar chemistries, comparable structures, and 
common overall architectural designs [43]. Generally speaking, FASs produce a small 
group of molecules, whereas PKSs synthesize a large, more oxygenated class of natural 
products, the polyketides [43]. To date, there is estimated to be over 10,000 known 
polyketides [43]. Through phylogenetic analysis, it was determined that acyl transferase 
(AT), ketosynthase (KS), and an acyl carrier protein (ACP) are the domains for 
condensation reactions performed by PKS and FAS [41, 42]. The three domains are 
essential for both enzymes [42]. For FAS, the ketoreductase (KR), enoyl reductase (ER), 
and dehydratase (DH) are essential for the full reduction of the acyl chain after 
condensation, whereas these three domains and a host of other modifying enzymes are 
selectively present or absent in PKSs [41, 42]. 
FASs can be further subdivided into type I or type II based on the organization of 
the enzyme [44]. Type I uses a single large, multifunctional polypeptide and the type II 
enzyme complex utilizes discrete monofunctional enzymes [44]. The details of the 
architecture of PKSs are more complicated than FASs (Figure 5). PKSs can be divided 
into type I, II, or III enzymes [45]. Type I and type II are similar to FASs, but type III are 
enzymes that do not use ACP domains [45]. Further analysis can divide type I into 
iterative and modular varieties [45]. Finally iterative enzymes can be divided into three 
categories: non-reducing (NR), partially reducing (PR), and highly reducing (HR) [45]. 
The domains of type I and type II FASs are essentially the same even though the 
organization is different. However, NR, PR and HR PKSs all have different domains [46]. 
NR PKSs have the core domains, AT, KS, and ACP, along with a malonyl-CoA domain 
(MAT) and product template domain (PT). PR PKSs have the core domains plus KR and 
possibly a DH domain, but not an ER domain. Finally, HR PKSs have the core domains 
plus the KR, ER, and DH similar to FAS. Environmental pressures are thought to drive 
the evolution of secondary metabolites and could be the reason for the variety of PKSs 
[43]. In a recent study of eukaryotes, genes encoding FASs and PKS were the subject of 
phylogenic analysis [42]. The functionality was conserved across the genes of FAS, 
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reflecting the evolutionary history of the organism [42]. The PKS genes function were 
expanded in the families and some of the genes were completely absent in some of the 
protest lineages suggesting some PKSs have undergone multiple duplication or deletion 
events through their evolutionary history allowing them to survive in nature [42]. 
 
 
 
Figure 5: Classes of FAS and PKS. A. FAS can be divided into type I or II enzymes. B. 
PKS can be classified as type I, II, or III. Type I can be subdivided to iterative and 
modular, and iterative type I enzymes can be subdivided to highly-reducing (HR), 
partially-reducing (PR), non-reducing (NR). 
 
In plants, type II FASs exists because there are a number of condensing enzymes 
involved [40]. Comparing the two, FASs seem simple compared to PKSs. However, 
FASs are more complicated than first understood, especially when it comes to their 
condensing enzyme, β-ketoacyl-ACP synthase (KAS). The condensation reaction occurs 
by three different condensing enzymes, KAS I, II, and III [40]. In the first step of FAS, 
the condensation reaction is catalyzed by KAS III using malonyl-ACP and acetyl-CoA as 
substrates [40]. After the initial condensation, a reduction by β-ketoacyl-ACP reductase, a 
dehydration by β-hydroxylacyl-ACP dehydrase, and a second conjugate reduction by 
enoyl reductase occurs to form butyrate [40]. This initial step is followed by cycles of 
reactions, condensation, reduction, dehydration, and a second reduction, each adding two 
FAS	 PKS	
Type	I	 Type	II	 Type	I	 Type	II	 Type	III	
Itera/ve	 Modular	
HR-PKS	 PR-PKS	 NR-PKS	
A.	 B.	
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carbons and finally a termination step [40]. For the elongation of butyrate to palmitate, 
the condensation reaction from butyrate to palmitate is catalyzed by KAS I [40]. The 
final condensation for C16 to C18 is catalyzed by KAS II [40]. The termination step can 
occur in various ways including by acyltransferases or thioesterases [40]. 
Though fatty acid biosynthesis is well understood there are still several things that 
remain unclear. The de novo fatty acid synthesis occurs in the chloroplast, but fatty acids 
can be transferred to other organelles such as the endoplasmic reticulum for further 
modification. The movement of fatty acids within a cell is biochemically less well 
defined than the initial synthesis [39]. It is known that acyl-CoA synthetases and acyl-
ACP desaturase act as acyl-CoA binding proteins to increase the solubility of acyl-CoAs, 
which can aid in the transfer between membranes [39, 47]. However, the exact 
mechanism for the targetted transfer of fatty acids from different organelles is still 
unclear [39]. 
Plants synthesize a variety of fatty acids, though only a few accumulate 
throughout the plant [40, 48]. The most common fatty acids produced by fatty acid 
synthesis are the saturated fatty acids, palmitate (16:0) and stearate (18:0). In plants, 
stearate is twice as abundant as palmitate [40]. Fatty acid biosynthesis primarily occurs in 
the chloroplast; limited fatty acid synthesis occurs in the mitochondria. The main purpose 
of mitochondria fatty acid synthesis is to make lipoic acid. In either case, once the acyl 
chain is produced further modifications can occur such as double bond(s), triple bond(s), 
conjugated polyen(yn)es, epoxides, hydroxyl groups, heterocyclic groups, and 
cycloprop(a/e)nyl rings (Figure 6) [49-55]. The examples shown are all fatty acids 
synthesized in the chloroplast and then modified at the ER.  
Fatty acids can also be modified to compounds that have biological functions such 
as glycolipids, phospholipids, and sphingolipids. Glycolipids are found in the outer leaflet 
of cell membranes to maintain stability of the membranes and to facilitate cellular 
recognition [56]. Phospholipids form lipid bilayers and are the major component of cell 
membranes; specifically for the cell membranes of the brain and nervous tissue, the major 
component is sphingolipids [57, 58]. Fatty acids can exist in the energetically dense form 
of triacylglycerols as a metabolic fuel for energy [48]. Several fatty acids are linked to 
biological processes; oleic acid can reduce blood pressure, docosahexaenoic acid (DHA) 
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has shown prevention of cancer and cardiovascular diseases, and γ-linoleic acid displays 
anti-inflammatory properties [59]. Free fatty acids and conjugated fatty acids in the form 
of diacylglycerol (DAG) are important in cell signaling [48]. Jasmonic acid is an oxylipin 
derived from linoleic acid, which can be synthesized to methyl jasmonate. It is known the 
methyl jasmonate plays a key role in signaling between plants [60]. Some specialized 
fatty acids have industrial uses. The epoxy fatty acid, lactobacillic acid, is used as a 
precursor to coatings, adhesives, and biopolymers [61, 62]. Conjugated fatty acids such 
as linolenic acid, are used in oxygen-initiated “quick-dry” oil paints and varnishes 
because it can easily be oxidized [63].   
 
 
 
Figure 6: Modifications of saturated fatty acids such as double bond(s), triple bond(s), 
conjugated polyen(yn)es, epoxides, hydroxyl groups, heterocyclic groups, and 
cyclopropan(e)nyl rings [64]. 
 
Hydroxylated fatty acids such as ricinoleic acid are continuing to be studied for 
their industrials application in chemicals, foods, and cosmetics [65]. Hydroxylated fatty 
acids are used as starting material for the synthesis of polymers [66]. They can also be 
used as additives for the manufacturing of lubricants, stabilizers, and emulsifiers [67]. 
For example, ricinoleic acid (Figure 6) is used in lubricants, hydraulic fluids, surfactants, 
and cosmetics [61, 68]. As a practical consideration, the isolation of ricinoleic acid from 
actual sources is less than ideal for commercial use due to potent toxins and allergens 
present in castor seeds [69]. Therefore, new hydroxylated fatty acids, whether from an 
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alternative plant source or by genetic engineering, could unlock this valuable product for 
a wide range of industrial applications.  
Very few plant species accumulate hydroxylated fatty acids. The most common is 
ricinoleic acid (12OH-18:1Δ9Z), which is produced by the castor bean (Ricinus communis) 
and makes up 80-90% of the seed oil (Figure 7) [69]. Hydroxylated fatty acids can also 
be found in several species in the Lesquerella genus [70]. Some species contain the C20 
homologue of ricinoleic acid, lesquerolic acid (14OH-20:1Δ11Z), while other species 
produce densipolic acid (12OH-18:2Δ9Z,15Z) [70]. Coriolic acid (13OH-18:2Δ9Z,11E) 
makes up 70% of the seed oil in Coriaria and kamlolenic acid (18OH-18:3Δ9Z,11E,13E) is 
produced by Mallotus philippinensis [71, 72]. Polyhydroxylated fatty acids are rare in 
plants. Cutin, a component of plant cuticle, contains C16 and C18 mono, di, and trihydroxy 
fatty acids [48]. Though other plant species make hydroxylated fatty acids, currently 
ricinoleic acid it is the only commercially used oil with a hydroxyl functional group [48].  
 
 
 
Figure 7: Monohydroxylated fatty acids that accumulate in plants. Ricinoleic acid 
accumulates at the largest concentration in seed oil and is well known for its commercial 
use. 
 
Ricinoleic acid is synthesized from oleic acid (18:1) [73, 74]. The reaction is 
catalyzed by the diverged Δ12 desaturase, Δ12-hydroxylase (FAH12); molecular oxygen 
and NADPH are both required substrates [73, 74]. FAH12 hydroxylates 18:1 esterified to 
the sn-2 position of phosphatidylcholine, which is then hydrolyzed to form free ricinoleic 
acid [74]. Through a series of steps, free ricinoleic acid is stored as a triacylglycerol 
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(TAG) [74]. The Van de Loo group determined that FAH12 had a 67% sequence 
homology to an oleate desaturase (FAD2) from Arabidopsis [75]. This indicated that 
hydroxylases are closely related to desaturases and provide an excellent example of 
enzyme evolution [75]. Furthermore, another FAH12 was isolated from Lesquerella 
fendleri [76]. When this Lesquerella FAH12 from was expressed with mutant FAD2 in 
Arabidopsis, desaturation activity of the mutant phenotype was only partial suppressed 
[76]. Both desaturase and hydroxylase activites were still present exhibiting bifunctional 
properties of this FAH12; this also proves the close evolutionary relationship of the two 
enzymes [76]. 
Specialized fatty acid biosynthesis such as hydroxylated fatty acids is an excellent 
example of secondary metabolism evolving from primary metabolism. The fatty acids 
16:0 and 18:0 are synthesized in all plants species, but each specialized fatty acid is 
unique to each plant species. Each specialized fatty acid identified adds another level of 
complexity to a once thought of simple pathway. 
2.1.2 Specialized fatty acids in the seed oils of the Brassicaeae 
Seed oils of the Brassicaceae are distinct from those of most plant families 
because of their high content of very long-chain fatty acids (VLCFAs) with carbon chain-
lengths ≥C20.  Seed oils from Brassicaceae such as Arabidopsis thaliana and Camelina 
sativa, for example, contain >15% of the C20 fatty acid 11-eicosenoic acid (20:1) [77, 78]. 
Seed oils of other Brassicacae such as Crambe abysinica and Brassica napus are enriched 
in the C22 fatty acid 13-docosenoic acid (erucic acid, 22:1) [77, 79, 80], and Lunaria 
annua and Cardamine graeca are enriched in the C24 fatty acid 15-tetracosaenoic acid 
(nervonic acid, 24:1) [80, 81].  The high content of VLCFAs make Brassicaceae seed oils 
valued for industrial applications, such as lubricants and chemical feedstocks [82].  Apart 
from their high VLCFA content, Brassicaceae seed oils are composed of typical C16-C18 
saturated and unsaturated fatty acids. The only known exception to this among 
Brassicaceae are the seed oils of Physaria and Paysonia (formerly Lesquerella) species 
that contain 40% to 60% of the C20 ω-6 hydroxy fatty acid 14-OH-11-eicosenoic acid 
(lesquerolic acid) [83, 84].   
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More elaborately modified fatty acids, such as lesquerolic acid, often termed 
“unusual fatty acids”, occur in seed oils of diverse plant species [85, 86].  These include 
monohydroxy fatty acids such as ricinoleic acid (12-OH-9-octadecenoic acid) prevalent 
in castor bean (Ricinus communis) seeds, epoxy fatty acids such as vernolic acid (12-
epoxy-9-octadecenoic acid) enriched in Stoke’s aster (Stokesia laevis) seeds, and 
conjugated fatty acids such as eleostearic acid (9,11,13-octadecatrienoic acid) found in 
high amounts in tung (Vernicia fordii) seeds [85, 86].  The discovery of these and other 
unusual fatty acids has been facilitated by gas chromatography (GC), which has enabled 
rapid screening of fatty acid methyl esters prepared from seeds.  These analyses were 
largely conducted during the 1960s and 1970s.  Since this time, very few “new” unusual 
fatty acids have been identified as major components of seed oils.  Many unusual fatty 
acids have considerable economic potential for a range of industrial uses [82].  However, 
most plants that make unusual fatty acids often have limited agronomic potential without 
extensive breeding efforts.  As a result, these plants have been used as sources of genes 
that can be transferred to established oilseed crops to generate novel oil functionalities 
[87].  In addition, the enzymes that make unusual fatty acids are divergent forms of 
widely-occurring fatty acid modification enzymes, such as fatty acid desaturases, and 
have proven to be valuable biochemical tools for understanding variant enzyme substrate 
specificities and reaction chemistries through heterologous expression (e.g., [88-90]). 
2.2 Materials and Methods 
1H, 13C, DEPT, COSY, HSQC, HMBC, and NOESY NMR spectra were recorded 
on a Bruker Avance-II NMR spectrometer using CDCl3 as solvent; residual CHCl3 (1H, δ 
7.26; 500 MHz) and CDCl3 (13C, δ 77.0; 125 MHz) were used as the internal chemical 
shift references. 19F NMR Conditions: CDCl3 was used as the solvent and 
trifluorotoluene (-63.72 ppm) was used as an internal standard. Peak multiplicities and 
shapes were annotated as follows: s, singlet; d, doublet; t, triplet; q, quartet; quint, quintet; 
m, multiplet; br, broad. Infrared spectra were recorded as neat films on NaCl plates with a 
Fourier-transform infrared spectrophotometer (Nicolet Avatar 330). Mass spectra were 
collected with an Agilent 6520 Q-ToF mass spectrometer or GC/MS. 
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Dichloromethane (DCM) was dried by distilling from CaH2. Tetrahydrofuran 
(THF) and diethyl ether were distilled from sodium and benzophenone.  Benzene and 
hexanes were used as received.  Most reagents were procured from Aldrich. Acetic acid, 
hydrogen peroxide and borane-Me2S complex were purchased from Fisher Scientific. 
Basic Al2O3 (W200) was purchased from M. Woelm Eschwege, Germany. Dess-Martin 
periodinane (DMP) was synthesized by the method of Boeckman [91]. Silica gel for 
chromatography from Dynamic Absorbents (60-200 micron, #020311) was slurry packed 
for flash chromatography using the indicated solvent. All glassware was oven-dried at 
120 °C and reactions were run under nitrogen, unless otherwise noted.  Quenched 
reaction mixtures were concentrated using a rotary evaporator with a water bath at 25 °C 
– 45 °C, unless otherwise specified. 
2.2.1  GC/MS protocols for the structure elucidation of 7,18-(OH)2-24:2Δ15, 21 
GC/MS analyses were performed using five methods with an Agilent 7890A 
GC/5975C MS using helium (99.99% UHP) as the carrier gas.  The column and oven 
programs for each method are detailed below.  
2.2.1.1  FAME and pyrrolidide GC/MS methods 
FAME analysis and pyrrolidide analysis were suspended in ACN and analyzed 
with a HP-5 (30 m x 250 µm x 0.25 µm) column, using oven programs GC1 and GC2, 
respectively (Figure 8). Samples were also silylated and run under the same conditions. 
 
Figure 8: GC oven programs for non-silylated and silylated FAME (GC1) and pyrrolidide 
analyses (GC2). 
 
150	°C,	3	min 
10	°C/min 
300	°C,	14	min GC2:	Pyrrolidide	Analysis 
100	°C,	3	min 10	°C/min 
200	°C,	3	min 2.5	°C/min	 
300	°C,	4	min GC1:	FAME	Analysis 
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GC/MS parameters were as follows:  
• Split-Splitless Inlet: Splitless 
• Inlet temperature: 250 °C 
• Pressure: 16.834 psi 
• Septum purge flow: 3 mL/min 
• He flow rate: 1.56 mL/min for 32 min 
The scan parameters were as follows: 
• Solvent Delay: 6 min 
• Scan Speed: Normal  
• Start Mass: 50.00 amu; Stop Mass: 800.00 amu 
• Threshold: 150; Scans/sec: 1.99 
2.2.1.2 Metathesis and racemic 3-cyclohexen-1-ol GC/MS methods 
Silylated metathesis products and silylated achiral 3-cyclohexen-1-ol were 
analyzed using a VF23-MS column (Varian; 30 m x 250 µm x 0.25 µm). Oven programs 
shown in Figure 9. 
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Figure 9: GC oven programs for silylated metathesis products (GC3) and silylated 
racemic 3-cyclohexen-1-ol (GC4).  
 
GC/MS parameters were as follows:  
• Split at a ration of 7:1 
• Inlet Temperature: 250 °C 
• Pressure: 15.236 psi 
• Septum Purge Flow: 3mL/min 
• He Flow Rate: 1.9 mL/min; 29.6 min 
  
GC3:	Metathesis	Products	
40	°C,	3	min		
10	°C/min	
150	°C,	5	min	 10	°C/min	
220	°C,	1	min	
50	°C/min	
250	°C,	2	min	
GC4:	Racemic	3-cyclohexen-1-ol 
40	°C,	5	min	 10	°C/min 
150	°C,	5	min 10	°C/min 
220	°C,	1	min 50	°C/min 
250	°C,	2	min 
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Scan Parameters were as follows 
• Solvent Delay: 3 min 
• Scan Speed: Normal 
• Start Mass: 50.00 amu; Stop Mass: 550.00 amu 
• Threshold: 150; Scans/sec: 1.99 
2.2.1.3 GC/MS method for chiral separations 
The separation of the enantiomers of 3-cyclohexen-1-ol was achieved using a 
Beta DEX 120 column (Supelco; 30 m x 250 µm x 0.25 µm column). Oven programs 
depicted in Figure 10.   
 
 
Figure 10: Oven programs for silylated racemic and enantioenriched 3-cyclohexen-1-ol 
(GC5). 
 
GC/MS parameters were as follows:  
• Split-Splitless Inlet: Splitless  
• Inlet Temperature: 200 °C  
• Pressure: 4.3792 psi 
• Septum Purge Flow: 3 mL/min  
• He Flow Rate: 0.659 mL/min for 30 min 
 
Scan parameters were as follows:  
• Solvent Delay: 6 min 
• Scan Speed: Normal 
30	°C/min	
70	°C,	15	min	
220	°C,	5	min	
50	°C/min	
70	°C,	2	min	
GC5:	Deriva6ves	of	3-Cyclohexen-1-ol	
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• Start Mass: 50.00 amu; Stop Mass: 800.00 amu 
• Threshold: 150; Scans/sec: 1.99  
2.2.2  Isolation of 7,18-(OH)2-24:2Δ15,21 from seed oil 
Seed oil (0.8918 g) was dissolved in 2.5% H2SO4 in methanol. The solution was 
homogenized in the vial and heated at 80 °C for 1 h. The dark green solution was cooled 
to room temperature, and the reaction was quenched with H2O (2 mL). Hexanes (2 x 1 
mL) was added, the mixture was vortexed, centrifuged, and organic layer removed. Crude 
FAMEs were concentrated under a stream of N2.  The oil was purified by SiO2 flash 
chromatography with hexane: Et2O: acetic acid (40:60:1) (Rf = 0.25) to yield 36% 
(0.3207 g). IR (neat) 𝑣 3385, 3005, 2929, 2855, 1740, 1653, 1456, 1437, 1363, 1259, 
1200, 1173, 1065, 1016, 870; 1H NMR (500 MHz, CDCl3) δ 5.53 (m, 2H), 5.38 (m, 1H), 
5.26 (m, 1H), 3.66 (s, 3H), 3.14 (d, J = 6.6 Hz, 2H), 2.47 (t, J = 7.4 Hz, 2H), 2.39 (m, 
4H), 2.29 (t, J = 7.3 Hz, 2H), 2.03 (m, 3H), 1.59 (m, 8H), 1.25-1.34 (m, 13H), 0.95 (t, J = 
7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 174.2, 133.5, 132.2, 128.5, 125.0, 71.8, 71.1, 
51.4, 37.5, 37.2, 36.7, 35.4, 34.0, 29.6, 29.4, 29.3, 29.19, 29.15, 27.4, 25.6, 25.3, 24.9, 
23.5, 20.5, 14.3 ; HRMS (ESI) m/z calcd for [M + H+] C25H47O4 411.3474, found 
411.3472. 
2.2.3  Derivatives of 7,18-(OH)2-24:2Δ15,21 
Fatty Acid Pyrrolidides (6):  In a conical vial, 1a/2a (ca. 1 mg) was 
azeotropically dried with benzene (3 x 1 ml) under a stream of N2.  The residue was then 
incubated with pyrrolidine (4.2 µL) and glacial acetic acid (2 µL) in a heating block at 80 
°C for 1 h.  After cooling, H2O (1 mL) and diethyl ether/hexane (1:1, 3 mL) were added.  
The mixture was thoroughly extracted by vortex mixing and centrifugation.  The 
resulting organic layer was washed twice with H2O (1 mL), the solvent evaporated was 
under a stream of N2, and the pyrrolidides were redissolved in 1 mL of hexane for 
GC/MS analysis (Method GC2). 
Silylation of Intact Fatty Acid Pyrrolidides (6a):  For the conversion of 6 to a 
TMS derivative, the hexane was removed from the alcohol and then BSTFA + 2% 
TMSCl (100 µL) was added to the vial. After overnight stirring at room temperature, the 
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silylating reagent was eliminated with a stream of N2.  The bis(silyloxy) derivative was 
analyzed as a solution in 200 µL of hexanes solution by GC-MS (Method GC2). 
Diketone (5):  In a 5-mL vial, a mixture of 1a/2a (1.8 mg, 4.5 mmol) was 
dissolved in CH2Cl2 and Dess-Martin reagent (4.0 mg, 9.4 mmol, 2.1 equiv) was added.  
After stirring for 2 h at room temperature, the solvent was removed by rotary evaporation.  
The crude product was dissolved in 5 mL hexanes and the solution was run through a 
SiO2 column constructed from a Pasteur pipette. The column was washed with hexane (2 
mL) and the hexane was removed under reduced pressure.  IR (neat) 𝑣 3008, 2930, 2855, 
1738, 1715, 1653, 1558, 1457, 1436, 1411, 1362, 1199, 1171, 1101, 665; 1H NMR (500 
MHz, CDCl3) δ 5.56 (dtt, J = 1.63, 7.5, 11 Hz, 1H), 5.39 (m, 1H), 5.37 (m, 1H), 5.34 (m, 
1H), 3.66 (s, 3H), 3.63 (m, 1H), 3.57 (m, 1H), 2.31 (t, J = 7.5 Hz, 2H), 2.22 (t, J = 6.5 Hz, 
2H), 2.13-2.16 (m, 2H), 2.05 (m, 4H), 1.63 (quint, J = 7.5 Hz, 2H), 1.53 (m, 2H), 1.37-
1.47 (m, 6H), 1.26-1.36 (m, 12H); 13C NMR (125 MHz, CDCl3) δ 211.2, 208.4, 174.0, 
133.7, 132.9, 127.1, 120.9, 51.5, 42.8, 42.4, 42.2, 41.8, 33.8, 31.6, 29.3, 29.2, 29.1, 28.7, 
27.5, 24.7, 23.8, 23.4, 21.6, 20.5, 14.3; HRMS (ESI) m/z calcd for [M + H]+ C25H42O4 
407.3156, found 407.3154. 
2.2.4  Configuration of C-18 in 7,18-(OH)2-24:2Δ15,21 
Fragmentation of 2b by Alkene Metathesis:  Ester 2b (ca. 1 mg) was dissolved 
in a dry CH2Cl2:2-methyl-2-butene mixture (1:1, 1 mL) before a CH2Cl2 solution of 
second-generation Grubbs catalyst (Aldrich 569747, 3.2 mg/ml, 60 µL) was added. The 
solution was stirred at room temperature overnight.  Activated carbon (100 mg) was 
added to absorb the catalyst; the suspension was stirred for 10 min before the mixture 
was filtered through silica gel, rinsing the absorbent with CH2Cl2:Et2O (1:1). A solution 
of BSTFA + 2% TMSCl agent (200 µL) was added to the solution, which was stirred at 
room temperature for 2 h to silylate the metathesis products.  GC/MS analysis was 
carried out using method GC3 for 9 and methods GC4 and GC5 for 10.  
Racemic 3-cyclohexen-1-ol (9b):  This procedure is based on the work of 
Donohoe [92].  All glassware was washed with 1 M NaOH, rinsed with H2O, and oven-
dried at 120 °C.  To a round-bottomed flask containing 1,4-cyclohexadiene (0.47 mL, 5 
mmol, 1.0 equiv) and dry THF (5 mL), 9-BBN (0.5 M in THF, 10 mL, 5 mmol, 1.0 
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equiv) was added dropwise. The solution was stirred at room temperature overnight.  The 
reaction was quenched by the sequential dropwise addition of NaOH solution (3 M, 1.5 
mL) and H2O2 (30% (v/v), 1.5 mL).  The resulting solution was heated to reflux for 1 h, 
cooled, and then poured into brine (25 mL).  The product was extracted with ether (2 x 25 
mL), dried with MgSO4, and the solvent was removed with a rotary evaporator until ~1 
mL remained.  Alcohol 9b was purified by SiO2 flash chromatography (pentane:Et2O, 
2:1). A solution of BSTFA + 2% TMSCl agent was added and the resulting mixture was 
stirred at room temperature for 2 h to provide racemic 9b, which was analyzed by 
GC/MS (Methods GC4 and GC5) without further purification.   
(R)-3-Cyclohexen-1-ol ((R)-9):  Using a method modified from Brown [93], 
diisopinocampheylborane was prepared by the dropwise addition (S)-(-)-α-pinene (7.8 
mL, 49.1 mmol, 2.0 equiv) to a stirred cooled solution of BMS(CH3)2S (2.4 mL, 25.0 
mmol) and 9 ml of THF at 0°C, and the mixture was allowed to react for 3 h.  In a 
separate flask, 1,4-cyclohexadiene (0.47 mL, 5 mmol, 1.0 equiv) was cooled to 0 °C and 
then a portion of the diisopinocampheylborane solution (1.8 mL, 5 mmol) was added 
dropwise.  The solution was stirred at 0 °C for 2 h and then maintained at 4 °C in a 
refrigerator for approximately 18 h. Sodium hydroxide (3 M, 1.5 mL) was added 
followed by the dropwise addition of H2O2 (30% w/v, 1.5 mL).  The solution was heated 
to reflux for 1 h and then cooled to room temperature before pouring into 25 ml of brine.  
The reaction mixture was extracted with ether (2 x 25 mL) and the separated organic 
phase dried with MgSO4 before the solvent was carefully evaporated with a rotary 
evaporator until ~1 mL remained.  The crude solution was purified by silica gel flash 
chromatography (pentane:Et2O, 2:1).  An aliquot of the alcohol was derivatized to 
enantioenriched 9a with BSTFA + 2% TMSCl agent at room temperature for 1 h and the 
product was analyzed without further purification.  
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2.2.5 Route 1 for the attempted synthesis of 7,18-(OH)2-24:2Δ15,21 
 
 
 
 2-Oxocanone (11): Using the method from Kai [94], cycloheptanone (2.6454 g, 
23.58 mmol) was stirred in DCM (as-received, 75 mL).  Solid 77% m-CPBA (5.5825 g, 
24.91 mmol, 1.05 equiv) was added to the ketone solution and the reaction was allowed 
to proceed at room temperature for 5 days. The reaction was quenched and the organic 
layer was washed with saturated NaHCO3 (4 X 100 mL), followed by H2O (200 mL). 
The DCM solution was dried with Na2SO4 prior to being concentrated under reduced 
pressure, and being carried on to the next step.  
 
 
 
Methyl 7-hydroxyheptanoate (12): Lactone 11 (~23 mmol) was dissolved in 33 
mL methanol. H2SO4 (220 µL) was added and the reaction was stirred for 15 h at room 
temperature. The solvent was removed and the residue dissolved in diethyl ether (35 mL). 
The organic layer was washed with H2O (2 x 35 mL) and dried with Na2SO4. Ether was 
removed to yield methyl 7-hydroxyheptanoate (0.8277 g, 22% yield). 1H NMR (500 
MHz, CDCl3) δ 3.67 (s, 3H), 3.64 (t, J = 6.5 Hz, 2H), 2.31 (t, J  = 7.5 Hz, 2H), 1.64 
(quint, J = 7.4 Hz, 2H), 1.57 (quint, J = 6.9 Hz, 2H), 1.34-1.37 (m, 4H); 13C NMR (125 
MHz, CDCl3) δ 174.3, 63.0, 51.6, 34.1, 32.7, 29.0, 25.5, 25.0. 1H and 13C spectral data 
were similar to that previously reported [94]. 
 
Cycloheptanone 11
O
O
O
O OH
12
O
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O
O
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 Methyl 7-oxoheptanoate (13): Pyridinium dichromate (18.5051 g, 49.2 mmol, 
1.5 equiv) and Celite (6.6322 g) were suspended with the aid of a magnetic stirrer in 53 
mL of DCM.  Methyl 7-hydroxyheptanoate, dissolved in DCM (10 mL), was added 
dropwise via an addition funnel and reaction was allowed to stir for 4 h at room 
temperature. The solvent was removed and the crude product was purified by column 
chromatography with hexane: EtOAc (4:1) to yield methyl 7-oxoheptanoate (2.2486 g, 
43%). 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.5 Hz, 1H), 3.67 (s, 3H), 2.44 (td, J = 
7.3, 1.5 Hz, 2H), 2.32 (t, J = 7.5 Hz, 2H), 1.65 (quint, J = 7.5 Hz, 4H), 1.36 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 202.5, 174.0, 51.6, 43.8, 33.9, 28.7, 24.8, 21.8. 1H and 13C 
spectral data were similar to that previously reported [94]. 
 
 
 
Methyl 7-octenoate (14): 7-Octenoic acid (0.1842 g, 1.30 mmol) was dissolved 
in methanol (0.284 mL, 5.4 equiv).  H2SO4 (29 µL, 0.54 mmol, 0.42 equiv) was added to 
initiate the reaction and the solution was stirred overnight. The reaction was quenched 
with H2O and allowed to stir for 5 minutes. The solution was extracted twice with diethyl 
ether, dried with MgSO4, and the solvent was removed to yield methyl 7-octenoate 
(0.1990 g, 98%). 1H NMR (500 MHz, CDCl3) δ 5.80 (ddt, J = 14, 10, 6.5 Hz, 1H), 4.99 
(dq, J = 17, 1.5 Hz, 1H), 4.94 (br d, J = 10 Hz, 1H), 3.67 (s, 3H), 2.31 (t, J = 7.5 Hz, 2H), 
2.05 (q, J = 7 Hz, 2H), 1.63 (quint, J = 7.5 Hz, 2H), 1.36 (m, 4H); 13C NMR (125 MHz, 
CDCl3) δ 174.4, 139.0, 114.5, 51.6, 34.2, 33.7, 28.7, 28.6, 25.0. 1H and 13C spectral data 
were similar to that previously reported [95]. 
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 Methyl 7,8-epoxyoctanoate (15):  In DCM (2.2 mL), methyl oct-7-enoate 
(0.0955 g, 0.6112 mmol) was dissolved followed by m-CPBA (77%, 0.2054 g, 0.9168 
mmol, 1.5 equiv).  The sides of the vial were washed with DCM (1 mL). The reaction 
was stirred at room temperature for 24 h before being quenched with saturated NaHCO3. 
The mixture was extracted with DCM and washed with saturated NaHCO3 (x5). The 
solvent was removed to yield methyl 7,8-epoxyoctanoate (0.0802 g, 0.4656 mmol, 76%). 
1H NMR (500 MHz, CDCl3) δ 3.67 (s, 3H), 2.90 (m, 1H), 2.74 (t, J = 4.5 Hz, 1H), 2.46 
(dd, J = 3, 5 Hz, 1H), 2.32 (t, J = 7.5 Hz, 2H), 1.65 (quint, J = 7.6 Hz, 2H), 1.56 – 1.37 
(m, 6H); 13C NMR (125 MHz, CDCl3) δ 174.3, 52.4, 51.6, 47.2, 34.1, 32.4, 29.1, 25.8, 
25.0. 1H and 13C spectral data were similar to that previously reported [96]. 
 
 
 
 8-Bromooctanal (16): Pyridinium dichromate (1.4379 g, 3.82 mmol, 1.5 equiv) 
and Celite (0.5254 g) were suspended in DCM (5 mL). 8-Bromooctanol (0.5323 g, 2.55 
mmol) was dissolved in DCM (1 mL) and added dropwise to the stirring suspension. 
During the course of the addition, the solution turned a dark brown color and was allowed 
to continue stirring at room temperature for 4 h. The solution was decanted from the tarry 
solid and was then purified via column chromatography with hexane: EtOAc (4:1) to 
yield 8-bromooctanal (0.5215 g, 98%). 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.8 Hz, 
1H), 3.40 (t, J = 6.8 Hz, 2H), 2.43 (td, J = 7.3, 1.8 Hz, 2H), 1.85 (quint, J = 7.1, 2H), 1.63 
(m, 2H), 1.43 (m, 2H), 1.35 (m, 4H). 1H spectral data was similar to that previously 
reported by [97]. 
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10-Bromo-2-methyldec-2-ene (17): Isopropyltriphenylphosphonium iodide 
(1.1289 g, 2.63 mmol, 1.05 equiv) was suspended in dry diethyl ether (13 mL). Potassium 
tert-butoxide (0.2820 g, 2.50 mmol, 1 equiv) was added and the reaction mixture 
immediately turned dark orange. The reaction was allowed to stir at room temperature for 
30 min. The aldehyde 16 (0.5215 g, 2.51 mmol, 1 equiv) was dissolved in dry ether (0.5 
mL) and added to the dark orange solution leading to the formation of a white precipitate. 
The suspension was stirred at room temperature for 2.5 h. The reaction was quenched 
with H2O (10 mL) and extracted with diethyl ether (20 mL). The solvent was removed 
from the organic layer and the crude product was purified by column chromatography 
with pentane: Et2O (5:1) to yield give a clear oil, 10-bromo-2-methyldec-2-ene (0.2465 g, 
42%). 1H NMR (500 MHz, CDCl3) δ 5.10 (t, J = 7.2 Hz, 1H), 3.40 (t, J = 6.9 Hz, 2H), 
1.96 (m, 2H), 1.85 (quint, J = 7.2 Hz, 2H), 1.68 (s, 3H), 1.59 (s, 3H), 1.43 (m, 2H), 1.29-
1.35 (m, 6H). 
2.2.6 Route 2 for the synthesis of 7,18-(OH)2-24:2Δ15,21 
 
 
 
(8-Bromooctoxy)(tert-butyl)dimethylsilane (19): 8-Bromooctanol (8.3876 g, 
40.12 mmol) was dissolved in DCM (200 mL) and the cooled to 0 °C with an ice-water 
bath. Imidazole (13.6546 g, 200.57 mmol, 5 equiv) and TBDMSCl (12.3346 g, 81.84 
mmol, 2 equiv) were added followed by a catalytic amount of DMAP (0.4878 g, 3.99 
mmol, 0.1 equiv).  The solution was stirred at room temperature for 24 h. The reaction 
was quenched with saturated NH4Cl, extracted with dichloromethane, and the solvent 
was removed. The product was purified via column chromatography with hexane: EtOAc 
(50:1) to yield (8-bromooctoxy)(tert-butyl)dimethylsilane (10.4518 g, 81%). 1H NMR 
(500 MHz, CDCl3) δ 3.60 (t, J = 6.5 Hz, 2H), 3.40 (t, J = 6.7 Hz, 2H), 1.85 (quint, J = 7 
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Hz, 2H), 1.51 (m, 2H), 1.42 (m, 2H), 1.31 (m, 6H), 0.89 (s, 9H), 0.05 (s, 6H); 13C NMR 
(125 MHz, CDCl3) δ 63.4, 34.1, 33.0, 29.4, 29.0, 28.9, 28.3, 26.1, 25.9, 18.5, -5.1. 1H and 
13C spectral data were similar to that previously reported [98]. 
 
 
 
(8-Iodooctoxy)(tert-butyl)dimethylsilane (20): The protected bromooctanol 19 
(10.4518 g, 32.34 mmol) was dissolved in acetone (86 mL). Potassium iodide (26.8401 g, 
161.69 mmol, 5 equiv) was added and reaction was stirred at reflux for 18 h. After 
cooling to room temperature, the reaction mixture was filtered over Celite and the solvent 
was removed to yield (8-Iodooctoxy)(tert-butyl)dimethylsilane (10.7604 g, 89%), that 
was used as without further purification. 1H NMR (500 MHz, CDCl3) δ 3.60 (t, J = 6.5 
Hz, 2H), 3.19 (t, J = 7.3 Hz, 2H), 1.82 (quint, J = 7 Hz, 2H), 1.51 (m, 2H), 1.39 (m, 2H), 
1.31 (m, 6H), 0.89 (s, 9H), 0.05 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 63.2, 33.6, 32.8, 
30.5, 29.2, 28.5, 26.0, 25.7, 18.4, 7.2, -5.3. 1H and 13C spectral data were similar to that 
previously reported [98]. 
 
 
 
Methyl 2-oxocycloheptanecarboxylate (21):  NaH (60% w/w suspension in 
mineral oil, 3.4763 g, 86.93 mmol, 1.9 equiv) was suspended in an ether (12 mL) solution 
of dimethyl carbonate (7.5 mL, 89.0 mol, 2 equiv). Cycloheptanone (5.3 mL, 45.0 mmol) 
was added dropwise to the suspension and allowed to stir at room temperature for 6 h. 
The solution was cooled in 0 °C and glacial acetic acid was added dropwise, followed by 
the slow addition of cold H2O. The solution was extracted with diethyl ether and washed 
with brine (2 x 10 mL).  The extract was dried with MgSO4, filtered, and the solvent was 
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removed. The product was purified by Kugelrohr distillation to yield methyl 2-
oxocycloheptanecarboxylate (2.1252 g, 28%). 1H and 13C spectral data were similar to 
that previously reported [99].  
 
 
 
Methyl 1-(8-(tert-butyldimethylsiloxy)octyl)-2-oxocycloheptane-1-carboxylate 
(22): Methyl 2-oxocycloheptanecarboxylate (0.3737 g, 2.20 mmol, 1 equiv) and (8-
iodooctoxy)(tert-butyl)dimethylsilane (20) (1.3176 g, 3.56 mmol 1.6 equiv) were 
dissolved in acetone (5.2 ml). Ce2CO3 (2.1487 g, 6.59 mmol, 3 equiv) was added and the 
reaction was heated at reflux (66 °C) for 16 h. The reaction was cooled to room 
temperature, filtered through Celite, and the solvent was removed. The crude product was 
purified via column chromatography with hexane: EtOAc (5:1) to yield Methyl 1-((8-
(tert-butyldimethylsiloxy)octyl)-2-oxocycloheptane-1-carboxylate (0.8914 g, 98%). IR 
(neat) 𝑣 2929, 2856, 1741, 1714, 1457, 1255, 1222, 1099, 836, 776; 1H NMR (500 MHz, 
CDCl3) δ 3.71 (s, 3H), 3.59 (t, J = 6.5 Hz, 2H), 2.60 (m, 1H), 2.48 (m, 1H), 2.14 (m, 1H), 
1.95 (m, 1H), 1.43-1.72 (m, 12H), 1.27 (m, 6H), 1.19 (m, 2H) 0.89 (s, 9H), 0.04 (s, 6H); 
13C NMR (125 MHz, CDCl3) δ 209.8, 173.2, 63.4, 52.2, 42.2, 35.6, 30.5 33.0, 32.9, 30.14, 
30.12, 29.5, 29.4, 26.1, 25.9, 25.8, 25.1, 24.7, 18.5, -5.1.  HRMS (ESI) m/z calcd for [M 
+ H]+ C23H45O4Si 413.3087, found 413.3097. 
 
 
 
2-(8-(tert-Butyldimethylsiloxy)octyl)cycloheptan-1-one (23): Using a method 
modified from Carling [99], the cycloheptanone derivative 22 (0.8914 g, 2.16 mmol) was 
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dissolved in DMSO (2.5 mL). Lithium chloride (0.2789 g, 6.58 mmol, 3 equiv) and water 
(58 µL, 3.22 mmol, 1.5 equiv) were added. The reaction was heated at 120 °C for 2 h. 
The solution was cooled to room temperature, extracted with pentane, and washed with 
brine. The organic layer was dried with MgSO4. The solvent was removed to yield 2-(8-
(tert-butyldimethylsiloxy)octyl)cycloheptan-1-one (0.5638 g, 74%). IR (neat) 𝑣  2928, 
2855, 1704, 1462, 1255, 1099, 835, 775; 1H NMR δ (500 MHz, CDCl3) 3.59 (t, J = 6.8 
Hz, 2H), 2.38-2.53 (m, 3H), 1.85 (m, 3H), 1.53-1.67 (m, 3H), 1.49 (quint, J = 6.8 Hz, 
2H), 1.25-1.38 (m, 14H), 0.89 (s, 9H), 0.04 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 216.7, 
63.3, 52.4, 42.6, 32.9, 32.4, 31.3, 29.7, 29.6, 29.5, 29.4, 28.4, 27.2, 25.8, 25.6, 24.7, 18.4, 
-5.3. m/z 75, 131, 201 
 
 
 
8-Trifluoroacetoxyoctyl-2-oxocanone (24): The TBDMS-protected 2-(8-tert-
butyldimethylsiloxyoctanyl)cycloheptanone 23 (0.0403 g, 0.11 mmol) was dissolved in 
DCM (1.5 mL). Urea hydrogen peroxide complex (0.1069 g, 1.14 mmol, 10 equiv) was 
added followed in dropwise fashion by trifluoroacetic anhydride (40 µL, 0.28 mmol, 2.4 
equiv). The reaction was stirred at room temperature overnight before being quenched 
with saturated NaHCO3. DCM (5 mL) was added and the organic layer was extracted. 
The solvent was removed. The product was purified via column chromatography with 
hexane: EtOAc (20:1) to yield 8-trifluoroacetoxyoctyl-2-oxocanone (0.0215 g, 54%). IR 
(neat) 𝑣 2932, 2859, 1786, 1729, 1461, 1403, 1352, 1221, 1166, 1006, 777, 731 ; 1H 
NMR (500 MHz, CDCl3) δ 4.53 (m, 1H), 4.34 (t, J = 6.7 Hz, 2H), 2.43-2.56 (m, 2H), 
1.90 (m, 1H), 1.82 (m, 1H), 1.55-1.78 (m, 6H), 1.40-1.54 (m, 4H), 1.22-1.40 (m, 10H); 
13C NMR (125 MHz, CDCl3) δ 176.9, 157.6 (q, J = 41.8 Hz), 114.5 (q, J = 283.7 Hz), 
78.8, 68.2, 37.3, 35.6, 32.5, 31.6, 29.2, 28.9, 28.8, 28.1, 26.4, 25.7, 25.4, 23.9. m/z 98, 
127 
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Methyl 7,15-dihydroxypentadecanoate (25): A solution of trifluoroacetate 24 
(0.1778 g, 0.50 mmol) in MeOH (0.5 mL) was prepared to which a solution of 24% 
tetramethylammonium hydroxide (0.5 mL) in methanol was added; the reaction was 
stirred at room temperature for 18 h. To this crude solution of the intermediate 
carboxylate salt, dimethylformamide (DMF) (5 mL) and methyl iodide (0.5 mL) were 
added and the mixture was then stirred until a precipitate formed (~20 min). The product 
was extracted from the reaction milieu with ethyl acetate and the collected organic layers 
were washed with water:brine (1:1) several times until all the DMF was removed. The 
product was purified via column chromatography with hexane: EtOAc (3:1) to yield 
methyl 7,15-dihydroxypentadecanoate (0.0871 g, 60%). IR (neat) 𝑣 3358, 2929, 2855, 
1739, 1462, 1439, 1353, 1260, 1199, 1172, 1109, 1056, 883, 801, 723, 672; 1H NMR 
(500 MHz, CDCl3) δ 3.67 (s, 3H), 3.64 (t, J = 6.7 Hz, 2H), 3.57 (m, 1H), 2.31 (t, J = 7.5, 
2H), 1.64 (quint, J = 7.4 Hz, 2H), 1.56 (quint, J = 6.9, 2H), 1.27-1.45 (m, 12H); 13C NMR 
(125 MHz, CDCl3) δ 174.3, 71.9, 63.1, 51.5, 37.5, 37.2, 34.0, 32.8, 29.6, 29.5, 29.3, 29.2, 
25.7, 25.6, 25.3, 24.9. 
 
 
 
 Methyl 7-hydroxy-15-oxopentadecanoate (26): Methyl 7,15-
dihydroxypentadeceanoate (0.0404 g, 0.14 mmol) was dissolved in DCM (1.2 mL). 
TEMPO (0.0022 g, 0.014 mmol, 0.1 equiv) and (diacetoxyiodo)benzene (0.0519 g, 0.16 
mmol, 1.15 equiv) were added to the mixture. The reaction stirred at room temperature 
for 2.5 h. The mixture was diluted with DCM (5 mL) and the reaction was then quenched 
with saturated Na2S2O3 The solution was extracted with DCM and washed with brine. 
The organic layer was dried with Na2SO4 and the solvent was removed. The product was 
purified via column chromatography with hexane: EtOAc (3:1) to yield methyl 7-
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hydroxy-15-oxopentadecanoate (0.0313 g, 73%). IR (neat) 𝑣 3446, 2930, 2855, 1734, 
1700, 1684, 1653, 1559, 1540, 1521, 1456, 1436, 1418, 1172, 1012, 668; 1H NMR (500 
MHz, CDCl3) δ 9.76 (t, J = 2 Hz, 1H), 3.67 (s, 3H), 3.57 (m, 1H), 2.42 (td, J = 7.4, 1.8 
Hz, 2H), 2.31 (t, J = 7.5 Hz, 2H), 1.64 (m, 4H), 1.37-1.48 (m, 6H), 1.29-1.36 (m, 10H); 
13C NMR (125 MHz, CDCl3) δ 202.8, 176.0, 71.8, 51.5, 43.9, 37.5, 37.3, 34.0, 29.4, 29.3, 
29.2, 29.1, 25.5, 25.3, 24.9, 22.0. 
 
 
 
Methyl (E)-7-hydroxy-16-methylheptadeca-2,15-dienoate (10b): Isopropyl 
triphenylphosphonium iodide (0.0996 g, 0.230 mmol, 2.1 equiv) was suspended in THF 
(0.95 mL). The solution was cooled to 0 °C and n-butyllithium (0.12 mL, 0.234 mmol, 
2.15 equiv) was added dropwise. The dark red solution was cooled to -78 °C with a dry 
ice/acetone bath. Aldehyde 26 (0.0313, 0.11 mmol) dissolved in THF (0.3 mL) was 
added slowly. The solution was stirred in the acetone bath slowly warming for 1 h to 0 °C 
prior to being quenched with saturated NaHCO3. The THF layer was isolated. The 
aqueous layer was then extracted with diethyl ether, the organic layers were combined, 
and the solvent was removed. The product was purified via column chromatography with 
hexane: EtOAc (10:1 to 5:1 to 3:1) to yield methyl (E)-7-hydroxy-16-methylheptadeca-2, 
15-dienoate (0.0056 g, 16%). IR (neat) 𝑣 420, 2927, 2854, 1741, 1456, 1436,1375, 1258, 
1199, 1172, 1105, 1014; 1H NMR (500 MHz, CDCl3) δ 5.12 (t, J = 6.7 Hz, 1H), 3.66 (s, 
3H), 3.57 (m, 1H), 2.31 (t, J = 7.5 Hz, 2H), 1.95 (m, 2H), 1.68 (s, 3H), 1.63 (m, 2H), 1.59 
(s, 3H), 1.28-1.46 (m, 18H); 13C NMR (125 MHz, CDCl3) δ 174.2, 131.1, 124.9, 71.9, 
51.4, 37.5, 37.2, 34.0, 29.9, 29.7, 29.5, 29.3, 29.2, 28.0, 25.7, 25.6, 25.3, 24.9, 17.6. m/z 
312, 294, 159, 69 
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2.2.7  Configuration of C-7 in 7,18-(OH)2-24:2Δ15,21 
 
 
 
Methyl 7-hydroxy-16-methylheptadec-15-enoate (10): Ester 2a (0.2349 g, 
0.572 mmol) was dissolved in a dry CH2Cl2:2-methyl-2-butene mixture (1:1, 10 mL). 
The solution was sparged with nitrogen before second-generation Grubbs catalyst 
(0.0195 g, 0.022 mmol, 0.04 equiv) was added. The solution was stirred at room 
temperature for 16 h under nitrogen.  Activated carbon was added to absorb the catalyst; 
the suspension was stirred for 10 min before the mixture was filtered through silica gel, 
rinsing the packing with CH2Cl2: Et2O (1:1). The solvent was removed and the crude 
product was purified by SiO2 flash chromatography with hexane: EtOAc (3:1) to yield 10 
(0.1251 g, 70%). Spectral data matches previous reported from earlier in the materials 
and methods above.  
 
 
 
Methyl (E)-14-(3,3-dimethyloxiran-2-yl)-7-hydroxytetradec-2-enoate (27): 
Sodium bis(trimethylsilyl)amide (0.6 M in THF, 2.6 mL, 1.535 mmol, 6.2 equiv) was 
cooled to -78 °C with an acetone/dry ice bath. Ester 10 (0.0774 g, 0.2476 mmol) was 
azeotropically dried twice with benzene before being dissolved in THF (1 mL) and added 
to the cooled sodium bis(trimethylsilyl)amide solution. The reaction mixture was stirred 
for 30 minutes at -78 °C and then a solution of phenylselenyl chloride (0.0584 g, 0.3049 
mmol, 1.2 equiv) in THF (1 mL) was added. After stirring for 1 h at -78 °C and then 
slowly being warmed to room temperature, the reaction was quenched with saturated 
NH4Cl and extracted with diethyl ether. The organic extract was dried with MgSO4,, 
filtered, and the solvent was removed by rotary evaporation. The crude α-phenylseleno 
intermediate was used in the next step without further purification. 
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  The α-phenylseleno intermediate was dissolved in DCM (5 mL) that had been 
passed through pipet column of Al2O3 prior to use.  The solution was cooled in an ice 
bath and 10% H2O2 (2.2 mL) added dropwise by pipet. The ice bath was removed and 
solution stirred for 1 h before being quenched with saturated NaHCO3. The solution was 
extracted with DCM and the organic layer was washed with brine, dried with MgSO4, 
filtered, and the solvent was removed with a rotary evaporator. The residual oil was 
purified by SiO2 flash chromatography with hexane: EtOAc, 3:1 to yield 27 (0.0185 g, 
25%). 1H NMR (500 MHz, CDCl3) δ 6.96 (dt, J = 15.7, 7 Hz, 1H), 5.82 (dt, J =15.6, 1.5 
Hz, 1H), 3.71 (s, 3H), 3.57 (m, 1H), 2.70 (t, J = 6.0 Hz, 1H), 2.22 (m, 2H), 1.24-1.53 (m, 
18H), 1.30 (s, 3H), 1.25 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 167.3, 149.4, 121.3, 71.8, 
64.7, 58.3, 51.5, 37.7, 37.0, 32.3, 29.69, 29.65, 29.5, 29.0, 26.7, 25.7, 25.0, 24.3, 18.9.  
 
Mosher Ester Analysis: This procedure was based on the work reported by Hoye [100]. 
Chloroform used in the reaction was purified by passage through a pipet column with 
basic Al2O3. Stock solutions were made for all reagents to facilitate reagent handling; 
their concentrations were approximately 0.2 M starting material, 0.9 M 4-
dimethylaminopyridine (DMAP), and  0.4 M for N, N'-dicyclohexylcarbodiimide and 
either (R)- or (S)-α-methoxy-α-trifluoromethylphenylacetic acid. Two reactions were run 
in parallel:  the starting alcohol (ca. 5 mg) and one of the (R)- or (S)-α-methoxy-α-
trifluoromethylphenylacetic acids (3.1 equiv) were stirred together in a small oven-dried 
vial. N, N'-Dicyclohexylcarbodiimide (3.1 equiv) was added followed by 4-
dimethylaminopyridine (1 equiv). The mixture was allowed to stir at room temperature 
overnight. As an initial cleanup, the esterification mixture was filtered through a paper-
plugged pipet and the solvent was removed. The crude product was purified by SiO2 flash 
chromatography with hexane: EtOAc, 10:1 (Rf = 0.38). 1H and 19F NMR spectra were 
collected of the esters; relevant data is described in the Results and Discussion section. 
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2.3  Results and Discussion 
2.3.1  Serendipitous discovery of novel oils in O. violaceus seeds 
Thin-layer chromatography (TLC) separation of neutral lipids from the seeds of 
several Brassicaceae species was conducted as part of a study to assess correlations 
between triacylglycerol fatty acid composition and vitamin E content of seeds.  O. 
violaceus was one species chosen because previous reports indicated that had an unusual 
seed oil, enriched in linoleic acid (18:2) and low in VLCFAs [35, 36].  Unexpectedly, O. 
violaceus seed extracts lacked a typical triacylglycerol (TAG) band on a silica TLC 
matrix using a neutral lipid solvent system (Figure 11A).  Abundant bands were instead 
detected with I2 near the origin of the TLC plate, suggesting that the oil contains fatty 
acids with greater polarity than those of fatty acids normally found in seeds of most 
plants.   Subsequent TLC separations using solvent systems with increased polarity 
revealed that O. violaceus seed oil had even less mobility than castor bean oil, which is 
enriched in TAG with three monohydroxy fatty acids (ricinoleic acid) (Figure 11B).   
Initial attempts to analyze the composition of O. violaceus seeds by GC indicated 
a fatty acid composition with a high 18:2 content, similar to published results [35, 36], 
but no apparent novel fatty acids.  Fatty acid profiles nearly identical to those of 
published results [35, 36] were observed even after silylation to enhance the mobility of 
potentially hydroxylated fatty acid methyl esters (FAMEs) (Figure 11C).  It was not until 
GC run times were extended beyond those required for resolution of C24 fatty acids that 
two abundant peaks (designated Peaks 1 and 2) eluted (Figure 11C).  These apparent 
FAMEs 1a and 2a, respectively, in a ratio of ~1:3 accounted for ~50 wt% of the total 
fatty acids.  The TLC-based oil profile and novel fatty acids were observed in multiple 
independent accessions of O. violaceus seeds. 
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Figure 11:  Analysis of O. violaceus seed oil.  A, B. TLC analyses of O. violaceus seed oil 
in solvent systems of different polarities.  TLC plates were developed in heptane:ethyl 
ether:acetic acid at ratios of 60:40:1 (v/v) in A and 40:60:1 (v/v) in B.  Shown for 
comparison are TLC analyses of Arabidopsis seed triacylglycerol (TAG), which lacks 
hydroxy fatty acids, and castor bean TAG, which is enriched in ricinoleic acid (OH-18:1), 
a monohydroxy fatty acid, and TAG species containing two (di-OH TAG) and three (tri-
OH-TAG) monohydroxy fatty acids. C. GC analyses using an extended run time of fatty 
acid methyl esters prepared from O. violaceus seeds without (-trimethylsilylation) or with 
trimethylsilyl derivatization (+trimethylsilylation). The novel silylated FAMES were 
initially named Peak 1 and Peak 2 consistent with their elution order. 
 
2.3.2 Structural identification of novel fatty acids from O. violaceus seeds 
GC-MS and NMR studies were undertaken to determine the chemical structures 
of the two abundant novel fatty acids.  Using a simple TLC method, FAMEs prepared 
from O. violaceus seeds were separated, and the novel FAMEs that displayed much 
higher polarities than typical FAMEs were purified from the TLC matrix.  GC-MS of the 
trimethylsilylated (TMS) novel FAMEs indicated that fragmentation of the Peak 1 
analyte ((TMS)2-1a) yielded ions identical to those corresponding to the ω-6 portion of 
the silylated methyl ester of ricinoleic acid, and fragmentation of the derivative in Peak 2 
((TMS)2-2a) generated a subset of ions differing by only two fewer mass units from the 
Peak 1 component as well as ions identical to those corresponding to the ω-6 portion of 
the methyl ester of silylated densipolic acid (Figure 12). The difference in two mass units 
indicated that the Peak 2 FAME has an additional double bond, most likely in the ω-3 
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position, relative to the Peak 1 FAME.  Apart from methyl-proximate fragments of the 
acyl chain that were identical to those formed from ω-6 hydroxylated fatty acids, the 
overall fragmentation patterns of silylated 1a and 2a suggested that the remainder of their 
structures is considerably larger than those of the known C18 and C20 monohydroxy fatty 
acids. 
 
 
Figure 12: GC-MS analysis of unusual fatty acids in O. violaceus seeds. Mass spectra of 
trimethylsilylated (TMS) fatty acid methyl esters for Peaks 1 (TMS-1a) (A) and 2 (TMS-
2a) (C) in the gas chromatogram in Figure 15C (lower panel).  For comparison, mass 
spectra are shown for TMS-methyl esters of ricinoleic acid (B) and densipolic acid (D). 
As shown, TMS-1a and TMS-2a contain ions consistent with fragmentation products 
containing ω-6 hydroxyl groups in mass spectra of TMS-methyl ricinoleic (m/z 187) and 
densipolic (m/z 185) acids, respectively. 
 
A similar approach to the initial purification was used to produce the methyl ester 
of 2a on a larger scale. FAMEs were prepared form O. violaceus seed oil. The crude 
material was purified by column chromatography with a solvent system of hexane: 
diethyl ether: acetic acid (40:60:1). The purified compound was found at an Rf of 0.25; 
removal of solvent allowed for further analysis. The methyl ester 2a provided a 
quasimolecular ion [M + H]+ with an m/z of 411.3472 consistent with the molecular 
formula C25H46O4 (calculated m/z 411.3469).  M-18 and M-36 water loss peaks in the ESI 
spectrum suggested the presence of two alcohols.  A functional group survey by IR 
spectroscopy indicated an OH stretching band at 3386 cm-1, alkene C-H, C-C and out-of-
plane bending stretches at 3005, 1653 cm-1 and 724 cm-1, respectively, a carbonyl stretch 
consistent with an ester at 1740 cm-1, and C-O stretches at 1199, 1171, and 1066 cm-1 for 
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methyl esters and secondary alcohols.  The 13C NMR and DEPT-135 spectra revealed 25 
different carbons (Table 1) including one quaternary, six methine, sixteen methylene, and 
two methyl groups.  The existence of two alkenes was established by the four 13C vinyl 
C-H resonances at 133.5, 132.2, 128.5 and 125.0 ppm.  With three oxygen-bearing 
carbons at δ 51.4, 71.1, and 71.8, and a carbonyl peak at 174.2 ppm, a formula of 
C25H46O4 was confirmed.   
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Table 1: NMR data for methyl wuhanate 2a 
Carbon 
# δ 13C δ 1H (m) J (Hz) DEPT 
1H-1H COSY 
Correlations 
13C-1H HMBC 
Correlations 
1' 51.4 3.66 s - CH3 H2w  
1 174.2 - - C  H1', H2, H3 
2 34.0 2.31 t 7.5 CH2 H3 H3 
3 24.9 1.63 qn 7.5 CH2  H4 
4 25.6 
1.40 m; 1.30 
m - CH2  H3, H5 
5 25.3 
1.42 m; 1.32 
m - CH2   
6 37.2 1.37-1.47 m - CH2 H5 H5 
7 71.8 3.57 m - CH H8, H6  
8 37.5 1.37-1.47 m - CH2   
9 29.6 1.30 m - CH2   
10 29.4 1.30 m - CH2   
11 29.3 1.30 m - CH2   
12 29.19 1.30 m - CH2   
13 29.15 1.30 m - CH2   
14 27.4 2.04 m - CH2 H17, H15 H15, H16 
15 133.5 5.56 dtt 11, 7.5, 1,63 CH H17, H14 H14, H16, H17 
16 125 5.39 m - CH H17, H14 
H14, H15, H17, 
H18 
17 35.4 2.22 t 6.5 CH2 H14 H15, H16, H19 
18 71.1 3.63 m - CH H19, H17 
H16, H19, H17, 
H20 
19 36.7 1.53 m - CH2 H18, H20 H21, H17, H20 
20 23.5 
2.16 m; 2.13 
m - CH2 H19 
H22, H21, H18, 
H19 
21 128.5 5.34 m - CH H23, H20 H19, H20, H23 
22 132.2 5.37 m - CH H23, H20 H20, H23, H24 
23 20.5 2.05 m - CH2 H24 H22, H21, H24 
24 14.3 0.96 t 7.5 CH3 H23 H22, H23 
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Initial substructures for the predicted linear dihydroxylated unsaturated ester were 
assembled from the COSY and HMBC data.  C1 and C1’ were assigned based on their 
chemical shifts, where C1 corresponded to the carbonyl and C1’ represents the CH3 
carbon of the methyl ester.  Long-range coupling of H1’ to H2 and 3JHH coupling 
between H2 to H3 was visible in the 1H-1H COSY.  An H4 to C3 correlation in the 
HMBC extended the spin system (Figure 13A). The COSY furnished the pairs of 
methylenes surrounding each alcohol generating two additional fragments (Figure 
13B,C). The correlations from the COSY and HMBC spectra identified the sets of vinylic 
carbons and protons; C15 and C16 are the carbons of one alkene and C21 and C22 are the 
carbons of the other. The connectivity in the C21-C22 alkene with could be expanded 
using coupling data in both directions along the alkyl chain (Figure 13D). The COSY 
spectrum showed H22 correlating to H23 and H23 coupled to H24. The HMBC further 
confirmed the ω end of the alkyl chain with a crosspeak of C22 to H24. The other vinylic 
hydrogen H21 correlated to H20, and C21 displayed long-range coupling to H19. For the 
other alkene functionality, both C15 and C16 correlate to H14 and H17 with crosspeak 
intensity favoring H17 being allylic to C16 (Figure 13E). nJCH correlations to the 
carboxyl-proximate side of H14 from C15 could not be unambiguously assigned. 
Fragment C connected fragments D and E together; C19 from fragment C appeared in the 
correlations observed for fragment D and C17 in fragment C is also present in the set of 
crosspeaks observed with fragment E.  Although the methylene resonances for C9-C13 
could not be fully assigned due to the low chemical shift dispersion in the range of 1-2 
ppm, only one supported connectivity appeared to be possible, which is depicted in 
Figure 13F. Nevertheless, the exact position of the second hydroxyl position could only 
be hypothesized due to the similarity in chemical shifts of the alkyl chain. 
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Figure 13: Substructures based on NMR correlations and coupling data.  A-E  Assigned 
nuclei in the five working structures were constructed using the 1H-1H-COSY (solid-line 
arrows) and 1H-13C HMBC heteronuclear correlations (dashed-line arrows) showing 1H 
correlations to 13C in Table 2 resulting in structure F.   Signals for C9-13 were not 
sufficiently dispersed for their assignment. The dotted box indicates possible locants for 
the hydroxyl group. 
 
The low NMR chemical shift dispersion for eight of the CH2 groups between the 
alkene and the carboxyl group impeded our development of an incontrovertible case for 
the structure.  Both the unsilylated electron impact (EI) mass spectrum for 2a (Figure 
14A) and disilylated (Figure 14B) FAMEs for 2a, as well as 1a and 5,16-OH-22:1Δ13 
(Figure 14D, E) were found to have anticipated fragments, as well as distinctive ions 
attributed to novel ene and rearrangement processes that aided in determining the correct 
connectivity shown in Figure 13F. Figure 14C shows γ-hydrogen atom transfer and H+ or 
TMS+ migration to the carboxyl group of pyrrolidide and ester derivatives may result in a 
molecular ion 3, which subsequently looses formaldehyde.  This is postulated to give rise 
to the 29 mass unit formal “CHO” loss from the β-cleavage ions of hydroxy fatty acids, 
such as 4. 
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Figure 14: EI-MS spectra of FAMES.  A. Mass spectrum of 2a with hypothetical 
fragmentation pathways shown in the inset.  The dihydroxy ester was observed to 
fragment through two major channels:  dehydration and β-scission producing M-1, M-
129, and M-233 fragments or the ene fragmentation followed by the losses of H2O and 
MeOH. B. Mass spectrum of (TMS)2-2a with the origins of major ions annotated on the 
inset structure.  The trimethylsilyl groups block the retro-ene reaction resulting in 
cleavage β to the ether oxygen, neutral loss reactions, and “deformylation” ions.  An m/z 
74 McLafferty cleavage ion was readily apparent. C. A γ-hydrogen atom transfer and H+ 
or TMS+ migration to the carboxyl group of pyrrolidide and ester derivatives. D. Mass 
spectrum for the methyl ester of 7,18-(TMSO)2-24:1Δ15. E. Mass spectrum for the methyl 
ester of 7,18-(TMSO)2-22:1Δ15 
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Figure 14 continued 
 
In an attempt to rigorously situate the hydroxy groups on the backbone, the two 
alcohol groups in 2a were oxidized with Dess-Martin periodinane to produce 5.  Upon 
oxidation, the expected formula for the ketone was confirmed (+ESI mode: C25H43O4 
observed 407.3154, calculated m/z 407.3156; -ESI mode: C25H41O4 observed 405.2979, 
calculated m/z 405.3005).  Both alcohol multiplets at 3.57 and 3.63 ppm disappeared in 
the 1H NMR leading to a new resonance at δ 3.14 for protons alpha to the β,γ – 
unsaturated ketone and a doubled IR stretch at 1738 and 1715 cm-1, the latter due to the 
appearance of an unconjugated ketone.  Finally, weak McLafferty fragmentation ions 
were observed at m/z 172 and 338 that first suggested the hydroxyl groups were at C-7 
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and C-18 (Figure 15).  Other NMR data supported the structure of the ketone but the data 
was still deemed insufficient to finalize the structure. 
 
 
Figure 15: Mass spectra of diketone from methyl wuhanate (5). 
 
Three chemical methods finally ensured the unambiguous assignment of the 
connectivity:  pyrrolidide derivatization, von Rudloff degradation, and alkene metathesis.  
To determine the position of the hydroxyl groups, 2a was incubated with pyrrolidine and 
glacial acetic acid to form 6. The MS for 6 exhibited two homologous series incremented 
by CH2 groups (Figure 16A).  The first series for the diol covered the range from m/z 126 
to 168. Following a major m/z 198 fragment resulting from a β-cleavage relative to the 7-
hydroxyl group, each ion in the m/z 180 to 264 (C8-13) series included a water loss.  
Beyond m/z 264, gaps of 26 amu localized the double bonds. Bis-trimethylsilylation of 
2b activated the ethers toward β-scission and provided intense ions neighboring each 
oxygenated carbon (Figure 16C). Collectively, the MS fragmentation indicated that the 
alcohols were at positions 7 and 18.    
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Figure 16: Electron-impact (EI) MS spectra of fatty acid pyrrolidides. A. Mass spectrum 
of the pyrrolidide of 7,18-(OH)2-24:2Δ15,21 (6). Correspondence between the proposed 
fragments and observed ions is shown in the inset.   The even-mass ions below the 
structure are proposed to result from the sequential chain scission of 6. The m/z 113 ion is 
consistent with a McLafferty cleavage.  Ions marked in bold font result from the 
dehydration from one or, as denoted by the bold underline, two hydroxy groups.  Ions 
above the structure are derived from cleavage processes beta to the oxygen and 
subsequent chemistry. B. The scission of the hydroxylated amide is consistent with a 
process reminiscent of an alkene-aldehyde ene reaction leads to the bold line 
fragmentation in A. C. Contrastingly, the dominant ions from (TMS)2-6 are formed 
disproportionately by beta-cleavage chemistry.  Ions 510 and 270 are distinguished by 
undergoing the formal loss of CHO. 
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To clarify the location of the carboxyl-proximate hydroxyl group in the acyl 
chains of 1a and 2a, a von Rudloff oxidation was conducted to cleave the FAMEs at their 
double bonds.  The oxidation products for Peak 1 (1a) and Peak 2 (2a) were consistent 
with cleavage at the ω-9 (or Δ15) double bond of the C24 FAME.  The mass spectra of one 
of the products following disilylation 7 or esterification + silylation 8 fragmented in a 
manner expected for a 7-hydroxyl group (Figure 17A).  Both spectra contained the m/z 
231 ion expected for fragmentation at the site of hydroxylation for the “front-end” 7-
hydroxylated product.  The “back-end” fragment differed by 58 mass units depending on 
whether the terminal carboxyl group is methylated (m/z 259) or trimethylsilylated (m/z 
317); both ions from the von Rudloff cleavage placed the first alkene or double bond at 
C15. Peak 2 (2a) had additional oxidation products due to the second alkene present. In 
the mass spectra of one of the products for 2a had a parent m/z of 528, indicative of Δ21 
or ω-3 double bond (Figure 17B). 
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Figure 17: Results from iodate-permanganate “von Rudloff” oxidation of 1a and 2a. A. 
The Δ15 bonds in 1a and 2a were cleaved. An m/z 231 fragment diagnostic of a 7-hydroxy 
fatty acid was observed during GC/MS analysis together with an m/z 317 fragment, 
following direct silylation to the trimethysilyl ester, or an m/z 259 ion when methylation 
preceded silylation. B. Additional fragmentation of 2a due to the additional alkene 
present. 
 
2.3.3 Configuration at the C18 stereocenter of 7,18-(OH)2-24:2Δ15,21 
All attempts to produce Mosher and O-methylmandelate derivatizations of the O. 
violaceus-derived FAMEs in an effort to assign the configurations of the hydroxylated 
carbons led to decomposition.  As an alternative approach, FAME 2a was converted by 
alkene cross-metathesis with 2-methyl-2-butene [101] into two products fully consistent 
with the sites of hydroxylation and desaturation above, 3-cyclohexen-1-ol (6a) and 7-
hydroxy-16-methyl-15-heptadecenoate (7a) (Figure 18).  
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Figure 18: To assign the 18-hydroxy stereocenter, alkene metathesis of 2a was performed 
in 2-methyl-2-butene.  Ring-closing metathesis (RCM) produced in 3-cyclohexenol (9) 
together with the C1-15 metathesis product (10) which were then trimethylsilylated with 
BSTFA-TMSCl. 
 
Following silylation of the mixture, cyclohexenol-derived 9a was identifiable 
from its dominant retro-Diels Alder fragment (m/z 116). This product was found to be 
identical to a synthetic standard based on its retention time and ion profile.  Resolutions 
of the racemic and a sample of enantioenriched 9a, prepared by an enantioselective 
reduction, were achieved by chiral GC/MS (Figure 19).  The ring-closing metathesis 
product coeluted with the (R)-isomer of 9a at 16.85 min, 0.14 min after the (S)-silyl ether, 
and permitted the assignment of the (18R)-stereocenter.   
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Figure 19: Comparison of TMS-modified enantioenriched (R)-(dotted line) and racemic 
(black dashes) cyclohexenol with the RCM product from natural 2a (red solid line) 
defines the stereochemistry as R. 
 
2.3.4 Configuration at the C7 stereocenter of 7,18-(OH)2-24:2Δ15,21 
Trying to take a similar approach for C7 proved more difficult than C18. A couple 
of synthetic pathways were attempted to synthesize 10. Cycloheptanone was oxidized 
with m-CPBA to form the lactone 11, which was immediately opened with methanol and 
H2SO4 to form, 12 (Figure 20A). The alcohol 12 was oxidized to the aldehyde to use in a 
Wittig reaction. However, after the addition of the aldehyde to the ylide the reaction, 
decomposition ensued. Therefore, an alternative method was used to reach 14.  
Fisher esterification of 7-octenoic acid led to the desired methyl ester, 14, which 
was then oxidized with m-CPBA to produce the epoxide 15. The epoxide was stored for 
later use with 17 from Figure 20B. To synthesize 17, 8-bromooctanol was oxidized to the 
aldehyde 16 using PDC. The aldehyde was used in a Wittig reaction with 
isopropyltriphenylphosphonium iodide to form 17. In order to synthesize 10 from the 
alkene 17 and the epoxide 15, first a lithium-bromine exchange needed to occur. Lithium 
with 4, 4’-bi-tert-butylbiphenyl was tried for the metal-bromine substitution, but the 
lithiated species never seemed to form. Instead of lithium, magnesium was used for the 
metal-halogen exchange. Ethylene bromide was a good activating reagent to use because 
it would not interfere in the next step. It was determined that the formation of the 
magnesium complex was best done by waiting for the reaction to become cloudy through 
	
9a 
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the action of the activator on the metal before adding the alkyl bromide. After the 
magnesium complex formed, it was converted to an organocuprate with the addition of 
CuBrSMe2. A catalytic amount of TMSOTf was added to selectively silylate the 
epoxide to the secondary alcohol [102]. Under these conditions, the procedure was tested 
using tert-butyl glycidyl ether and bromooctane as a model system. Selective acylation of 
to 1-(tert-butyoxy)undecan-2-ol was successful. However, when using the alkyl bromide 
17 and epoxide 15, the product polymerized. Although it was realized that this synthetic 
route would have led to a final product one carbon longer than the desired alkene 
metathesis product, the synthetic pathway was still worth exploring.  If all the steps had 
been successful, it would have been possible to complete the synthesis starting with 7-
bromoheptanol to reach the desired product. The problem with the polymerization of the 
final product was unlikely to be related to the chain length difference, but rather occurred 
with production of an alkoxide in the presence of the ester moiety. 
 
72 
 
 
Figure 20: Attempted pathway to synthesize methyl 7-hydroxy-17-methyoctadeca-16-
enoate. 
 
A second pathway was devised that employs a convergent pathway (Figure 
21A/B). The first intermediate was generated by protecting 8-bromooctanol as an 
TBDMS silyl ether (19) and then substituting the bromo group with a better iodo leaving 
group (20).  
Separately, cycloheptanone underwent acylation with dimethyl carbonate to form 
the β-ketoester 21. Activated 21 was alkylated by the previous synthesized 20 to form 22 
and decarboxylated using LiCl at 180 °C to produce 23. The cycloheptanone ring was 
regiospecifically oxidized using UHP and TFAA to form the lactone 24. It was observed 
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that, in the process, the TBDMS group was removed replaced by a trifluoroacetate group. 
The lactone was opened and the trifluoroacetate group was concomitantly removed with 
24% tetramethylammonium hydroxide (TMAH) in methanol producing the diol 25. The 
terminal alcohol needed to be selectively oxidized to the aldehyde. Using TEMPO and 
(bisacetoxyiodo)benzene (BAIB), with a short duration for the reaction, the aldehyde 26 
was formed. This aldehyde was then immediately used in a Wittig reaction with 
isopropylidene triphenylphosphonium ylide completing the successful synthesis of 10b. 
Unfortuantely, neither racemic 10b nor its derivatives could be separated by chiral 
GC/MS.  
 
 
 
 Figure 21: Synthesis of methyl 7-hydroxy-16-methyheptadeca-15-enoate used for chiral 
GCMS analysis to determine the C-7 configuration. 
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The similarity of the alkyl chains of 10 around C7 precluded the stereochemical 
assignment. The previous metathesis reaction was scaled-up to convert 2a into two 
products, 3-cyclohexen-1-ol (9) and 7-hydroxy-16-methyl-heptadec-15-enoate (10) was 
again used (Figure 22). Purifying by column chromatography allowed 7a to be isolated 
for further analysis. Using a method from Hoye, diastereomeric (S)- and (R)-α-methoxy-
α-trifluoromethylphenylacetic acid (MTPA) esters were prepared from 7a in two 
mirrored experiements, 7b and 7c [100]. The corresponding (S)- or (R)-MTPA is 
dissolved in dry DCM. A carboxylic acid-activating agent, in this case N,N’-
dicyclohexylcarbodiimide (DCC), was used to convert the carboxylic acid to an acid 
chloride. The alcohol was added to reaction mixture and was acylated by the acid 
chloride to form the diastereomeric Mosher esters, designated R or S specifying the 
stereochemistry of the acid that was used. 
 
 
 
Figure 22: Synthesis and functionalization of methyl 7-hydroxy-16-methyheptadeca-15-
enoate. Both 10d and 10e were used for Mosher analysis to determine the configuration 
of C-7. 
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NMR analysis was completed on compounds 10d and 10e. From 1H NMR 
analysis of the Mosher esters of 10d and 10e, the proton shift differences were calculated 
(ΔδSR) between the diastereomeric esters. Again the similarity in the acyl chains around 
C7 provided some difficulty. Any variations at C6 and C8 were useless because the 
protons on these carbons were indistinguishable. Instead, we considered only assigned 
protons further down the acyl chain towards the alkene and the α-methyl ester for 
assignable peaks. For 10d and 10e, the chemical shift differences were detected at C2, 
C14, and C15 in the 1H NMR (Table 2). Based on the methods described in the literature, 
protons with positive ΔδSR (C14 and C15) are found in R1 and those that are negative 
(C2) are in R2, thus the configuration of C7 must be R.  
 
Table 2: Mosher ester analysis of 10d and 10e 
 
 
 
A dehydrogenative strategy was pursued in order to increase the dissimilarity 
between the alkyl chains surrounding C7. The method used needed to alter the alkyl 
chain without changing the stereochemistry of C7. Starting from the alkene metathesis 
product 10, a selenoxide elimination reaction was used to insert an alpha-beta double 
bond into compound 27 (Figure 23). During the elimination, the preexisting alkene was 
oxidized to the epoxide. The new alkene added an additional functional group to the long 
alkyl chain.  
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Figure 23: Synthesis and functionalization of methyl (E)-7-hydroxy-16-methyheptadeca-
2,15-dienoate. Both 27a and 27b were used for Mosher analysis to determine the 
configuration of C-7. 
 
For 27a and 27b, the chemical shift differences were detected at C2, C3, and C15 
(Table 3). The addition of the alpha-beta double bond caused a larger shift difference at 
C2 and C3. However the epoxide formation diminished the chemical shift differences on 
the omega end of the chain. C15 and C14 for the R-acid derived ester became more 
shielded and the protons on C14 could no longer be unambiguously assigned. The 
difference in chemical shift had approximately the same magnitude at C15 whether it was 
the epoxide or an alkene. As with 10, the only protons used for to calculate the different 
in chemical shifts were those that could unambiguously be assigned, and C6 and C8 were 
still indistinguishable. The protons that are positive (C15) are found in the ω-end and 
those that are negative (C2 and C3) neighbor the methyl ester, thus the configuration of 
C7 must be R. In the paper by Hoye, they tested their experiment method on (-)-menthol 
[100]. Their ΔδSR values ranged from |0.32| to |0.01| [100]. Other studies have similarly 
found the effects observed from Mosher analysis is typically observed to the 2nd decimal 
place due to the field strength of the instrument [103-105]. This indicates our most 
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reliable data from 10d and 10e is at C2 and for 27a and 27b, C2 and C3. Though more 
recently, Guido et al. published an article showing new precision measurements could be 
used for 1H NMR experiment [106]. They reported that the standard two decimal rule 
adequately reflect 1H chemical shifts at a magnetic field strength of ≤ 100 MHz, but with 
an increase in proton field strength to ≥300 MHz, data can be meaningfully analyzed in 
the 4th decimal place [106]. In our case, our 500 MHz instrument allows us to carry out 
the data to 4 decimal places, thus using all the chemicals shifts from the unambiguously 
assigned protons providing further evidence C7 is R. 
 
Table 3: 1H chemical shifts from Mosher analysis of 27a and 27b. 
 
 
 
19F NMR spectra of each set of Mosher esters were also analyzed as a further 
check on the C7 configuration. However, it is important to keep in mind that work done 
by Kakisawa and Kashman has shown 19F NMR lacks reliability and is dependent on the 
bulkiness of the R1 and R2 groups [103]. In the preferred conformation, the 
trifluoromethyl group is eclipsed with the carbonyl group, and the chemical shift 
difference of the R1 and R2 depends on the phenyl group [103]. The aryl group produces 
an anisotropic, magnetic shielding effect on the protons on R1 for the R acid or R2 for the 
S acid. The shielding effect by the phenyl group depends on the steric bulkiness of the R1 
and R2 substituents [103]. Due to the high similarity of the alkyl chains on either side of 
10 and 27, there was no chemical shift difference in 19F NMR spectra.  Nebraskanic acid 
(1) was thought to the monounsaturated version of wuhanic acid (2) and, therefore, the 
stereochemistry at the hydroxyl groups is presumed to be the same. 
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Finally, by a combination of 1H-1H NOESY, 3JHH, and IR analysis, the double 
bond was determined to be Z. NOESY signals were observed between H15-H16 and 
H15-H14, and no correlation was found for H15-H17.  Similarly, a NOESY crosspeak 
was found for H21-H20 but not H21-H23.  C=C stretching and out-of-plane bending 
vibrations at 1653 and 724 cm-1, respectively, further support the cis stereochemistry.  
The cis 3JHH coupling constant at C15 was clearly visible at 11 Hz. This establishes the 
final structure of wuhanic acid as (7R,15Z,18R,21Z)-7,18-dihydroxytetracosa-15,21-
dienoic acid 2 and monounsaturated nebraskanic acid 1 shown in Figure 24. 
  
 
 
 
Figure 24: Final structures of the very-long chain dihydroxy fatty acids from O. violaceus 
seed oil. The structures of mono and diunsaturated nebraskanic (1) and wuhanic (2) fatty 
acids, respectively, supported by the MS, NMR, IR, and degradation analyses.  
2.3.5 Oil composition 
Gas chromatographic analysis of the total fatty acids of O. violaceus seeds 
revealed not only the accumulation of nebraskanic and wuhanic acids to 50 wt% of the 
total fatty acids, but also the presence of C18-C24 monohydroxy fatty acids that accounted 
for <2% of the total fatty acids.  These included C18-C24 fatty acids with ω-6 
hydroxylation based on GC-MS analyses.  TLC separation of the O. violaceus seed oil 
indicated no detectable TAG containing exclusively non-hydroxy fatty acids.  However, 
at least two of the TLC-separated bands from O. violaceus oil contained >60 wt% of 1 
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and 2, suggesting that the oil from these seeds is more complex than that typically found 
in hydroxyl fatty acid-containing seeds such as those of castor bean.  This may reflect the 
occurrence of TAG estolides in O. violaceus seed oil as shown previously for seed oils 
containing hydroxy fatty acids (Figure 25) [107-111].  Given that VLCFAs are typically 
excluded from the sn-2 position of Brassicaceae seed oils [112], it is likely that the C24 
dihydroxy fatty acids are at the sn-1 and sn-3 positions of O. violaceus TAG. 
 
 
Figure 25: Hypothetical structure of TAG-estolides found in O. violaceus seed oil [107].  
 
 Based on the structures of nebraskanic and wuhanic acids, biosynthetic pathways 
for these fatty acids likely involve two hydroxylations to form the 7- and 18-hydroxyl 
groups and elongation reactions to extend a de novo C18 fatty acid to a C24 fatty acid.  
Given the position of the 18-hydroxyl group in the ω-6 position, it is likely that it is 
formed by a FAD2-type hydroxylase, similar to biosynthesis of the ω-6 hydroxyl group 
in ricinoleic acid in castor bean seeds and lesquerolic acid in P. fendleri seeds [113, 114].  
Presumably, this reaction uses oleic acid bound to PC, as previously shown for ricinoleic 
acid synthesis in castor been seeds [115].  Fatty acid elongation likely requires one or 
more FAE1-encoded β-ketoacyl-CoA synthase for three cycles of chain elongation from 
C18 to C24.    
Unclear is the biosynthetic origin of the 7-hydroxyl group. Clues were generated 
from detailed mass spectrometric analyses of fatty acids and acyl-CoAs of O. violaceus 
seeds.  The Cahoon group, used selected ion searches of silylated fatty acid methyl esters 
prepared from O. violaceus seeds, compounds with prominent m/z 73, 185, and 187 ions 
arising from the ω-6 hydroxyl group were detected. This included trace amounts (<0.1% 
of total fatty acids) of the C22 precursors (5,16-(OH)2-22:1Δ13, designated “indianic acid”, 
and 5,16-(OH)2-22:2Δ13,19) of nebraskanic and wuhanic acids and a compound with a 
mass spectrum containing fragments partially consistent with those expected for the C20 
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precursor of nebraskanic acid (3,14-(OH)2-20:1Δ11) (Figure 26 A,B).  In addition, C24 
dihydroxy fatty acyl-CoAs and C22 and C20 dihydroxy acyl-CoAs were detected in 
developing O. violaceus seeds by ESI-MS/MS analyses of acyl-CoA pools. 
 
 
 
Figure 26: Mass spectra of fatty acid methyl esters (FAMEs) from O. violaceus seeds and 
transgenic Arabidopsis seeds.  Results shown in A and B are from GC-MS analysis of 
trimethylsilyl (TMS) derivatives of minor dihydroxy FAMEs in O. violaceus seeds. 
Shown in A is a mass spectrum consistent with the methyl ester of TMS2-5,16-OH-22:1 
and in B is a mass spectrum consistent with that of the methyl ester of TMS-3,14-OH-
20:1.   
 
Collectively, these findings are most consistent with a biosynthetic pathway 
involving ω-6 hydroxylation of oleoyl-PC to form ricinoleoyl (12-OH-18:1Δ9)-PC and 
subsequent release of ricinoleic acid to the acyl-CoA pool (Figure 27).  This is followed 
by elongation of the C18 ricinoleoyl-CoA with introduction of a 3-hydroxyl group at the 
C20 stage to form 3,14-OH-20:1Δ11-CoA and two further elongation cycles to 
sequentially generate 5,16-(OH)2-22:1Δ13-CoA and the CoA ester of nebraskanic acid 
(7,18-(OH)2-24:1Δ13-CoA).   The ω-3 unsaturation of wuhanic acid likely is introduced 
by FAD3, presumably at the C18 stage using ricinoleoyl-CoA as a substrate [116] 
followed by the same elongation-hydroxylation pathway used for nebraskanic acid 
synthesis.  Alternatively, the 3-hydroxy group could arise from a Δ3 desaturase- or 
cytochrome P450-related hydroxylase (Figure 27, Pathway 2) or be introduced during the 
C18 to C20 elongation by “missed” dehydration of the β-hydroxyl-acyl-CoA intermediate 
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such as that found in Arabidopsis pas2 3-hydroxy-acyl-CoA dehydratase mutants [117] 
(Figure 27, Pathway 1).  In the case of the pas2-1 mutant, 3-hydroxy-fatty acyl-CoAs are 
detectable in acyl-CoA pools but are not further elongated [117].  3-Hydroxy-fatty acids 
also occur in bacteria, mammals, and fungi but are also not further elongated [118-121].  
As such, discontinuous elongation of a 3-hydroxy-acyl-CoA in O. violaceus would 
represent an unprecedented pathway in hydroxy fatty acid metabolism. This pathway is 
supported by the ability to partially reconstruct the nebraskanic acid biosynthesis in 
Arabidopsis seeds by co-expression of the O. violaceus FAE1 and FAD2-type 12-oleic 
acid hydroxylase.   
 
 
Figure 27: Hypothetical biosynthetic pathway for nebraskanic acid. The pathways shown 
are consistent with the detection of C20 and C22 dihydroxy precursors of nebraskanic acid 
in seed fatty acids and acyl-CoA pools of O. violaceus seeds through discontinuous 
elongation of the 3-hydroxy intermediate arising from ricinoleoyl-CoA (Pathway 1) or by 
3-hydroxylation of the full C20-elongation product of ricinoleoyl-CoA (Pathway 2). The 
characterization of OvFAD2-2 as an oleic acid 12-hydroxylase accounts for the ω-6 
hydroxyl group of nebraskanic acid. Though not demonstrated, a second FAE1 (e.g., 
OvFAE1-2) may be associated with subsequent elongation steps. 
82 
 
2.4  Conclusion 
In this chapter, a seed oil rich in two very-long chain dihydroxy fatty acids was 
identified in the Brassicaceae O. violaceus.  The structures of these fatty acids were 
elucidated using multiple and independent approaches as 7,18-dihydroxy-24:1Δ15 
(nebraskanic acid) and 7,18-dihydroxy-24:2Δ15,21 (wuhanic acid).  The detection of C20-
C22 dihydroxy intermediates in the fatty acid and acyl-CoA pools of O. violaceus seeds is 
consistent with the introduction of the 7-OH group as a 3-OH precursor at the C20 stage 
of fatty acid elongation (Fig. 31, Pathway 1). The synthesis of nebraskanic acid in 
Arabidopsis seeds without the introduction of a second hydroxylase is consistent with the 
formation of the 3-OH as a fatty acid elongation intermediate during the conversion 
ricinoleoyl-CoA to the C20 product (Figure 31, Pathway 1).  Because of the low 
accumulation of nebraskanic acid in the engineered Arabidopsis seeds, it is likely that 
additional components of the very long-chain fatty acid biosynthesis are also specialized 
for nebraskanic and wuhanic acid TAG biosynthesis.  For example, a second O. violaceus 
FAE1 may be required for more efficient elongation of the C20 and C22 dihydroxy fatty 
acyl-CoAs and/or the 3-hydroxy-acyl-CoA dehydratase in O. violaceus seeds may not 
effectively use ricinoleoyl-CoA as a substrate. In addition, the ω-3 double bond of 
wuhanic acid likely arises from FAD3 activity, but it is currently unclear in which 
biosynthetic step that this double bond is introduced.  Elucidation of these details of the 
biosynthesis of nebraskanic and wuhnaic acids will provide the basis for an alternative 
pathway for hydroxy fatty acid biosynthesis of biochemical and biotechnological 
significance.  In addition, our findings also unveil O. violaceus as a potential industrial 
crop with oil properties for applications such as lubricants and chemical feedstock 
synthesis distinct from those of castor bean oil.  Although O. violaceus is currently used 
for ornamental purposes, extensive germplasm exists in China for selection and breeding 
of cultivars with suitable agronomic performance [31, 32]. 
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CHAPTER 3. THE CONVERGENCE OF TWO PATHWAYS IN 
THE BIOSYNTHESIS OF ALKAMIDES FROM ECHINACEA 
3.1 Introduction 
A goal of the research described in this chapter was to identify means to probe 
both the acyl chain and the amine moieties of alkamides in E. purpurea, to gain insight 
into poorly understood desaturation, chain-length determining, and amide forming 
aspects of this pathway.  First, isotopic labeling experiments were completed in order to 
determine if branched chain amino acids (BCAA), specifically Val and Ile, are verifiably 
precursors to the amine moiety [1]. Further desaturation of the acyl chain must be 
occurring in order to provide the more complex alkene and alkyne functionality of the 
accumulating alkamides. If the fatty acid synthesis and branched-chain amino acids 
pathways converge to make alkamides, fatty acids may be desaturated prior to merging 
with the BCAA; alternatively, saturated fatty acids might be utilized for alkamide 
synthesis and then the alkamides are further desaturated. Given that the natural products 
universally bear the conjugated 2E alkene, short-chain, unsaturated fatty acids (12:1Δ2E, 
13:1Δ2E, 14:1Δ2E) and alkamides (NiBu/12:1Δ2E, NiBu/13:1Δ2E, NiBu/14:1Δ2E) were 
synthesized. These compounds were used in plant experiments attempting to intersect the 
biosynthetic pathway. Finally, acyl-CoAs (12:1, 12:2, and 12:4) were synthesized and 
used in an activity assay with a cloned enzyme, EpLigase, isolated by the Nikolau group 
[122]. Km and Vmax were calculated and compared to 12:0. Confirmation of the product 
formed from the assay was completed. 
3.1.1 Convergence of two metabolic pathways 
Fatty acids are most often modified with additional functional groups on the alkyl 
chain. Other chemistry can occur naturally at the carboxylic acid moiety within plants. 
An example of fatty acid modification is the biosynthesis of sorgoleone, an 
allelochemical that is secreted from the roots of sorghum (Figure 28) [123]. The 
convergence of two metabolic pathways, fatty acid synthesis and polyketide synthesis, 
leads to the biosynthesis of sorgoleone [124]. De novo fatty acid synthase and desaturase 
produce 16:3Δ9Z,12Z,15Z –CoA [123]. This fatty acid is the starter unit for a polyketide 
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synthase that produces a resorcinolic lipid intermediate that is further oxidized to yield 
sorgoleone [123]. Through 13C-labeled substrate experiments, a better understanding of 
the biosynthetsis of sorgoleone was determined [124]. [2-13C]Glucose incorporated into 
acyl chain and into the ring of sorgoleone, whereas [1-13C]acetate incorporated into the 
ring only suggesting PKS and FAS are taking place in different cellular compartments. 
 
 
 
Figure 28: Examples of natural products synthesized from the integration of fatty acid 
synthesis with another pathway. Sorgoleone is derived from fatty acid and polyketide 
synthesis. Capsaicin is synthesized from phenylpropanoid and branched-chain fatty-acid 
synthesis. Alkamides look to be another example of the convergence of fatty acid with 
another pathway, but the biosynthetic pathway is still unknown. 
 
Capsaicinoids are secondary metabolites responsible for the hot taste in peppers, 
where capsaicin and dihydrocapsaicin are the main determinants of capsaicinoid content 
[125].  Capsaicinoids bind to the vanilloid receptor subtype I (TRPV1), which can also be 
stimulated with heat, explaining the similar sensation given by capsaicinoids. Capsaicin 
and other capsaicinoids are synthesized by convergence of two metabolic pathways, 
phenylpropanoid synthesis and branched-chain fatty-acid synthesis (Figure 29) [126]. 
Through a series of steps, phenylalanine is converted to vanillylamine through 
phenylpropanoid synthesis [126]. Separately, pyruvate is converted to valine, which is 
synthesized to isobutyryl-CoA [126]. Then through branched chain fatty acid synthesis, 
8-methyl-6-nonenoyl-CoA is produced [126]. Finally, the two pathways join through the 
condensation of vanillylamine and 8-methyl-6-nonenoyl-CoA to yield capsaicin [125]. 
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Many of the enzymes in this pathway are known, but they are not well characterized and 
the regulation not understood. In particular, the key acyl transferase is unknown, but in 
recent work a gene, CA01g32970, has been identified as a possibility to encode the AT 
[126]. Further studies still need to be completed to characterize the enzyme and better 
understand regulation of the pathway.  
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Figure 29: Biosynthetic pathway of capsaicin. Multiple arrows indicate that several steps 
occur, but not all of the steps are known to generate the next intermediate. An 
acyltransferase is thought to be responsible for the last step; a recent study has shown 
CA01g32970 as a possible gene encoding the AT.  
 
The Echinacea genus from the Asteraceae family produces alkamides, secondary 
metabolites similar in structure to capsaicin. It has been proposed that the alkamides 
produced by Echinacea can act as immunomodulatory agents in humans, but continued 
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research is needed to verify a biological purpose [127]. The biosynthetic pathway is also 
unknown; however, similar to sorgoleone and capsaicin, alkamides also seem to be 
derived from two pathways. The structure resembles capsaicin in that all alkamides have 
an amide moiety. Though in alkamides amino acids, such as valine or isoleucine, look to 
derive the amine instead of the acyl chain like in capsaicin. Like sorgoleone and 
capsaicin, the alkyl chain looks to be derived from fatty acid biosynthesis. Alkamides are 
unique for their several desaturations along the alkyl chains. It has been proposed that the 
branched-chain amino acid could react with the carboxylic acid end of a fatty acid to 
produce the amide moiety similar to the biosynthesis of alkamides from Acmella radicans 
(Asteraceae) [128].  If this is true, it would be another example of fatty acids being 
further modified in plants, the convergence of two biosynthetic pathways, and further 
evolution of secondary metabolism.  
 
3.1.2 Alkamide biosynthesis in Echinacea 
The purple coneflowers Echinacea (Asteraceae) are native to North America and 
Europe [129]. They are well known for their medicinal uses including the prevention of 
colds, influenza, and upper respiratory tract infections [129]. Of the thirteen known 
species, Echinacea purpurea, E. pallida, and E. angustifolia, are the most used for 
alternative medical purposes [129]. Echinacea contains a family of metabolites, the 
alkamides, in relatively high concentrations that could be one of the origins of the 
medicinal properties of Echinacea [129]. 
 The convergence commercial holistic Echinacea therapeutics contain one or more 
of the Echinacea species that produces alkamides [130]. Alkamides also known as alkyl-
amides are found in 33 plant families and comprise about 200 chemically related 
compounds [1, 131]. They contain an acyl chain and amine functional groups connected 
by an amide [132]. In Echinacea, the acyl moiety is 11 to 16 carbons in length, typically 
with a trans-configured double bond located at the alpha position [131]. The degree to 
which the acyl chain is desaturated varies between alkamides. Most of the acyl chains are 
further desaturated and include a double bond at the 4, 8, and/or 10 positions; the 
acetylenic bonds are found at the 8 or 10 position [132, 133]. In Echinacea, their amide 
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end is generally an isobutyl or 2-methylbutylamide [134].  In Figure 30, eight Bauer 
alkamides are shown that correspond to the typical structural variations found in 
Echinacea. Originally Bauer renamed the alkamides from the systematic IUPAC naming 
system to a lab-specific BA nomenclature (Bauer alkamides, BA) 1, 2, 3…etc. However 
this naming system provides no insight to the chemical structure of each alkamide. 
Therefore, during the course of our research, a new naming system was developed and 
published based on that is the more widely accepted and descriptive fatty acid 
nomenclature. For example, BA2 can be named NiBu/11:2Δ2Z,4E,8a,10a. The “NiBu” 
indicates an isobutyl group is bonded to the amide nitrogen to a fatty acid 11-carbon 
chain length that has two double bonds at the 2 and 4 position, which are Z and E 
configurations, respectively. The two acetylenic bonds are at the 8 and 10 positions. 
Similar to shorthand fatty acid nomenclature, the number after the colon only indicates 
carbon-carbon double bonds [1]. 
 
 
Figure 30: Abundant alkamides from Echinacea purpurea that are known as Bauer 
alkamides 
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 The structure of alkamides most resembles that of common endocannabinoids, 
such as anandamide; alkamides have been found to have analogous pharmacological 
activities (Figure 31) [1, 132, 135]. Endocannabinoids bind to CB2 receptors of T cells, 
macrophages, and hematopoietic cells. The N-alkyl branch stimulates the CB2 receptors 
in the immune system. Another endogenous fatty acid alkamide is N-
palmitoylethanolamine (Figure 31). It is not considered an endocannabinoid because it 
lacks the ability to bind to CB1 and CB2, but it does enhance anandamide activity [136-
138]. Due to their structural similarities, it has been proposed that alkamides could be 
functional analogs of anadamide or N-palmitoylethanolamine, and as a result could be 
beneficial in the fight against colds and the influenza virus [130, 135]. However, in 2011, 
a study reported patients taking Echinacea extracts showed no improvement in cold 
symptoms compared to those not taking the extracts [132, 139]. Another study showed a 
potential role for alkamides in plant signaling [140, 141].  It was found that alkamides 
modified root growth and differentiation in Arabidopsis by interacting with a cytokinin-
signaling pathway [140, 141]. Plants synthesize N-acylethanolamines (NAE), NAE-12:0 
and NAE 14:0, which are structurally similar to alkamides. NAEs are used for plant 
defense by signal transduction and in innate immunity [142-144]. Other groups have 
proposed that alkamides specifically could stimulate jasmonic acid biosynthesis [145]. 
 
 
Figure 31: Endogenous fatty acid amides with important biological activities 
 
 Alkamides also resemble the structure of sphingolipids, critical components of 
eukaryotic cell membranes [146]. The basic structure of ceramide, a sphingolipid from 
animal systems, shown in Figure 32 can be further modified by differences in chain 
length, degree of unsaturation, insertion of additional hydroxyl groups, and methyl 
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branching [146]. In animal systems, ceramide contains a Δ4-trans double bond that is 
generated by a desaturase and not by a dehydrogenase [146]. Sphingolipids also have an 
additional C8 unsaturation that can be either in the cis or trans configuration [146]. A Δ8 
fatty acid desaturase discovered by Chen produced 8E and 8Z in a 4:1 ratio in 
sphingolipids [147]. Tian et. al. discovered a Δ10E-spingolipid desaturase that catalyzes 
desaturation in the sphingolipid fusaruside. This example may serve as a window into 
how desaturation occurs in alkamide biosynthesis [148]. 
 
 
 
Figure 32: Sphingosine backbone of ceramide where R is the fatty acid residue. 
 
The location where alkamides are abundant fluctuates across Echinacea species. 
Both E. angustifolia and E. purpurea have abundant alkamides in the roots and certain 
aerial parts, whereas E. pallida have about the same abundance in their aerial parts, but 
lower concentration in the roots [132, 149]. Beyond the knowledge of the structures of 
alkamides and their taxonomical distribution, only a few aspects of the biosynthetic 
pathway has been explored. 
 The enzymatic conversion of fatty acids to generate complex, specialized 
metabolites such as anadamide, N-palmitoylethanolamine, and sorgoleone is well known 
[132, 135, 150-152]. Endocannabinoid biosynthesis may give insight to the biosynthesis 
of alkamides. Endocannabinoids are synthesized by transferring arachidonic acid (C20) 
from a phospholipid to the primary amine of a phosphatidylethanolamine [128, 132]. 
Previous work completed by Bohlmann and Dallwitz in 1974 helps support this 
hypothesis for alkamides [153]. Using metabolites from the crepeneynate pathway and a 
cell-free extract of E. purpurea, Bohlmann and Dallwitz showed a low level of (0.1%) 
incorporation from [10-14C1]methyl oleate (18:1∆9Z), [16-14C1]methyl enediynoate 
(18:2∆9Z,12a,14a), [12-14C1]anacyclin (NiBu/14:2∆2E,4E,8a,10a) into NiBu/11:2Δ2E,4E,8a,10a [153]. 
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Though the incorporation was low, it was hypothesized that alkamides are derived 
through oleic acid biosynthesis [153]. Intermediates of the pathway would have to 
undergo stepwise desaturation followed by chain shortening to achieve the desired chain 
length [153]. In addition, a study of alkamides within A. radicans cell cultures showed 
the amide moiety was derived from decarboxylated L-[2H8]valine and L-
[2H8]phenylalanine [128]. These observations along with literature on acetylenic fatty 
acid biosynthesis were the basis for the Minto group to propose that the acyl chain of 
alkamides is derived from de novo fatty acid biosynthesis and the amine from 
decarboxylated amino acids [132]. 
While not specifically addressed by the study completed by Bohlmann and 
Dallwitz, fatty acids can be synthesized by two different pathways either via the 
chloroplast or mitochondria [154]. For most eukaryotes, de novo fatty acid synthesis 
occurs in the cytosol, but in plants it occurs in the chloroplast [154]. The chloroplastic 
pathway uses pyruvate to create the basic building block acetyl-CoA which is then 
carboxylated to malonyl-CoA [154]. This pathway synthesizes 16:0-ACP which can be 
hydrolyzed to produce palmitic acid (16:0) or portioned to palmitoyl CoA (Figure 33A) 
[154]. Furthermore, 16:0-ACP can be elongated to stearoyl-ACP (18:0-ACP), which can 
either be released to the CoA pool, incorporated into phospholipids, transferred to 
complex lipids or desaturated to 18:1-ACP. 18:1-ACP can be hydrolyzed to produce 18:1 
[154].  Again, plant fatty acid synthesis slightly differs from other eukaryotes. In plants, 
except for the Poaceae family, mitochondrial fatty acid uses cytosolic malonate because 
it lacks the ability to produce malonate directly [154-158]. Mitochondrial fatty acid 
synthase synthesizes three main fatty acids C8, C16 and C18 [158]. C8-ACP is an 
intermediate in the production of lipoic acid, an essential sulfur-containing cofactor 
(Figure 33B) [154, 157, 158]. Mitochondrial fatty acid synthase also produces minor fatty 
acids, such as C10, C12, and C14, and 3-hydroxylated forms of each of the acyl 
intermediates [158]. 
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Figure 33: A. Fatty acid synthesis in the chloroplast, and B. in the mitochondria [154].  
 
 Our group has worked on gaining insight to the biosynthetic pathway of 
alkamides by using labeled compounds to probe both the acyl chain and the amine moiety. 
Initial experiments were completed with [1-13C1]glucose. Feeding experiments completed 
with [1-13C1]glucose showed an increased labeling (M + 2 10.9%, M + 3 4.6%, M + 4 
1.4%) in comparison to [1-13C1]acetate (M + 2 2.28%) [132]. The impact on labeling of 
[6-13C1]glucose was similar to that of [1-13C1]glucose [132]. These observations appear to 
rule out loading of the acetyl-CoA pool from the oxidative pentose phosphate pathway 
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(OPPP) as a source of intermediary metabolites for alkamide biosynthesis. During the 
oxidative phase, C-1 is lost as CO2, often leading to the formation of fructose 6-
phosphate; therefore, comparable labeling of [1-13C1]glucose and [6-13C1]glucose would 
not be observed if OPPP was providing the acetyl-CoA for alkamides biosynthesis [132]. 
 [1,2-13C2]Glucose showed an envelope of M + 1 to M + 8 which was shifted to M 
+ 4 to M + 10 when [U-13C6]glucose was used [132]. The isotopomer peaks of even 
integers were present at a higher abundance than the odd-increment peaks consistent with 
the metabolism of the carbohydrate to C2 units [132]. Alkamides isolated from seedlings 
fed with sodium[1,2-13C2]acetate and [U-13C6]glucose gave HSQC data [132]. Cross-
peaks showed bonded 13C-13C unit interspersed between 12C atoms (12CH-3CH-13CH-
12CH) [132]. This reinforced that the acetate units were being incorporated. 
 Deuterium and carbon-13 labeled fatty acids [15,15,16,16,16-2H5]palmitate 
([2H5]16:0), [17,17,18,18,18]-2H5]stearate ([2H5]18:0), [12,12,12-2H3]laurate ([2H3]12:0), 
[U-13C8]octanoate ([13C8]8:0), and [U-13C18]oleate ([13C18]18:1Δ9Z) were provided to 
seedlings in an attempt to intersect the acyl portion of alkamide biosynthesis [132]. 
[2H5]16:0 and [2H5]18:0 showed no intact incorporation into BA 8/9, but there was intact 
incorporation in downstream fatty acids [132]. Therefore, as hoped, they were taken up 
by the plants and converted to a form capable of being used for fatty acid synthesis [159]. 
The fatty acids were also broken down into acetate units. These labeled acetate units were 
observed in NiBu/12:4Δ2E,4E,8Z,10E/Z as the only route to isotopic incorporation by an 
enhancement of M + 2 peak (1.12% for [2H5]16:0 and 1.77% for [2H5]18:0) [132]. Short 
chain fatty acids, [2H3]12:0, and [13C8]8:0, also showed no intact incorporation into 
NiBu/12:4Δ2E,4E,8Z,10E/Z; a small incorporation of 13C from the octanoate was detected at M 
+ 2 (2.70%) [132].  
Oleate is a precursor to polyunsaturated fatty acid only produced by the plastids 
which can further be desaturated to 18:2 [154]. While desaturation can occur in the 
chloroplast, most oleate is transported to the endoplasmic reticulum to produce 
polyunsaturated fatty acids [40].  Consistent with the above observations, [13C18]18:0Δ9Z 
was a precursor to 18:2 and 18:3 but was not a precursor to alkamide biosynthesis.  
[13C18]18:0Δ9Z showed no intact incorporation in BA 8/9, but led to indirect incorporation 
as M + 2 (2.23%) [132]. [13C18]18:0Δ9Z provided an in planta control for lipid uptake by 
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showing intact labeling of 18:2Δ9Z,12Z (2.38%) and 18:3Δ9Z,12Z,15Z (0.142%) [132]. 
Collectively, this data does not appear to support the expectation that the acyl chains of 
alkamides biosynthesis came from plastidal FAS [132]. 
 To examine the potential origins of the acyl chain in alkamides biosynthesis, an 
inhibition study of fatty acid synthesis was undertaken. Metronidazole inhibits several 
enzymes in plant fatty acid biosynthesis including stearoyl and linoleoyl desaturases and 
the elongase acting on palmitate [160, 161]. Metronidazole strongly perturbed the 
labeling patterns in BA 8/9. Plants fed [U-13C6]glucose and varying concentrations of 
metronidazole showed a significant reduction in the 13C content within 
NiBu/12:4Δ2E,4E,8Z,10E/Z from 33% to 2.7% [132]. There was also a significant decrease in 
polyunsaturated fatty acids, which is consistent with reports that show metronidazole 
inhibits ferredoxin desaturation pathways for plant lipid biosynthesis [161]. For saturated 
fatty acids, which mostly come from the chloroplast, there seemed to be no simple 
concentration-dependent changes [132]. The significant reduction in labeling of 
NiBu/12:4Δ2E,4E,8Z,10E/Z within fatty acids showed that metronidazole obstructed alkamides 
biosynthesis significantly more than plastidial fatty acids [132]. The metronidazole 
inhibition study along with the patterns from stable isotope labeling fatty acids and lack 
of oleate incorporation led our group to look for a de novo non-chloroplastic fatty acid 
pathway for alkamides biosynthesis [132]. 
 Mitochondria produce short-, medium-, and long-chain fatty acids ranging from 
C8-C18 with an even number of carbons [158]. This is achieved through the action of a 
type II fatty acid synthase (FAS).  FAS are “type II” if they require each of the conserved 
enzymes β-ketoacyl-ACP synthase, β-ketoacyl-ACP reductase, β-hydroxyl-ACP 
dehydrase, and enoyl-ACP reductase as individual subunits. Different from plastidial 
FAS, the KAS in mitochondria catalyzes all of the condensation steps; it does not have 
chain length specificity [162]. Mitochondria FAS uses malonate formed by carboxylation 
of acyl-CoA units by a multifunctional ACCase in the cytosol [163]. The mfACCase 
within the cytosol is different than the ACCase present within the plastid as it can be 
inhibited by several classes of herbicides [132]. Select herbicides, fenoxaprop-p-ethyl and 
tepraloxydim, were used for probing mitochondria FAS. When 50 mM [U-13C6]glucose 
was fed with 100 nM concentrations of both inhibitors, labeling of BA 8/9 decreased by 
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88-89% [132]. There was a reduction in VLCFA (24:0) from 51.4% (control) to 30.3% 
(fenoxaprop-p-ethyl) and 36.8% (tepraloxydim) [132]. There was also a reduction 
observed in oleate from 19.2% to about 13.0% for both inhibitors [132]. It is worth noting 
that there was no reduction in labeling of plastidial fatty acids 18:2Δ9Z,12Z and 
18:3Δ9Z,12Z,15Z [132]. This was interpreted to show there was a significant change of the 
cytosolic malonate pool by the mfACCase inhibitors that blocked alkamide labeling, 
therefore fatty acid synthesis coming from the mitochondria must contribute to the acyl 
chain formation of alkamide biosynthesis [132]. 
 As stated previously, the mitochondrion produces three major acyl-ACPs, C8, C16, 
and C18, along with minor acyl-ACPs, C10, C12, and C14. Since the fatty acid synthesis 
from the mitochondria must be contributing to the acyl chain formation of alkamide 
biosynthesis, this describes the formation of even-chain length alkamides, but there are 
alkamides, such as NiBu/13:2Δ2E,7Z,10a,12a, that have an odd acyl chain length. It has been 
proposed that odd-chain alkamides could be formed through alpha-ketoester synthase 
(αKES), α-oxidation of fatty acids, or synthesis initiated with a propinoyl-CoA starter 
unit [132]. The main source of fatty acid synthase is acetyl-CoA, but for uneven chain 
lengths, propionyl-CoA can be substituted [164, 165]. Propionyl-CoA is an uncommon 
precursor in eukaryotes except plants, it can be incorporated by Corynebacterium 
glutamicum, which uses fasA and fasB to synthesize uneven fatty acids 15:0, 17:0, 17:1 
[166]. Higher plants and bacteria also use propionyl-CoA as an intermediate in 
polyketide synthesis [132, 167]. When 1 mM [U-13C3]propionate was fed to E. purpurea 
seedlings, but no M + 3 labeling occurred in either odd or even-chain alkamides and thus 
suggesting that propionyl-CoA is not a starter unit for odd-chain FAS in this 
circumstance [132].  
 Heteronuclear single-quantum coherence (HSQC) analysis was used to look at the 
pattern of [1,2-13C2]acetate incorporation of BA6 [132]. The most noticeable observation 
occurred at C13 with a lack of coupling partner [132]. If α-oxidation was taking place 
C13 should couple with C12 in the acyl chain and the carboxyl carbon would be 
uncoupled to other incorporated carbon-13 atoms. On the contrary, this result supports 
the loss of coupling between C12 and C13 could occur via ω-oxidation of the acyl chain 
[132].  
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In summary, studies by the Minto lab support a model that the acyl chain of the 
alkamides is formed through mitochondrial fatty acid biosynthesis. Diversification to 
produce odd-chain alkamides, such as BA6, could occur from ω-oxidation instead of an 
initially hypothesized propionyl-CoA starter unit or α-oxidation. The current evolution of 
our modular pathway for alkamides is shown in Figure 34 [132]. 
 
 
Figure 34: Proposed modular pathway for alkamides biosynthesis in E. purpuea. 
Reproduced with permission from [132]. 
 
3.2 Materials and Methods 
Dichloromethane (DCM) was dried by distillation from CaH2. THF and Et2O 
were distilled from sodium and benzophenone. Benzene and hexanes were used as 
received. 1,3-Diaminopropane was dried by distillation from barium oxide. Unless 
otherwise stated, reagents were procured from Aldrich. Acetic acid, hydrogen peroxide 
and borane-Me2S complex were purchased from Fisher Scientific.  Dess-Martin 
periodinane (DMP) was synthesized by the method of Boeckman [91]. Silica gel for 
chromatography from Dynamic Absorbents (60-200 micron, #020311) was slurry packed 
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for silica gel flash chromatography using the indicated solvent. All glassware was oven-
dried at 120 °C and reactions run under nitrogen unless otherwise noted. 
Stable isotope labeled small-molecule precursors [deuterated and 13C isotopologs 
of glucose (99%), valine (98%), isoleucine (98%), 2-methylpropylamine HCl (99.5%), 
and butyric acid (99%)] were obtained from Cambridge Isotope Laboratories 
(Tewksbury, MA). Chlorsulfuron was purchased from Fluka.  N,O-
Bis(trimethylsilyl)trifluoroacetamide (BSTFA) was purchased by Sigma Aldrich. The 
components used to make liquid and solid growth media were Plant Preservation Mixture 
(PPM) (Plant Cell Technology; Washington, DC), MS Basal medium with Gamborg 
vitamins (MP Biomedicals; Solon, OH), and sucrose and MES (MP Biomedicals; 
Waltham, MA).  Murashige and Skoog basal salt mixture (MS) contains ammonium 
nitrate, boric acid, calcium chloride, cobalt chloride, cupric sulfate, disodium EDTA, 
ferrous sulfate, magnesium sulfate, manganese sulfate, molybdic acid, potassium sulfate, 
potassium nitrate, monobasic potassium phosphate, and zinc sulfate. The pH of the solid 
growth media was adjusted to 5.4 by 1M KOH. E. purpurea seeds were either purchased 
from Prairie Nursery (Westfield, WI) or provided by the North Central Regional Plant 
Introduction Station, USDA (Ames, IA).  
1H, 13C, DEPT, COSY, HSQC, HMBC, and NOESY NMR spectra were recorded 
on a Bruker Avance-II NMR spectrometer using CDCl3 as solvent; residual CHCl3 (1H, δ 
7.26; 500 MHz) and CDCl3 (13C, δ 77.1; 125 MHz) were used as internal chemical shift 
reference. Peak multiplicities and shapes were annotated as follows: s, singlet; d, doublet; 
t, triplet; q, quartet; quint, quintet; m, multiplet; br, broad. Infrared spectra were recorded 
as neat films on NaCl plates with a Fourier-transform infrared spectrophotometer 
(Nicolet Avatar 330). High-resolution mass spectra were collected with an Agilent 6520 
Q-ToF mass spectrometer. Mass spectra for fatty acid methyl ester analysis was collected 
via an Agilent 7890A GC/5975C MS, and mass spectra from labeled isotope feeding 
experiments were obtained with an Agilent 6410 Triple Quadrupole MS. Sample 
preparation for FAME and alkamide analyses of E. purpurea was completed in glass 
conical tubes. An IEC HN-SII centrifuge was used at 2000 rpm during FAME 
preparation and other analyses unless otherwise stated. 
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3.2.1 Germination and growth of E. purpurea seedlings 
E. purpurea seeds (Prairie Nursery, Westfield, WI) were cold-stratified in a 10% 
aqueous solution of Plant Preservation Mixture (PPM; Plant Cell Technologies, 
Washington, DC) for 16 h at 4 °C. The solution was decanted and seeds were washed 
sequentially with 70% ethanol (aq.), 0.5% NaOCl bleach solution containing 0.02% 
Tween-20, and repeatedly with autoclaved nanopure H2O until the odor of bleach was 
eliminated.  Typically, about 2 g of seed were treated with 10 mL of each solution.  The 
seeds were then placed on ½-strength MS agar plates containing sucrose (11 mM), MES 
(2.56 mM), pH 5.4, PPM (0.2%) and placed in an incubator at 22 °C with a 18 h light/6 h 
dark cycle. The light intensity was 100-µmol•m-2•s-1 at the level of the plants.  Seedlings 
for labeling experiments were staged for use when the first leaf unfurled (“Stage 5”). 
 
 
 
Figure 35: Stage 5 of E. purpurea seedlings used in feeding experiments 
 
3.2.2 Alkamide analysis 
Alkamides were extracted using a method modified by Hudaib et al. [168]. The 
seedlings were homogenized and ground with two aliquots of 70% v/v methanol. 
Samples were extracted with 2 mL n-hexane:ethyl acetate (1:1 v/v), vortexed, and 
centrifugation at 3500 rpm for 5 min. The organic phases were collected, pooled, and 
evaporated in a heated block (50-60 °C) under a stream of N2 gas. For LC-MS, analysis 
samples were dissolved in 200 µL of hexanes. For GC-MS analysis, the dried samples 
were dissolved in 1 ml of acetonitrile, and silylated by incubating at 70 °C for 20 min 
with 70 µl of N,O-bis(trimethylsilyl)trifluoroacetamide containing 1% 
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chlorotrimethylsilane. After evaporating the excess reagents under a stream of N2 gas, the 
samples were dissolved in acetonitrile. 
 
3.2.3 Isotopic labeling experiments 
Stable isotope incorporation experiments were performed in sterile 90-mm 
polystyrene Petri dishes each containing a 70-mm Whatman No. 1 filter disc and flooded 
with 6 mL of ½-strength MS containing MES (2.56 mM), PPM (0.2%). Chlorsulfuron 
(30 nM), methyl jasmonate (10 µM), amino acids (15 mM) and other precursors were 
added to the MS medium as required. Seedlings were placed on top of the paper and 
incubated at the germination conditions for 3 days. To synthesize deuterium-labeled 
alkamides and fatty acids, experiments were performed in sterile 90-mm glass Petri dish 
without a filter disc. Six mL of ½-strength MS containing MES (2.56 mM) and PPM 
(0.2%) liquid media with methyl jasmonate (10 µM) was pleased in the dish. The d3-
labeled lipids were dissolved in DMSO (50 mM) and 60 µL was added to the liquid 
media. L-valine-d8 (3.6 mg), used as an internal standard, was added to the liquid media.  
For LC-MS analysis, three seedlings were homogenized and extracted using a 
mortar and pestle with two aliquots of 70% (v/v) aqueous methanol. After centrifugation 
for 5 min, the pooled supernatants were extracted with two 2-mL aliquots of hexane-
EtOAc (1:1 v/v). The organic phases were collected and pooled for analysis. The MS 
parameters for triple quadrupole analysis (Agilent 6410) were as follows: MS2 full scan 
method, ESI positive mode, Fragmentor voltage: 135 V, Gas temperature: 300 °C, Gas 
flow: 10 L/min, Nebulizer pressure: 45 psi, Capillary: +/- 4000 V. The chromatographic 
parameters were: Waters XBridge-C18 column (4.6 x 150 mm, 5 µm particle size); 
Solvent A: H2O + 0.1% formic acid. Solvent B: CH3CN + 0.1% formic acid; Flow rate: 1 
mL/min; 70 → 100% B over 10 min with a 1-min hold and then ramped back to 70% B 
over 3 min; post time: 2 min. 
For GC/MS, the organic extracts were evaporated under a stream of N2 gas, 
dissolved in 1 mL of acetonitrile and silylated by incubating at 70 °C for 20 min with 70 
µL of N,O-bis(trimethylsilyl)trifluoroacetamide containing 1% chlorotrimethylsilane. 
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After evaporating the excess reagents under a stream of N2 gas, the samples were 
dissolved in 200 µL of acetonitrile and subjected to GC/MS analysis. 
For toxicity tests stock solutions of the synthesized compounds, 14:0 and 
NiBu/14:1Δ2E were made with 2-methoxyethanol. Dilutions from the stock solutions were 
made and 100, 50, 30, 20, and 5 mM concentrations were tested with E. purpurea. Two 
seedlings per concentration were used and 2 µL of the respective concentration were 
placed on both leaves of a stage 5 seedling; they were then grown for 3 days. 
 
3.2.4 Equations used to calculate incorporation levels 
 Two different equations were used to determine the isotopic incorporation levels 
in the analyzed natural products; the first determined the percentage of labeling across a 
complete isotopic envelope while the second was used to calculate the relative intensity 
of a specific isotopic peak by percentage. Equation 1 uses the sum of all abundances from 
mass isotopic peaks (M + 1, M + 2, M + 3…etc.) divided by the whole envelope. For the 
second equation, the abundance of the specific ion, for example M + 2, was divided by 
the parent ion. 
%  envelope labeled =  
[(M +1) + (M + 2) + (M + 3)…] 
X 100     (1) 
[(M) + (M + 1) + (M + 2) + (M + 3)…] 
   
 
% isotopic peak = 
[(M + n)] 
X 100     (2) 
[(M)] 
 
3.2.5 Fatty acid methyl ester preparation for MS analysis 
 Seedlings were also analyzed for their fatty acid content. Fatty acids from the 
plant were converted to their respective methyl esters for GC/MS analysis. Fatty acid 
methyl esters (FAMES) were prepared by the addition of 1 mL of 2% H2SO4 in methanol 
to three seedlings in a glass conical vial. The mixture was heated at 80 °C for 2 h. The 
reaction was quenched with 1 mL of H2O and extracted with two 1-mL hexanes.  The 
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organic layers were combined and evaporated at 60 °C under a stream of N2 gas before 
dissolving in 200 µL of hexane for GC/MS analysis.  
 
3.2.5.1 Protocols for alkamide and FAME analysis by GC/MS and LC/MS  
Chromatography by either gas or liquid chromatography was used for analyte 
separation in most experiments. Samples were injected via the system autosampler. The 
column and oven programs for GC/MS analysis were as follows. 
 
Figure 36: GC oven programs for alkamide analysis (GC1). 
Alkamides analysis were suspended in ACN, silylated with TMS, and analyzed 
with a HP-5 (30 m x 250 µm x 0.25 µm) column.  
GC/MS parameters were as follows:  
• Split-Splitless Inlet: Splitless 
• Inlet Temperature: 250 °C 
• Pressure: 15.408 psi 
• Septum Purge Flow: 3 mL/min 
• He Flow Rate: 1.56 mL/min for 56 min 
 
 
 
 
 
80 °C, 2 min 10 °C/min 
200 °C, 20 min 
3 °C/min  
250 °C, 5 min 
GC1: Silyated Alkamides 
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The scan parameters were as follows: 
• Solvent Delay: 6 min 
• Scan Speed: Normal 
• Start Mass: 50.00 amu; Stop Mass: 800.00 amu  
• Threshold: 150; Scans/sec: 1.99 
 
 
Figure 37: GC oven programs for FAMEs analysis from fatty acids (GC2) and FAMEs 
analysis from acyl-CoA (GC3). 
 
FAMES, including those determined during the analysis of acyl-CoAs, were suspended 
in hexanes and analyzed with a VF23 (30 m x 250 µm x 0.25 µm) column. 
 
GC/MS parameters were as follows:  
• Split-Splitless Inlet: Splitless  
• Inlet Temperature: 250 °C 
• Pressure: 16.834 psi 
• Septum Purge Flow: 3 mL/min; 
• He Flow Rate: A. 1.89 mL/min for 14 min; B. 1.89 mL/min for 24.6 min 
 
 
80 °C 10 °C/min 
150°C, 5 min 10°C/min  
220 °C, 1 min GC2: FAME 
Analysis 
 
A
. 
60 °C 
10 °C/min 
150°C, 5 min 
GC3: FAMEs from Acyl-CoAs 
 
B. 
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The scan parameters were as follows: 
• Solvent Delay: 6 min 
• Scan Speed: Normal 
• Start Mass: 50.00 amu; Stop Mass: 800.00 amu 
• Threshold: 150; Scans/sec: 1.99 
 
 
Figure 38: LC method for extracted alkamides. 
 
Alkamide analysis was completed on a triple quadrupole MS. Samples were 
injected via the autosampler with the use of a Waters XBridge-C18 column (4.6 x 150 
mm, 5 µm particle size). The mobile phase parameters are listed below. 
The source parameters were set as follows: 
• MS2 full scan method 
• ESI positive mode 
• Fragmentation: 135 V 
• Gas temp: 300 °C 
• Gas flow: 10 L/min 
• Nebulizer: 45 psi 
• Capillary: +/- 4000 V 
70% B 
10 min 
100% B; 1 min 
QQQ LC/MS: Alkamides 
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The parameters for the chromatograph were: 
• Solvent A: H2O + 0.1% formic acid. Solvent B: CAN + 0.1% formic acid 
• Flow rate: 1 mL/min; 70 è 100% B over 10 min with a 1-min hold and then 
ramped back to 70% B during the completion of the run 
• Run time: 14 min 
• Post time: 2 min 
 
3.2.6 Synthesis of aldehydes and [d3]-aldehydes 
General synthesis of terminal alkynes: A three-necked flask was equipped with 
a stopper, an addition funnel, and condenser. Dry 1,3-diaminopropane (30 mL, 360 mmol, 
36 equiv) was added to the round-bottom flask under N2. Lithium (0.4200 g, 60.52 mmol, 
6 equiv) was rinsed with hexane and cut into small pieces before being added to the 1,3-
diaminopropane. The mixture was stirred at RT for 30 min and then heated at 70 °C for 4 
h. The lithium reacted giving an initial blue color and then a white solid formed giving 
the suspension a gray-blue color. To this mixture, t-BuOK (4.4200 g, 39.4 mmol, 4 equiv) 
was added. The reaction was stirred for 20 min at room leading to a pale green solution 
and then the alcohol (9.98 mmol) was added dropwise over a 10-minute period. The 
addition funnel was washed with 1,3-diaminopropane (2 mL). After stirring for 30 min at 
room temperature, the reddish-orange solution was slowly poured over 100 mL of an 
ice/water mixture. The quenched reaction was extracted with hexane (4 x 50 mL). The 
organic phases were washed once with H2O (100 mL), 10% HCl (100 mL), and brine 
(100 mL). The organic layer was dried over sodium sulfate and solvent was removed by 
reduced pressure. 
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8-Nonyn-1-ol (28): Clear oil (72%). 1H NMR (500 MHz, CDCl3) 3.63 (t, J = 6.5 
Hz, 2H), 2.18 (td, J = 7.1, 2.5 Hz, 2H), 1.93 (t, J = 2.5 Hz, 1H), 1.47-1.63 (m, 4H), 1.23-
1.44 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 84.7, 68.1, 63.0, 32.7, 28.9, 28.7, 28.4, 25.6, 
18.4. 1H and 13C spectral data were similar to that previously reported [169]. 
 
 
 
9-Decyn-1-ol (29): Clear oil (80%). NMR (500 MHz, CDCl3) δ 3.64 (t, J = 6.6 
Hz, 2H), 2.18 (td, J =  7.1, 2.6 Hz, 2H), 1.93 (t, J = 2.6 Hz, 1H), 1.49-1.60 (m, 4H), 1.31-
1.43 (m, 8H); 13C NMR (125 MHz, CDCl3) δ 84.7, 68.1, 63.0, 32.8, 29.3, 29.0, 28.7, 28.4, 
25.7, 18.4. 1H and 13C spectral data were similar to that previously reported [170]. 
 
 
 
10-Undecynol (30): Lithium aluminum hydride (0.5588 g, 14.7 mmol, 2.1 equiv) 
was dissolved in dry THF (40 mL) in a 100-mL round-bottom flask. Undec-10-ynoic acid 
(1.2687 g, 6.96 mmol) dissolved in THF (10 mL) was added slowly and H2 gas was given 
off. The solution stirred at room temperature for 1 h. The reaction was quenched with 
H2O (10 mL). The organic layer was washed with 15% NaOH (7 mL) and H2O (5 mL). 
The salt was collected and washed with with EtOAc. The organic layer was dried with 
MgSO4 and solvent was removed under reduced pressure to yield 10-undecynol (1.0797 
g, 92%). IR (neat) 𝑣 3309, 2929, 2855, 2116, 1462, 1056; 1H NMR (500 MHz, CDCl3) δ 
3.64 (t, J = 6.8 Hz, 2H), 2.18 (td, J = 7.1, 2.7 Hz, 2H), 1.94 (t, J = 2.5 Hz, 1H), 1.49-1.59 
HO
3 HO 6
28non-3-yn-1-ol
HO 7
29
HO
4
dec-3-yn-1-ol
HO 8
30
HO
O
7
undec-10-ynoic acid
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(m, 4H), 1.30-1.42 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 84.8, 68.1, 63.1, 32.8, 29.4, 
29.3, 29.0, 28.7, 28.5, 25.7, 18.4. HRMS (ESI) m/z calcd for [M + H]+ C11H21O 169.1587, 
found 169.1612. 
 
General procedure to synthesize THP-protected alcohols: Alcohol (5.50 mmol) 
was dissolved in dry DCM (3.5 mL). DHP (6.60 mmol, 1.2 equiv) was added, and the 
solution stirred for 30 min. TsOH (0.55 mmol, 0.1 equiv) was added and reaction was 
stirred at room temperature for 20 h. The reaction was quenched by the addition of 1 M 
NaOH (3 mL) and mixture was allowed to stir for 30 min. The mixture was extracted 
with DCM, washed with brine, dried with MgSO4, and solvent was removed by rotary 
evaporation to give a dark red solution. The crude product was purified by column 
chromatography with hexane: EtOAc (5:1). 
 
 
 
2-(8-Nonyn-1-oxy)tetrahydro-2H-pyran (31): Clear oil (96%). 1H NMR (500 
MHz, CDCl3) δ 4.57 (dd, J = 2.8, 4.3 Hz, 1H), 3.87 (m, 1H), 3.73 (dt, J =  9.6, 6.9 Hz, 
1H), 3.50 (m, 1H), 3.38 (dt, J = 9.6, 6.7 Hz, 1H), 2.18 (td, J = 7.1, 2.7 Hz, 2H), 1.93 (t, J 
= 2.7 Hz, 1H), 1.82 (m, 1H), 1.71 (m, 1H), 1.50-1.63 (m, 8H), 1.31-1.44 (m, 6H); 13C 
NMR (125 MHz, CDCl3) δ 98.9, 84.7, 68.1, 67.6, 62.4, 30.8, 29.7, 28.9, 28.7, 28.4, 26.1, 
25.5, 19.7, 18.4. 1H and 13C spectral data were similar to that previously reported [171]. 
 
 
 
2-(9-Decyn-1-oxy)tetrahydro-2H-pyran (32): Clear oil (93%). 1H NMR (500 
MHz, CDCl3) δ 4.57 (t, J = 3.6 Hz, 1H), 3.87 (m, 1H), 3.72 (dt, J = 9.6, 6.9 Hz, 1H), 3.50 
(m, 1H), 3.38 (dt, J = 9.6, 6.7 Hz, 1H), 2.17 (td, J = 7.1, 2.6 Hz, 2H), 1.93 (t, J = 2.6 Hz, 
HO 6 THPO 6
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1H), 1.82 (m, 1H), 1.71 (m, 1H), 1.49-1.61 (m, 8H), 1.32-1.42 (m, 8H); 13C NMR (125 
MHz, CDCl3) δ 98.9, 84.8, 68.0, 67.6, 62.4, 30.8, 29.7, 29.3, 29.0, 28.7, 28.5, 26.2, 25.5, 
19.7, 18.4. 1H and 13C spectral data were similar to that previously reported [170]. 
 
 
 
2-(10-Undecyn-1-oxy)tetrahydro-2H-pyran (33): Clear oil (88%). 1H NMR 
(500 MHz, CDCl3) δ 4.57 (dd, J = 3, 4.5 Hz, 1H), 3.85-3.89 (m, 1H), 3.73 (dt, J = 9.5, 
7.0 Hz, 1H), 3.48-3.52 (m, 1H), 3.38 (dt, J = 9.5, 6.8 Hz, 1H), 2.18 (td, J = 7.3, 2.8 Hz, 
2H), 1.93 (t, J = 2.8 Hz, 1H), 1.80-1.84 (m, 1H), 1.74-1.69 (m, 1H), 1.49-1.62 (m, 8H), 
1.28-1.41 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 98.9, 84.8, 68.1, 67.7, 62.3, 30.8, 
29.7, 29.42, 29.39, 29.0, 28.7, 28.5, 26.2, 25.5, 19.7, 18.4. 1H and 13C spectral data were 
similar to that previously reported [172]. 
 
General procedure of methylation and d3-methylation: THP-protected alcohol 
(3.0 mmol) was dissolved in THF (5 mL). The solution was cooled to 0 °C and n-BuLi 
(2.4 M, 4.5 mmol, 1.5 equiv) was added slowly followed by the addition of MeI (4.5 
mmol, 1.5 equiv). The solution was stirred at 0 °C for 3 h after which H2O (15 mL) was 
added. The mixture was extracted with hexane, washed with H2O, and brine. The organic 
layer was dried with MgSO4 and the solvent was removed. 
 
 
 
2-(8-Decyn-1-oxy)tetrahydro-2H-pyran (34): Clear oil (58%). IR (neat) 𝑣 2934, 
2858, 1136, 1120, 1078, 1033, 986; 1H NMR (500 MHz, CDCl3) δ 4.57 (dd, J = 2.9, 4.3 
Hz, 1H), 3.87 (m, 1H), 3.73 (dt, J = 9.6, 6.9, 1H), 3.50 (m, 1H), 3.38 (dt, J = 9.6, 6.7, 1H), 
2.11 (m, 2H), 1.84 (m, 1H), 1.77 (t, J = 2.6 Hz, 3H), 1.71 (m, 1H), 1.48- 1.58 (m, 6H), 
HO 8 THPO 8
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1.47 (quint, J = 7.3 Hz, 2H), 1.28-1.40 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 98.9, 
79.4, 75.3, 67.6, 62.3, 30.8, 29.7, 29.03, 29.02, 28.8, 26.2, 25.5, 19.7, 18.7, 3.5. 
 
 
 
2-(9-Undecyn-1-oxy)tetrahydro-2H-pyran (35): Yellow oil (95%). IR (neat): 𝑣 
2932, 2856, 1454, 1351, 1200, 1136, 1120, 1078, 1032, 988; 1H NMR (500 MHz, CDCl3) 
δ 4.57 (t, J = 3.6 Hz, 1H), 3.87 (m, 1H), 3.72 (dt, J = 9.6, 6.9 Hz, 1H), 3.50 (m, 1H), 3.38 
(dt, J = 9.6, 6.7 Hz, 1H), 2.10 (m, 2H) 1.83 (m, 1H), 1.78 (t, J = 2.5 Hz, 3H), 1.71 (m, 
1H), 1.50-1.62 (m, 6H), 1.46 (quint, J = 7.3 Hz, 2H), 1.30-1.39 (m, 8H);; 13C NMR (125 
MHz, CDCl3) δ 98.9, 79.4, 75.3, 67.7, 62.3, 30.8, 29.7, 29.4, 29.1, 29.0, 28.8, 26.2, 25.5, 
19.7, 18.7, 3.5. HRMS (ESI) m/z calcd for [M + H]+ C16H29O2 253.2162 found 253.2157. 
 
 
 
2-(10-Dodecyn-1-oxy)tetrahydro-2H-pyran (36): Yellow oil (46%). IR (neat) 𝑣 
2929, 2855, 1454, 1351, 1200, 1136, 1120, 1078, 1032, 988; 1H NMR (500 MHz, CDCl3) 
δ 4.57 (t, J = 3.5 Hz, 1H), 3.84-3.89 (m, 1H), 3.72 (dt, J =10.0, 6.8 Hz, 1H), 3.47-3.51 (m, 
1H), 3.37 (dt, J = 9.5, 6.8 Hz, 1H), 2.10 (m, 2H), 1.79-1.86 (m, 1H), 1.77 (t, J = 2.5 Hz, 
3H), 1.68-1.74 (m, 1H), 1.49-1.58 (m, 6H), 1.46 (quint, J = 7.3 Hz, 2H), 1.25-1.38 (m, 
10H); 13C NMR (125 MHz, CDCl3) δ 98.9, 79.4, 75.3, 67.7, 62.3, 30.8, 29.8, 29.5, 29.4, 
29.1, 29.0, 28.9, 26.2, 25.5, 19.7, 18.7, 3.5.  
 
 
THPO 7
32
THPO 7
35
THPO 8
33
THPO 8
36
109 
 
 
 
[10,10,10-2H3]-2-(8-Decyn-1-oxy)tetrahydro-2H-pyran (37): Yellow oil (79%). 
IR (neat) 𝑣 2934, 2857, 2216, 2213, 1163, 1120, 1078, 1033; 1H NMR (500 MHz, CDCl3) 
δ 4.57 (dd, J = 3.0, 4.3 Hz, 1H), 3.87 (m, 1H), 3.73 (dt, J = 9.6, 6.9 Hz, 1H), 3.50 (m, 1H), 
3.38 (dt, J = 9.6, 6.7 Hz, 1H), 2.11 (t, J = 7.1 Hz, 2H), 1.83 (m, 1H), 1.71 (m, 1H), 1.50-
1.60 (m, 6H), 1.47 (quint, J = 7.4 Hz, 2H), 1.28-1.41 (m, 6H); 13C NMR (125 MHz, 
CDCl3) δ 98.9 79.4, 75.3, 67.7, 62.3, 30.8, 29.7, 29.03, 29.02, 28.8, 26.2, 25.5, 19.7, 18.7.  
 
 
 
[11,11,11-2H3]-2-(9-Undecyn-1-oxy)tetrahydro-2H-pyran (38): Yellow oil 
(73%). IR (neat) 𝑣 2932, 2856, 2213, 2113, 1200, 1136, 1120, 1078, 1032, 988; 1H NMR 
(500 MHz, CDCl3) δ 4.57 (t, J = 3.6 Hz, 1H), 3.84-3.89 (m, 1H), 3.72 (dt, J = 9.6, 6.9 Hz, 
1H), 3.47-3.52 (m, 1H), 3.38 (dt, J = 9.6, 6.7 Hz, 1H), 2.11 (t, J = 7.1 Hz, 2H) 1.78-1.86 
(m, 1H), 1.68-1.74 (m, 1H), 1.50-1.62 (m, 6H), 1.46 (quint, J = 7.3 Hz, 2H), 1.25-1.39 (m, 
8H) ; 13C NMR (125 MHz, CDCl3) δ 98.9, 79.4, 75.3, 67.7, 62.3, 30.8, 29.7, 29.4, 29.1, 
29.0, 28.8, 26.2, 25.5, 19.7, 18.7.  
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[12,12,12-2H3]-2-(10-Dodecyn-1-oxy)tetrahydro-2H-pyran (39): Yellow oil 
(88%). IR (neat) 𝑣 2930, 2855, 2213, 2113, 1464, 1351, 1200, 1136, 1120, 1078, 1033, 
988; 1H NMR (500 MHz, CDCl3) δ 4.57 (dd, J = 3.0, 4.0 Hz, 1H), 3.84-3.89 (m, 1H), 
3.72 (dt, J = 9.5, 6.9 Hz, 1H), 3.47-3.51 (m, 1H), 3.37 (dt, J = 9.5, 6.8 Hz, 1H), 2.10 (t, J 
= 7.3 Hz, 2H) 1.79-1.86 (m, 1H), 1.68-1.74 (m, 1H), 1.49-1.61 (m, 6H), 1.46 (quint, J = 
7.8 Hz, 2H), 1.23-1.38 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 98.9, 79.4, 75.3, 67.7, 
62.3, 30.8, 29.8, 29.5, 29.4, 29.1, 29.0, 28.9, 26.2, 25.5, 19.7, 18.7.  
 
General procedure for the reduction of alkynes: NaI (5.76 mmol, 3 equiv) was 
dissolved in THF (3 mL) and cooled to -20 °C in an acetone/dry ice bath. The 
Wilkinson’s catalyst (0.194 mmol, 0.1 equiv) was added. The acetylenic compound 
(0.4964 g, 1.94 mmol) was added slowly. After purging with argon, the mixture was 
flushed with hydrogen and heated at 45 °C for 2.5 h. The mixture was cooled to room 
temperature and was stirred for 17 h. Excess catalyst was filtered and the THF removed. 
The crude product was purified by column chromatography with hexane: EtOAc (5:1). 
 
 
 
2-Decanoxytetrahydro-2H-pyran (40): Clear oil (63%). 1H NMR (500 MHz, 
CDCl3) δ 4.58 (t, J = 3.5 Hz, 1H), 3.88 (m, 1H), 3.73 (dt, J = 9.5, 7.0 Hz, 1H), 3.50 (m, 
1H), 3.38 (dt, J = 9.5, 6.8 Hz, 1H), 1.83 (m, 1H), 1.72 (m, 1H), 1.49-1.62 (m, 6H), 1.23-
1.39 (m, 14H), 0.88 (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 98.9, 67.7, 62.3, 
31.9, 30.8, 29.8, 29.6, 29.5, 29.4, 29.3, 26.2, 25.5, 22.7, 19.7, 14.1. 1H and 13C spectral 
data were similar to that previously reported [173]. 
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2-Undecanoxytetrahydro-2H-pyran (41): Clear oil (65%). IR (neat): 𝑣 2925, 
2854, 1464, 1352, 1260, 1201, 1127, 1079, 1034, 988, 870, 814; 1H NMR (500 MHz, 
CDCl3) δ 4.57 (t, J = 3.6 Hz, 1H), 3.87 (m, 1H), 3.73 (dt, J = 9.5, 6.9 Hz, 1H), 3.50 (m, 
1H), 3.38 (dt, J = 9.6, 6.7 Hz, 1H), 1.82 (m, 1H), 1.71 (m, 1H), 1.49-1.62 (m, 6H), 1.24-
1.35 (m, 16H), 0.88 (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 98.8, 67.7, 62.3, 
31.9, 30.8, 29.8, 29.62, 29.60, 29.5, 29.4, 29.3, 26.2, 25.5, 22.7, 19.7, 14.11.  
 
 
 
Dodecanoxytetrahydro-2H-pyran (42): Clear oil (90%). IR (neat) 𝑣 2924, 2853, 
1119, 1078, 1033; 1H NMR (500 MHz, CDCl3) δ 4.57 (dd, J = 3.0, 4.0 Hz, 1H), 3.87 (m, 
1H), 3.73 (dt, J = 9.5, 7.0 Hz, 1H), 3.50 (m, 1H), 3.38 (dt, J = 9.5, 6.8 Hz, 1H), 1.80-1.86 
(m, 1H), 1.67-1.74 (m, 1H), 1.50-1.62 (m, 6H), 1.24-1.35 (m, 18H), 0.88 (t, J = 6.5 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 98.9, 67.7, 62.3, 31.9, 30.8, 30.3, 29.8, 29.7, 29.6, 
29.6, 29.5, 29.4, 26.3, 25.5, 22.7, 19.7, 14.11. HRMS (ESI) m/z calcd for [M + H]+ 
C17H35O2 271.2632, found 271.2632. 
 
 
 
[10,10,10-2H3]-2-Decanoxytetrahydro-2H-pyran (43): Clear oil (78%). IR (neat) 𝑣 2924, 2854, 2212,1122, 1078, 1033; 1H NMR (500 MHz, CDCl3) δ 4.58 (dd, J = 2.9, 
4.3 Hz, 1H), 3.87 (m, 1H), 3.73 (dt, J = 9.6, 6.9 Hz, 1H), 3.38 (dt, J = 9.6, 6.7 Hz, 1H), 
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1.83 (m, 1H), 1.71 (m, 1H), 1.49-1.62 (m, 6H), 1.23-1.38 (m, 14H); 13C NMR (125 MHz, 
CDCl3) δ 98.9, 67.7, 62.3, 31.8, 30.8, 29.8, 29.62, 29.60, 29.5, 29.4, 26.2, 25.5, 22.4, 19.7.  
 
 
 
[11,11,11-2H3]-2-Undecanoxytetrahydro-2H-pyran (44): Clear oil (71%). IR 
(neat) 𝑣 2924, 2854, 2213, 1464, 1351, 1200, 1183, 1122, 1078, 1033, 988, 905, 869; 1H 
NMR (500 MHz, CDCl3) δ 4.58 (t, J = 3.6 Hz, 1H), 3.87 (m, 1H), 3.73 (dt, J = 9.6, 7.0 
Hz, 1H), 3.50 (m, 1H), 3.38 (dt, J = 9.6, 6.7 Hz, 1H), 1.82 (m, 1H), 1.71 (m, 1H), 1.49-
1.62 (m, 6H), 1.25-1.35 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 98.9, 67.7, 62.3, 31.8, 
30.8, 29.8, 29.62, 29.60, 29.5, 29.4, 26.2, 25.5, 22.4, 19.7. HRMS (ESI) m/z calcd for [M 
+ H]+ C16H30D3O2 274.2820, found 274.2819. 
 
 
 
[12,12,12-2H3]-2-Dodecanoxytetrahydro-2H-pyran (45): Light yellow oil 
(49%). IR (neat) 𝑣 2924, 2853, 2213, 1122, 1078, 1032; 1H NMR (500 MHz, CDCl3) δ 
4.57 (dd, J = 3.8, 4.3 Hz, 1H), 3.85-3.90 (m, 1H), 3.73 (dt, J = 9.5, 7.0 Hz, 1H), 3.48-3.52 
(m, 1H), 3.38 (dt, J = 9.5, 6.6 Hz, 1H), 1.80-1.86 (m, 1H), 1.68-1.74 (m, 1H), 1.49-1.62 
(m, 6H), 1.23-1.38 (m, 18H); 13C NMR (125 MHz, CDCl3) δ 98.8, 67.7, 62.3, 31.8, 30.8, 
29.8, 29.7, 29.64, 29.62, 29.61, 29.5, 29.4, 26.3, 25.5, 22.4, 19.7.  
 
General procedure for removing a THP-protecting group: The protected 
alcohol (0.4938 g, 2.01 mmol) was dissolved in methanol (12 mL) in a 25-mL round-
bottom flask. Solid p-toluenesulfonic acid monohydrate (0.0760 g, 0.400 mmol, 0.2 equiv) 
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was added. The reaction was stirred at RT for 2 h before NaOH (1 M, 10 mL) was added 
followed by H2O (26 mL). The mixture was extracted with diethyl ether (10 mL). The 
combined organic layers were washed with brine (10 mL), dried with MgSO4, and ether 
was removed by rotary evaporation. 
 
 
 
Decanol (46): Clear oil (91%). 1H NMR (500 MHz, CDCl3) δ 3.63 (t, J = 6.6 Hz, 
2H), 1.56 (quint, J = 6.9 Hz, 2H), 1.24-1.37 (m, 14H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 63.1, 32.8, 31.9, 29.6, 29.5, 29.4, 29.3, 25.8, 22.7, 14.1. 1H and 13C 
spectral data were similar to that previously reported [174]. 
 
 
 
 Undecanol (47): Clear oil (61%). 1H NMR (500 MHz, CDCl3) δ 3.64 (t, J = 6.6 
Hz, 2H), 1.56 (quint, J = 6.7 Hz, 2H), 1.24-1.37 (m, 16H), 0.87 (t, J = 6.6 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 63.1, 32.8, 31.9, 29.61, 29.60, 29.4, 29.3, 25.8, 22.7, 14.1. 1H 
and 13C spectral data were similar to that previously reported [175]. 
 
 
 
 Dodecanol (48): Clear oil (54%). 1H NMR (500 MHz, CDCl3) δ 3.64 (t, J = 6.8 
Hz, 2H), 1.56 (quint, J = 6.8 Hz, 2H), 1.22-1.35 (m, 18H), 0.88 (t, J = 6.8 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 63.1, 32.8, 31.9, 29.7, 29.64, 29.62, 29.60, 29.4, 29.3, 25.7, 
22.6, 14.1. 1H and 13C spectral data were similar to that previously reported [176]. 
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[10,10,10-2H3]-Decanol (49): Clear oil (76%). IR (neat) 𝑣 3336 (br), 2924, 2854, 
2212, 1463, 1056; 1H NMR (500 MHz, CDCl3) δ 3.64 (t, J = 6.7 Hz, 2H), 1.57 (quint, J = 
7.0 Hz, 2H), 1.21-1.36 (m, 14 H); 13C NMR (125 MHz, CDCl3) δ 63.1, 32.8, 31.8, 29.6, 
29.5, 29.4, 29.3, 25.7, 22.4.  
 
 
 
[11,11,11-2H3]-Undecanol (50): Light yellow oil (93%). IR (neat): 𝑣 3330 (br), 
2924, 2854, 2213, 1464, 1056; 1H NMR (500 MHz, CDCl3) δ 3.63 (t, J = 6.7 Hz, 2H), 
1.56 (quint, J = 7.0 Hz, 2H), 1.26-1.38 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 63.1, 
32.8, 31.8, 29.61, 29.60, 29.59, 29.4, 29.3, 25.7, 22.4.  
 
 
 
[12,12,12-2H3]-Dodecanol (51): Light yellow oil (72%) IR (neat) 𝑣 3329, 2924, 
2854, 2213, 1463, 1056; 1H NMR (500 MHz, CDCl3) δ 3.64 (t, J = 6.6 Hz, 2H), 1.56 
(quint, J = 6.8 Hz, 2H), 1.25 (m, 18H); 13C NMR (125 MHz, CDCl3) δ 63.1, 32.8, 31.8, 
29.7, 29.64, 29.62, 29.60, 29.4, 29.3, 29.2, 25.8, 22.4.  
 
General procedure for the oxidation of alcohols to aldehydes: DMP (0.7144 g, 
1.68 mmol, 1.1 equiv) was dissolved in DCM (10 mL) in a 50-mL round-bottom flask. In 
a separate vial, the respective alcohol (0.2462 g, 1.53 mmol) was dissolved in DCM (10 
mL) and added to the stirred DMP solution. The reaction stirred at room temperature for 
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2 h. Et2O (25 mL) was added followed by NaOH (1 M, 10 mL), and then the mixture 
stirred for 10 min at room temperature. The Et2O layer was extracted, washed with H2O, 
dried with MgSO4, and solvent was removed. The crude product was purified by column 
chromatography with hexane: EtOAc (1:1). 
 
 
 
Decanal (52): Clear oil (87%). 1H NMR (500 MHz, CDCl3) 9.76 (t, J = 1.8 Hz, 
1H), 2.41 (dt, J = 1.8, 7.4 Hz, 2H), 1.62 (quint, J = 7.0 Hz, 2H), 1.25-1.30 (m, 12H), 0.87 
(t, J  = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 203.0, 43.9, 31.9, 29.4, 29.3, 29.2, 
29.1, 22.7, 22.1, 14.1. 1H and 13C spectral data were similar to that previously reported 
[177]. 
 
 
 
 Undecanal (53): Clear oil  (86%). 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.9 
Hz, 1H), 2.41 (t, J = 1.9, 7.3 Hz, 2H), 1.62 (quint, J = 7.0 Hz, 2H), 1.25-1.30 (m, 14H), 
0.88 (t, J  = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 203.0, 43.9, 31.9, 29.6, 29.5, 
29.4, 29.2, 29.1, 22.7, 22.1, 14.1. 1H data were similar to that previously reported [178]. 
 
 
 
Dodecanal (54): Clear oil (94%). 1H NMR (500 MHz, CDCl3) δ 9.96 (t, J =1.8 
Hz, 1H), 2.41 (dt, J = 1.8, 7.4 Hz, 2H), 1.62 (quint, J = 7.1 Hz, 2H), 1.22-1.38 (m, 16H), 
0.87 (t, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 203.0, 43.9, 31.9, 29.9, 29.6, 
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29.4, 29.3, 29.2, 24.7, 22.7, 22.1, 14.1. 1H and 13C data were similar to that previously 
reported [179] 
 
 
 
[10,10,10-2H3]-Decanal (55): Light yellow (58%). IR (neat) 𝑣 2926, 2855, 2713, 
2212, 2085, 1728, 1466, 948; 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.9 Hz, 1H), 
2.42 (td, J = 7.4, 1.9 Hz, 2H), 1.63 (quint, J = 7.3 Hz, 2H), 1.21-1.33 (m, 12H); 13C NMR 
(125 MHz, CDCl3) δ 202.9, 43.9, 31.8, 29.4, 29.35, 29.25, 29.20, 22.4, 22.1.  
 
 
 
[11,11,11-2H3]-Undecanal (56): Clear oil (80%). IR (neat) 𝑣 2924, 2855, 2212 
1728, 1463, 1256; 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.8 Hz, 1H), 2.41 (td, J = 
1.8, 7.4 Hz, 2H), 1.63 (quint, J = 7.3 Hz, 2H), 1.25-1.30 (m, 14H); 13C NMR (125 MHz, 
CDCl3) δ 203.0, 43.9, 31.8, 29.5, 29.4, 29.34, 29.30, 29.2, 22.4, 22.1.  
 
 
 
[12,12,12-2H3]-Dodecanal (57): Clear oil (96%). IR (neat) 𝑣 2925, 2854, 2713, 
2213 1727, 1463; 1H NMR (500 MHz, CDCl3) δ 9.76 (s, 1H); 2.41 (t, J = 7.3 Hz, 2H), 
1.62 (quint, J = 7.0 Hz, 2H), 1.25-1.30 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 203.0, 
43.9, 31.8, 29.6, 29.5, 29.4, 29.36, 29.34, 29.2, 22.4, 22.1.  
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3.2.7 Synthesis of alkamides and [d3]-alkamides 
 
 
 
Ethyl 2-(diethoxyphosphoryl)acetate (58): Ethyl bromoacetate (6.2094 g, 31.20 
mmol) and triethyl phosphite (5.4481 g, 32.76 mmol, 1.05 equiv) were added to a round-
bottom flask. The mixture was heated at 100 °C for 6 h. The reaction was cooled to room 
temperature to give clear liquid, ethyl 2-(diethoxyphosphoryl)acetate (6.9929 g, 99%). 1H 
NMR (500 MHz, CDCl3) δ 4.14 (m, 6H), 2.93 (d, J = 21.5 Hz, 2H), 1.32 (t, J = 7 Hz, 6H), 
1.26 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 167.8 (d, J = 6.3 Hz), 62.7 (d, J = 
6.3 Hz), 61.5, 34.4 (d, J = 133.8 Hz), 16.3 (d, J = 6.3 Hz), 14.1. 1H and 13C spectral data 
were similar to that previously reported [180]. 
 
 
 
 2-(Diethoxyphosphoryl)acetic acid (59): Triethyl phosphonoacetate 58 (5.0046 
g, 22.32 mmol) was dissolved in H2O (3 mL) and cooled to 0 °C. NaOH (10 N, 2.7 mL, 
1.2 equiv) was added dropwise to the stirred reaction mixture. When the base was added, 
the reaction was stirred for 1 h at 0 °C before being warmed to room temperature and 
stirred for an additional 2 h. The solution was cooled back down to 0 °C and 12 N HCl 
was added until the solution was at a pH of 1. The solution was extracted with DCM and 
washed with saturated NaCl. The organic layer was dried down to give a pale yellow 
liquid, 2-(diethoxyphosphoryl)acetic acid (4.0198 g, 92%). 1H NMR (500 MHz, CDCl3) 
δ 4.20 (m, 4H), 3.00 (d, J = 22 Hz, 2H), 1.34 (t, J = 7.3 Hz, 6H); 13C NMR (125 MHz, 
CDCl3) δ 167.9 (d, J = 5.0 Hz), 63.5 (d, J =6.3 Hz), 34.3 (d, J = 133.8 Hz), 16.4 (d, J = 
6.3 Hz). 1H and 13C spectral data were similar to that previously reported [181]. 
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Diethyl (2-isobutylamino-2-oxoethyl)phosphonate (60): 2-
(Diethoxyphosphoryl)acetic acid 59 (0.3943 g, 2.01 mmol) was dissolved in dry DCM (5 
mL). CDI (0.3244 g, 2.01 mmol, 1 equiv) was dissolved in DCM (5 mL) and added to the 
stirred solution. After stirring at room temperature for 30 min, isobutylamine (0.146 g, 
2.01 mmol, 1 equiv) was added and the reaction was stirred at room temperature 
overnight. The reaction was quenched with saturated NaHCO3, extracted with DCM, and 
dried with MgSO4. The solvent was removed to give a light yellow oil, diethyl (2-
isobutylamino-2-oxoethyl)phosphonate (0.2601 g, 51 %). IR (neat) 𝑣 3295, 3084, 2961, 
2931, 2871, 1659, 1556, 1443, 1319, 1292, 1246, 1098, 969, 731; 1H NMR (500 MHz, 
CDCl3) δ 4.09-4.15 (m, 4H), 3.08 (t, J = 6.6 Hz, 2H), 2.82 (d, J = 20.5, 2H), 1.77 (sept, J 
= 6.8 Hz, 1H), 1.32 (t, J = 7 Hz, 6H), 0.91 (d, J = 7 Hz, 6H); 13C NMR (125 MHz, CDCl3) 
δ 163.9 (d, J = 13.6 Hz), 62.7 (d, J = 25.7), 47.2, 35.5, 34.4, 28.4, 20.0, 16.3 (d, J =24.3); 
HRMS (ESI) m/z calcd for [M + H]+ C10H22NO4P 252.1359, found 252.1347. 
  
General procedure for the synthesis of NiBu/12:12E, NiBu/13:12E, NiBu/14:12E, 
d3-NiBu/12:12E, d3-NiBu/13:12E, d3-NiBu/14:12E: A procedure similar to the method of 
Matovic was used [182]. NaH (60%, 0.87 mmol, 1.1 equiv) is suspended in dry ether (4 
mL) and cooled to 0 °C, then the phosphonate 60 (0.2000 g, 0.79 mmol) was added 
slowly and H2 given off. After stirring for 15 min, the aldehyde (0.87 mmol, 1.1 equiv) in 
diethyl ether (0.3 mL) was added and reaction stirred for 10 min. The ice bath was 
removed and the reaction was quenched with H2O (10 mL). The reaction was extracted 
with hexanes (10 mL), washed with H2O (2 x 5 mL), brine (5 mL), and dried with 
MgSO4. The solvent was removed and the crude product was purified by column 
chromatography with hexane: EtOAc (3:1). 
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 (E)-N-Isobutyl-2-dodecenamide (61): White crystals (51%). 1H NMR (500 MHz, 
CDCl3) δ 6.82 (dt, J = 7, 15 Hz, 1H), 5.75 (d, J = 15 Hz, 1H), 3.15 (t, J = 6.8 Hz, 2H), 
5.45 (br, 1H), 2.16 (q, J = 7.3 Hz, 2H), 1.79 (sept, J = 6.8 Hz, 1H), 1.43 (m, 2H), 1.25-
1.30 (m, 12H), 0.92 (d, J = 7 Hz, 6H), 0.88 (t, J = 7 Hz, 3H); 13C NMR (125 MHz, CDCl3) 
δ 166.1, 144.8, 123.6, 46.8, 32.0, 31.9, 29.5, 29.4, 29.3, 29.2, 28.6, 28.3, 22.7, 20.1, 14.1; 
1H data was similar to that previously reported [183]. 
 
 
 
(E)-N-Isobutyl-2-tridecenamide (62): White crystals (49%). IR (KBr pellet) 𝑣 
3304, 2951, 2924, 2854, 1668, 1631, 1550, 1466, 1371, 1265, 1160, 982, 721; 1H NMR 
(500 MHz, CDCl3) δ 6.82 (dt, J = 15, 7 Hz, 1H), 5.75 (d, J = 15.5 Hz, 1H), 5.49 (br, 1H), 
3.14 (t, J = 6.5 Hz, 2H), 2.16 (q, J = 7.3 Hz, 2H), 1.79 (sept, J = 6.8 Hz, 1H), 1.43 (m, 
2H), 1.23-1.29 (m, 14H), 0.92 (d, J = 6.5 Hz, 6H), 0.88 (t, J = 7 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 166.1, 144.8, 123.6, 46.8, 32.0, 31.9, 29.6, 29.5, 29.4, 29.3, 29.2, 28.6, 
28.3, 22.7, 20.1, 14.1; HRMS (ESI) m/z calcd for [M + H]+ C17H34NO 268.2635, found 
268.2623. 
 
 
 
 (E)-N-Isobutyl-2-tetradecenamide (63): White crystals (52%). IR (KBr pellet) 𝑣 
3309, 2955, 2921, 2850, 1665, 1619, 1543, 1468, 1370, 986, 972; 1H NMR (500 MHz, 
N
H
P
OO
EtO
OEt
60
O
N
H8
61
N
H
P
OO
EtO
OEt
60
O
N
H9
62
N
H
P
OO
EtO
OEt
60
O
N
H10
63
120 
 
CDCl3) δ 6.82 (dt, J = 15, 7 Hz, 1H), 5.75 (d, J = 15.5 Hz, 1H), 5.42 (br, 1H), 3.15 (t, J = 
6.5 Hz, 2H), 2.16 (q, J = 7.3 Hz, 2H), 1.80 (sept, J = 6.7 Hz, 1H), 1.43 (m, 2H), 1.25-1.31 
(m, 18H), 0.92 (d, J = 6.5 Hz, 6H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) 
δ 166.1, 144.8, 123.6, 46.8, 32.0, 31.9, 29.64, 29.62, 29.5, 29.4, 29.3, 29.2, 28.6, 28.3, 
22.7, 20.1, 14.1; HRMS (ESI) m/z calcd for [M + H]+ C18H36NO 282.2791, found 
282.2799. 
 
 
 
[12,12,12-2H3]-(E)-N-Isobutyl-2-dodecenamide (64): White crystals, (30%). IR (neat) 𝑣 
3301, 3084, 2957, 2921, 2851, 2212, 1667, 1553, 1466, 1369, 1339, 1271, 1224, 1160, 
979, 665 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.82 (dt, J = 15.2, 7.3 Hz, 1H), 5.75 (d, J 
=15.3 Hz, 1H), 5.49 (br, 1H), 3.14 (t, J = 7.1 Hz, 2H), 2.15 (q, J  = 7.2 Hz, 2H), 1.79 
(nonet, J = 6.7 Hz, 1H), 1.43 (quint, J = 7.1 Hz, 2H), 1.25-1.33 (m, 12H), 0.92 (d, J = 6.7 
Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 166.1, 144.7, 123.6, 46.8, 32.0, 31.8, 29.5, 29.4, 
29.3, 29.2, 28.6, 28.3, 22.4, 20.1. 
 
 
 
[13,13,13-2H3]-(E)-N-Isobutyl-2-tridecenamide (65): White crystals (24%). IR (neat) 𝑣 3304, 2921, 2211, 2851, 1666, 1625, 1552; 1H NMR (500 MHz, CDCl3) δ 6.82 (dt, J = 
7.1, 15.3 Hz, 1H), 5.75 (d, J = 15.3 Hz, 1H), 5.51 (br, 1H), 3.14 (t, J = 6.5 Hz, 2H), 2.15 
(q, J = 7.2 Hz, 2H), 1.79 (nonet, J = 6.7 Hz, 1H), 1.43 (quint, J = 7.2 Hz, 2H), 1.23-1.31 
(m, 14H), 0.92 (d, J = 6.7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 166.1, 144.7, 123.6, 
46.8, 32.0, 31.8, 29.6, 29.5, 29.4, 29.3, 29.2, 28.6, 28.3, 22.4, 20.1; HRMS (ESI) m/z 
calcd for [M + H]+ C17H31D3NO 271.2823, found 271.2818. 
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[14,14,14-2H3]-(E)-N-Isobutyl-2-tetradecenamide (66): White crystals (44%). IR (neat) 𝑣 3304, 3083, 2956, 2920, 2850, 2212, 1666, 1624, 1552, 1466; 1H NMR (500 MHz, 
CDCl3) δ 6.83 (dt, J = 7.3, 15.3 Hz, 1H), 5.75 (d, J = 15.2 Hz, 1H), 5.42 (br, 1H), 3.15 (t, 
J = 6.5 Hz, 2H), 2.16 (q, J = 7.1 Hz, 2H), 1.80 (nonet, J = 6.7 Hz, 1H), 1.43 (quint, J = 
7.0 Hz, 2H), 1.25-1.37 (m, 16H), 0.92 (d, J = 6.7 Hz, 6H); 13C NMR (125 MHz, CDCl3) 
δ 166.1, 144.8, 123.6, 46.8, 32.0, 31.8, 29.6, 29.5, 29.4, 29.3, 29.2, 28.6, 28.3, 22.4, 20.1; 
HRMS (ESI) m/z calcd for [M + H]+ C18H33D3NO 285.2980, found 285.2999. 
 
3.2.8 Synthesis of fatty acids and [d3]-fatty acids 
 
General procedure for the synthesis of α,β-unsaturated ethyl esters: NaH 
(60%, 1.1 mmol, 1.1 equiv) was suspended in dry ether (4 mL) in a 15-mL round-bottom 
flask and cooled to 0 °C. The phosphonate 58 (0.22 g, 0.98 mmol) was added slowly; H2 
was given off. After stirring for 15 min, the aldehyde (1.08 mmol, 1.1 equiv) in diethyl 
ether (0.3 mL) was added dropwise and reaction was stirred for 10 min. The ice bath was 
removed and the reaction was quenched with H2O (10 mL). The mixture was extracted 
with hexane (10 mL). The organic layer washed with H2O (2 x 5 mL), saturated brine (5 
mL), and dried with MgSO4. The solvent was removed and the crude product was 
purified by column chromatography with hexane: EtOAc (20:1). 
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 Ethyl (E)-2-dodecenoate (67): Clear oil (51%). 1H NMR (500 MHz, CDCl3) δ 
6.96 (dt, J = 16.0, 6.9 Hz, 1H), 5.80 (d, J = 15.5 Hz, 1H), 4.18 (q, J = 7.2 Hz, 2H), 2.19 
(q, J = 7.3 Hz, 2H), 1.42-1.46 (m, 2H), 1.26-1.30 (m, 15H), 0.88 (t, J = 6.8 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 166.8, 149.5, 121.2, 60.1, 32.2, 31.9, 29.5, 29.4, 29.3, 29.1, 
28.0, 22.7, 14.2, 14.1. 1H and 13C spectral data were similar to previously reported data 
[184] 
 
 
 
 Ethyl (E)-2-tridecenoate (68): Clear oil (59%). 1H NMR (500 MHz, CDCl3) δ 
6.96 (dt, J = 15.5, 7 Hz, 1H), 5.81 (d, J = 15.5 Hz, 1H), 4.18 (q, J = 7.2 Hz, 2H), 2.19 (q, 
J = 7.2 Hz, 2H), 1.42-1.46 (m, 2H), 1.26-1.30 (m, 17H), 0.88 (t, J = 7 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 166.8, 149.5, 121.2, 60.1, 32.2, 31.9, 29.6, 29.5, 29.4, 29.3, 29.1, 
28.0, 22.7, 14.3, 14.1. 1H and 13C spectral data were similar to that previously reported 
[185]. 
 
 
 
 Ethyl (E)-2-tetradecenoate (69): Clear oil (48%). 1H NMR (500 MHz, CDCl3) δ 
6.96 (dt, J = 15.5, 7 Hz, 1H), 5.80 (d, J = 15.5 Hz, 1H), 4.18, (q, J = 7 Hz, 2H), 2.18 (q, J 
= 7.2 Hz, 2H), 1.41-1.47 (m, 2H), 1.26-1.30 (m, 19H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 166.8, 149.5, 121.2, 60.1, 32.2, 31.9, 29.62, 29.61, 29.5, 29.4, 29.3, 
O
P
OO
EtO
OEt
O
O8
58 67
O
P
OO
EtO
OEt
O
O9
58 68
O
P
OO
EtO
OEt
O
O10
58 69
123 
 
29.1, 28.0, 22.7, 14.3, 14.1. 1H spectral data was similar to that previously reported in 
reference [186]. 
 
 
 
[12,12,12-2H3]-Ethyl (E)-2-dodecenoate (70): Clear oil  (39%). IR (neat) 𝑣 2925, 
2855, 1724, 2212, 1723, 1654, 1462, 1264, 1180, 1044; 1H NMR (500 MHz, CDCl3) δ 
6.96 (dt, J = 15.7, 7.0 Hz, 1H), 5.81 (dt, J = 15.7, 1.5 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 
2.19 (q, J = 7.0 Hz, 2H), 1.45 (quint, J = 7.2 Hz, 2H), 1.25-1.36 (m, 15H); 13C NMR (125 
MHz, CDCl3) δ 166.8, 149.5, 121.2, 60.1, 32.2, 29.7, 29.5, 29.4, 29.3, 29.1, 28.0, 22.4, 
14.3.  
 
 
 
[13,13,13-2H3]-Ethyl (E)-2-tridecenoate (71): Clear oil (96%). IR (neat): 2925, 
2855, 2212, 1724, 1264, 1180 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.96 (dt, J = 15.7, 7.0 
Hz, 1H), 5.81 (d, J = 15.7 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.18 (q, J = 7.1 Hz, 2H), 
1.45 (quint, J = 7.2 Hz, 2H), 1.25-1.36 (m, 17H); 13C NMR (125 MHz, CDCl3) δ 166.8, 
149.5, 121.2, 60.1, 32.2, 29.7, 29.6, 29.5, 29.4, 29.3, 29.1, 28.0, 22.4, 14.3. HRMS (ESI) 
m/z calcd for [M + H]+ C15H26D3O2 244.2350, found 244.2357. 
 
 
 
 [14,14,14-2H3]-Ethyl (E)-2-tetradecenoate (72): Clear oil (79%). IR (neat) 
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𝑣 2924, 2854, 2213 1723, 1264, 1179; 1H NMR (500 MHz, CDCl3) δ 6.96 (dt, J = 15.7, 
7.4 Hz, 1H), 5.81 (d, J = 15.6 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.19 (q, J = 7.1 Hz, 2H), 
1.44 (m, 2H), 1.23-1.30 (m, 19H); 13C NMR (125 MHz, CDCl3) δ 166.8, 149.5, 121.2, 
60.1, 32.2, 29.63, 29.61, 29.5, 29.4, 29.3, 29.15, 29.13, 28.0, 22.4, 14.3. HRMS (ESI) m/z 
calcd for [M + H]+ C16H28D3O2 258.2507, found 258.2521. 
 
General procedure for the synthesis of α,β-unsaturated fatty acids: Ester 67 
(10.0 mmol) was dissolved in ethanol (15 mL) in a 100-mL flask and then 1 M KOH (20 
mL, 20 equiv) was added. The reaction was heated at reflux for 18 h. It was cooled to 
room temperature and the ethanol was removed by rotary evaporation. Hexanes were 
added and 1 M HCl was added by pipet until the aqueous layer was acidic as determined 
by pH paper. The hexane layer was collected, dried with NaSO4, and the solvent removed 
under reduced pressure. The crude product was purified by column chromatography with 
hexane: EtOAc (10:1) containing 1% acetic acid. 
 
 
 
 (E)-2-Dodecenoic acid (73): Colorless oil (76%). IR (neat) 𝑣 3120 (br), 2955, 
2926, 2855, 1697, 1651, 1464, 1420, 1307, 1464, 1420, 1307, 1286, 982; 1H NMR (500 
MHz, CDCl3) δ 7.08 (dt, J = 15.5, 7 Hz, 1H), 5.82 (dt, J = 15.5, 1.5 Hz, 1H), 2.23 (q, J = 
7.3 Hz, 2H), 1.47 (quint, J = 7.13 Hz, 2H), 1.29-1.27 (m, 12H), 0.88 (t, J = 7 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 171.7, 152.5, 120.5, 32.3, 31.9, 29.5, 29.4, 29.3, 29.1, 27.9, 
22.7, 14.1. HRMS (ESI) m/z calcd for [M + H]+ C12H23O2 199.1693, found 199.1690. 
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 (E)-2-Tridecenoic acid (74): Colorless solid (83%). IR (KBr pellet) 𝑣 3119 (br), 
2955, 2925, 2854, 1699, 1652, 1466, 1420, 1284, 1225, 983, 931, 862, 721, 543; 1H 
NMR (500 MHz, CDCl3) δ 7.09 (dt, J = 15.5, 7.0 Hz, 1H), 5.82 (dt, J = 15.5, 1.5 Hz, 1H), 
2.23 (q, J = 7.3 Hz, 2H), 1.46 (quint, J = 7.3 Hz, 2H), 1.29-1.26 (m, 14H), 0.88 (t, J = 7.3 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 171.7, 152.5, 120.5, 32.3, 31.9, 29.6, 29.5, 29.4, 
29.3, 29.1, 27.9, 22.7, 14.1. HRMS (ESI) m/z calcd for [M + H]+ C13H25O2 213.1849, 
found 213.1848. 
 
 
 
 (E)-2-Tetradecenoic acid (75): Colorless solid (56%). 1H NMR (500 MHz, 
CDCl3) δ 7.08 (dt, J = 15.5, 7.0 Hz, 1H), 5.82 (d, J = 15.5 Hz, 1H), 2.23 (q, J = 7 Hz, 2H), 
1.46 (quint, J = 7.8 Hz, 2H), 1.26-1.32 (m, 18H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 171.8, 152.5, 120.5, 32.3, 31.9, 29.62, 29.61, 29.5, 29.4, 29.3, 29.2, 27.9, 
22.7, 14.1. 1H spectral data was similar to that previously reported by [187]. 
 
General procedure for the synthesis of the deuterated α,β-unsaturated fatty 
acids: The ester (0.30 mmol) was dissolved in ethanol (2 mL) and 1 M KOH (1.5 mL, 5 
equiv) was added. The reaction mixture was heated at reflux for 18 h. It was cooled to 
room temperature and the ethanol was removed by rotary evaporation. Hexanes were 
added and 1 M HCl was added by pipet until the aqueous layer was acidic as determined 
by pH paper. The hexane layer was collected, dried with NaSO4, and the solvent removed 
under reduced pressure. The crude product was purified by column chromatography with 
hexane: EtOAc (10:1) containing 1% acetic acid. 
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[12,12,12-2H3]-(E)-2-Dodecenoic acid (76): Colorless oil (46%). IR (neat) 𝑣 
3059 (br), 2925, 2855, 2212, 1689, 1462, 1420, 1285 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.08 (dt, J = 15.4, 6.8 Hz), 5.82 (d, J = 15.5 Hz, 1H), 2.23 (q, J = 7.0 Hz, 2H), 1.47 (quint, 
J = 7.1 Hz, 2H), 1.20-1.32 (m, 12H); 13C NMR (125 MHz, CDCl3) δ 172.0, 152.5, 120.5, 
32.3, 31.8, 29.7, 29.5, 29.4, 29.3, 29.1, 27.9, 22.4.  
 
 
 
 [13,13,13-2H3]-(E)-2-Tridecenoic acid (77): Colorless solid (33%). IR (neat) 𝑣 
3018 (br), 2921, 2211, 2849, 1692, 1654, 1466, 1419, 1286; 1H NMR (500 MHz, CDCl3) 
δ 7.08 (dt, J = 15.6, 7.4 Hz, 1H), 5.82 (d, J = 15.6 Hz, 1H), 2.23 (q, J = 7.2 Hz, 2H), 1.46 
(quint, J = 7.1 Hz, 2H), 1.22-1.30 (m, 14H); 13C NMR (125 MHz, CDCl3) δ 172.0, 152.5, 
120.6, 32.3, 31.8, 29.6, 29.5, 29.4, 29.3, 29.1, 27.9, 22.4.  
 
 
 
 [14,14,14-2H3]-(E)-2-Tetradecenoic acid (78): Colorless solid (56%). IR (neat) 𝑣 
3031 (br), 2920, 2849, 2215, 1692, 1654, 1466, 1286; 1H NMR (500 MHz, CDCl3) δ 7.08 
(dt, J = 15.6, 7.4 Hz, 1H), 5.82 (d, J = 15.7 Hz, 1H), 2.23 (q, J = 7.2 Hz, 2H), 1.46 (quint, 
J = 7.2 Hz, 2H), 1.25-1.30 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 171.9, 152.5, 120.5, 
32.3, 31.8, 29.6, 29.5, 29.4, 29.37, 29.35, 29.14, 29.13, 27.9, 22.4; HRMS (ESI) m/z 
calcd for [M + H]+ C14H24D3O2 230.2194, found 230.2199. 
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3.2.9 Synthesis of (E,E)-2,4-dodecadienoic acid 
 
 
 
Methyl (E)-2-butenoate (78): Crotonic acid (12.2100 g, 0.1419 mol) was 
dissolved in MeOH (35 mL, 0.86 mol, 6 equiv) in a 100-mL flask. Sulfuric acid (1.362 
mL, 0.0256 mol, 0.18 equiv) was added and reaction was heated to reflux for 20 h. The 
solution was cooled to room temperature and H2O (35 mL) was added. The mixture was 
extracted with diethyl ether (50 mL). The organic layer was washed with saturated 
NaHCO3, and dried with MgSO4. The solvent was removed to give the pale yellow oil 
methyl (E)-2-butenoate (7.3729 g, 54%). IR (neat) 𝑣 3050, 2976, 1701, 1656, 1444, 1316, 
1224, 1103, 967, 908; 1H NMR (500 MHz, CDCl3) δ 6.98 (dq, J = 15.5, 7 Hz, 1H), 5.85 
(dq, J = 15, 2 Hz, 1H), 3.72 (s, 3H), 1.88 (dd, J = 7, 2 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 167.2, 144.9, 122.6, 51.5, 18.1. HRMS (ESI) m/z calcd for [M + H]+ C5H9O2 
101.0597, found 101.0576. 1H data were similar to that previously reported [188]. 13C 
data were similar to that previously reported [189]. 
 
 
 
 Methyl (E)-4-bromobut-2-enoate (79): Methyl (E)-2-butenoate (1.9438 g, 19.37 
mmol) was dissolved in benzene (25 mL) in a 50-mL flask and N-bromosuccinimide 
(3.7923 g, 21.31 mmol, 1.1 equiv) was added. The solution was heated to reflux and 
benzoyl peroxide (0.0567 g, 0.2341 mmol, 0.012 equiv) was added through the top of the 
condenser. The reaction was heated at reflux for 3 h. Once the solution cooled the 
succinimide crystals were filtered. The filtrate was concentrated to yield methyl E-4-
bromobut-2-enoate (3.4322 g, 99%). IR (neat) 𝑣 3062, 2999, 2952, 1724, 1657, 1436, 
1284, 1136, 924, 837, 730; 1H NMR (500 MHz, CDCl3) δ 7.01 (dt, J = 15, 7 Hz, 1H), 
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6.03 (dt, J = 15.5, 1.3 Hz, 1H), 4.01 (dd, J = 7.3, 1.3 Hz, 2H), 3.76 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 166.1, 142.1, 124.4, 52.0, 29.2. 1H data were similar to that 
previously reported [190].  
 
 
 
 Methyl (E)-4-(diethoxyphosphoryl)-2-butenoate (80): Methyl E-4-bromobut-2-
enoate (3.4322 g, 19.2 mmol) and triethyl phosphite (3.9054 g, 23.4 mmol, 1.2 equiv) 
were mixed together and heated at 100 °C for 18 h. The reaction was cooled to room 
temperature and dissolved in hexane:EtOAc (3:1). The solution was loaded onto a silica 
gel column to removed excess triethyl phosphite. Solvent was removed to yield methyl 
(E)-4-(diethoxyphosphoryl)-2-butenoate (3.2762 g, 13.8 mmol, 72%). 1H NMR (500 
MHz, CDCl3) δ 6.88 (sextet, J = 7.7 Hz, 1H), 5.97 (ddt, J = 15.6, 5, 1.4 Hz, 1H), 4.10 (m, 
4H), 3.74 (s, 3H), 2.75 (ddd, J = 9.5, 8, 1.5 Hz, 2H), 1.32 (t, J = 7 Hz, 6H); 13C NMR 
(125 MHz, CDCl3) δ 166.2, 137.8, 125.6, 62.5, 51.8, 31.3, 30.2, 16.5. 1H spectral data 
was similar to that previously reported [191]. 
 
 
 
 Methyl (E,E)-dodeca-2,4-dienoate (81): To a mixture of NaH (60%, 0.2072 g, 
5.18 mmol, 1.2 equiv) suspended in diethyl ether (16 mL), methyl (E)-4-
(diethoxyphosphoryl)-2-butenoate (1.0051 g, 4.25 mmol) was added dropwise at 0 °C; H2 
gas given off during the addition. After the reaction was stirred for 30 minutes, octanal 
(1.40 mL, 8.95 mmol, 2.1 equiv) was added. The solution was heated at reflux for 2 h 
before cooling to room temperature and quenched with H2O (15 mL). The mixture was 
extracted with hexanes (2 x 10 mL). The organic layer was washed with H2O (10 mL), 
washed with brine (10 mL), dried with MgSO4, and the solvent was removed by reduced 
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pressure. Crude product was purified with silica gel column hexane:ethyl acetate (20:1) 
to yield methyl (E,E)-dodeca-2,4-dienoate (0.1442 g, 16%). 1H NMR (500 MHz, CDCl3) 
δ 7.26 (dd, J = 9.9, 15.3 Hz, 1H), 6.14 (m, 2H), 5.78 (d, J = 15.4 Hz, 1H), 3.73 (s, 3H), 
2.16 (q, J = 6.9 Hz, 2H), 1.42 (quint, J = 7.0 Hz, 2H), 1.26-1.28 (m, 8H), 0.88 (t, J = 6.9 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 167.7, 145.4, 144.9, 128.3, 118.6, 51.4, 32.9, 
31.7, 29.1, 29.0, 28.7, 22.6, 14.1. 1H and 13C data were similar to that previously reported 
[192]. 
 
  
 
(2E,4E)-Dodecadienoic acid (82): Methyl (2E,4E)-dodecadienoate (0.1442 g, 
0.6856 mmol) was dissolved in ethanol (1.688 mL) and 1M KOH (5.070 mL, 5.070 
mmol, 7.4 equiv) was added. The reaction was heated at reflux overnight. After cooling 
to room temperature, hexanes were added followed by 1M HCl until the aqueous layer 
was acidic. The organic layer was extracted and solvent removed to yield (2E, 4E)-
dodecadienoic acid (0.1023 g, 76%). IR (neat) 𝑣 3119 (br), 2955, 2925, 2854, 1699, 1652, 
1466, 1420, 1284, 1225, 983, 931, 862, 721, 543; 1H NMR (500 MHz, CDCl3) δ 7.34 (m, 
1H), 6.19 (m, 2H), 5.78 (d, J = 15.3, 1H), 2.18 (q, J = 7.1 Hz, 2H), 1.65 (quint, J = 7.5 Hz, 
2H), 1.43 (m, 2H), 1.26-1.69 (m, 6H), 0.88 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 172.3, 147.5, 146.3, 128.2, 118.1, 33.1, 31.8, 29.1, 29.0, 28.6, 22.6, 14.1. 1H 
spectral data was similar to that previously reported by [193]. 
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3.2.10 Synthesis of (2E,4E,8Z,10E)-dodecadienoic acid 
 
 
 
(4-Ethoxy-4-oxobutyl)triphenylphosphonium bromide (83): Ethyl 4-
bromobutanoate (10.0128 g, 51.33 mmol) was dissolved in acetonitrile (12 mL). 
Triphenylphosphine (13.7129 g, 51.33 mmol, 1 equiv) was added and the reaction was 
heated at 90 °C for 3 days. To the solution, toluene (50 mL) was added dropwise; crystals 
formed during the addition. The mixture was cooled to room temperature and toluene was 
decanted. The wet crystals were dried under high vacuum to yield (4-ethoxy-4-
oxobutyl)triphenylphosphonium bromide (20.3099 g, 87%). 1H NMR (500 MHz, CDCl3) 
δ 7.87 (m, 6H), 7.79 (m, 3H), 7.70 (m, 6H), 4.09 (q, J = 7.2 Hz, 2H), 4.00 (m, 2H), 2.87 
(t, J = 5.5 Hz, 2H), 1.92 (m, 2H), 1.23 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
173.4, 135.1 (d, J = 2.85 Hz), 133.9 (d, J = 10.0 Hz), 130.6 (d, J = 12.6 Hz), 60.8, 33.4 (d, 
J = 18.75 Hz), 22.1, 21.7, 18.2, 14.3. 1H and 13C spectral data were similar to that 
previously reported [194]. 
 
 
 
Ethyl (Z,E)-octa-4,6-dienoate (84): In THF (30 mL), (4-ethoxy-4-
oxobutyl)triphenylphosphonium bromide (10.1752 g, 22.3 mmol) was suspended and 
potassium tert-butoxide (2.5750 g, 22.9 mmol, 1 equiv) was added; the solution turned 
bright orange. The reaction was stirred for 30 min at room temperature. Crotonaldehyde 
(1.85 mL, 22.3 mmol, 1 equiv) was added and reaction was stirred at room temperature 
for 18 h giving a pale orange solution. The reaction was quenched with H2O (100 mL). 
The solution was extracted with ethyl acetate. The ethyl acetate layer was dried with 
MgSO4, and the solvent was removed by rotary evaoporation. The crude product was 
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purified by silica gel column hexane:ethyl acetate (20:1) to yield ethyl (4Z,6E)-
octadienoate (1.5789 g, 42%). IR (neat) 𝑣 3020, 2981, 2915, 1737, 1448, 1372, 1349, 
1254, 1172, 1099, 1041, 985, 947, 926, 821 cm-1; 1H NMR NMR (500 MHz, CDCl3) δ 
6.33 (dd, J = 12, 13 Hz, 1H), 5.97 (t, J = 10.7 Hz, 1H), 5.70 (dq, J = 14.5, 7.1 Hz, 1H), 
5.24 (dd, J = 7.5, 18 Hz, 1H), 4.13 (t, J = 7 Hz, 2H), 2.48 (qt, J = 7.3 Hz, 2H), 2.37 (t, J = 
7.5 Hz, 2H), 1.77 (d, J = 6.5 Hz, 3H), 1.25 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 173.2, 130.2, 130.0, 127.0, 126.8, 60.5, 34.5, 23.4, 18.4, 14.4.  
 
 
 
 (Z,E)-Octa-4,6-dienal (85): Ethyl (Z,E)-octa-4,6-dienoate (0.7715 g, 4.59 mmol) 
was dissolved in diethyl ether (5.4 mL) and cooled to -78 °C. with an acetone/dry ice 
bath. DIBAL (5.3 mL, 5.0 mmol, 1.1 equiv) was added dropwise. After the addition was 
complete, the reaction was stirred for 30 min at -78 °C. The solution was warmed to 0 °C 
with an ice-water bath and 10 g of 4 N HCl was cooled and added dropwise. The mixture 
was then warmed to room temperature. The mixture was extracted with diethyl ether. The 
organic layer was washed with brine, dried with MgSO4, and the solvent was removed 
under reduced pressure. The crude product was purified by silica gel column 
hexane:ethyl acetate (5:1) to yield (Z,E)-octa-4,6-dienal (0.2473 g, 1.99 mmol, 43%). IR 
(neat) 𝑣 3020, 2959, 2914, 2852, 2724, 1726, 1653, 1449, 1409, 1388, 1376, 1055, 985, 
948, 820; 1H NMR NMR (500 MHz, CDCl3) δ 9.80 (t, J = 1.5 Hz, 1H), 6.34 (t, J = 13 Hz, 
1H), 6.01 (t, J = 11 Hz, 1H), 5.74 (dq, J = 14.5, 6.5 Hz, 1H), 5.26 (dd, J = 7.5, 17.5 Hz, 
1H), 2.53 (m, 4H), 1.80 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 202.1, 130.6, 
130.1, 126.6, 124.1, 43.9, 20.6, 18.4.  
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 Methyl (E,E,Z,E)-dodeca-2, 4, 8, 10-tetraenoate (86): NaH (0.09382 g, 2.33 
mmol, 1.1 equiv, 60%) was suspended in diethyl ether (6 mL) in a 25-mL round-bottom 
flask.  Phosphonate ester (0.4553 g, 1.93 mmol) was added dropwise; H2 given off and 
the solution turned yellow. After the reaction was stirred for 30 min at room temperature, 
Z,E-octa-4,6-dienal (0.2632 g, 2.12 mmol, 1.1 equiv) in diethyl ether (0.5 mL) was added. 
The solution was stirred for a further 22 h at room temperature. The reaction was 
quenched with H2O (10 mL) and extracted with hexanes (10 mL). The organic layer was 
washed with H2O (5 mL), washed with brine (5 mL), dried with MgSO4, and the solvent 
was removed by rotary evaporation. The crude product was purified by methyl (E,E,Z,E)-
dodeca-2,4,8,10-tetraenoate (0.0225 g, 6 %). IR (neat) 𝑣 2925, 2855, 1724, 2212, 1723, 
1654, 1462, 1264, 1180, 1044 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.50 (m, 1H), 6.27 (m, 
1H), 6.03 (m, 2H), 5.72 (m, 3H), 5.61 (m, 1H), 3.80 (s, 3H), 2.01 (m, 4H), 1.58 (d, J = 
6.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 167.6, 142.9, 141.7, 130.3, 131.3, 129.52, 
129.50, 126.9, 119.9, 52.0, 33.01, 33.03, 19.3.  
 
 
 
(E,E,Z,E)-Dodeca-2, 4, 8, 10-tetraenoic acid (87): Methyl (E,E,Z,E)-dodeca-
2,4,8,10-tetraenoate (0.0318 g, 0.162 mmol) was dissolved in ethanol (0.5 mL) and 1 M 
KOH (0.551 mL, 0.551 mmol, 3.4 equiv) was added. The reaction was heated at reflux 
for 2 h. After cooling to room temperature, hexanes were added. 1 M HCl was added 
until the aqueous layer was acidic. The organic layer was extracted and solvent removed 
to yield  (2E,4E,8Z,10E)-dodecatetraenoic acid (0.0249 g, 0.1295 mmol, 80%). IR (neat) 𝑣 3119 (br), 2955, 2925, 2854, 1699, 1652, 1466, 1420, 1284, 1225, 983, 931, 862, 721, 
543 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.50 (m, 1H), 6.27 (m, 1H), 6.03 (m, 2H), 5.72 
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(m, 3H), 5.61 (m, 1H), 2.01 (m, 4H), 1.58 (d, J = 6.4 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 167.6, 142.9, 141.7, 130.3, 131.3, 129.52, 129.50, 126.9, 119.9, 33.01, 33.03, 
19.3.  
 
3.2.11 Synthesizing acyl-CoAs 
Fatty acid (~0.25 mmol) was dissolved in 2 mL of THF. Et3N (60 µL) and ethyl 
chloroformate (40 µL) were added resulting in the formation of a white precipitate. The 
mixture was stirred for 1 h. The mixture was filtered through a pipet with a glass wool 
plug. The solvent was removed by rotary evaporation and the crude mixed anhydride was 
checked by 1H NMR.  
The trilithium salt of CoA was dissolved in a solution of NaHCO3 (50 mg) in 
H2O:THF (3:2) and the reaction flask was flushed with N2. The mixed anhydride was 
dissolved in THF (2 mL) in a separate flask and was then added to the CoA solution. 
Water was added until the organic and aqueous phases were miscible and the reaction 
mixture was stirred at room temperature for 2 h. 
The reaction was concentrated by rotary evaporation to remove most of the THF 
prior to transferring the solution to a conical tube by a Pasteur pipet. The aqueous layer 
was acidified with 5% HClO4 until a precipitate stopped forming. The mixture was 
centrifuged and the supernatant was removed with a pipet. The solid was purified by 
washing with 0.8% HClO4 (1 mL). During this step, the mixture was vortexed to ensure 
mixing, centrifuged, and decanted. Washing steps using the same operations were carried 
out with dry acetone (2 x 1 mL) and diethyl ether (1 mL). The solid was dried in 60 °C 
heat block under N2 to remove excess diethyl ether. The acyl-CoA sample was dissolved 
in 80 mM NaHCO3 (250 µL) and stored at -80 °C. 
 
3.2.12 Calculating concentrations of acyl-CoAs 
 To calculate the concentration calculated by UV-vis based on the amount of CoA 
present, following a similar procedure completed by Merrill [195]. The CoA sample (5 
µL) was added to a separate vial and dissolved in 0.1 M potassium phosphate (pH 7.0). 
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The sample was placed in a cuvette and UV-VIS readings were taken at 260 nm [195]. 
The absorbance at 260 nm was measured and the concentration of the diluted sample was 
calculated using equation 2, where A is the absorbance, the path length is 1, and the 
extinction coefficient was 15,400 M-1cm-1 [195]. 
 𝐶! =  !!•!",!""      (3) 
 
To determine the original concentration of the CoA sample, C1V1=C2V2 was used to 
solve for C2. C1 was the concentration calculated from equation 1. V1 was 2 mL and V2 
was 0.005 mL.  
 The concentration was independently calculated by GC-MS based on the fatty 
acid content. Concentration curves were made from analysis of methyl esters of 12:1, 
12:2, 12:4, and 15:0. The slopes of each methyl ester were calculated by graphing the 
corrected area of each peak of the total ion chromatogram versus the concentrations of 
the FAME solutions (0.4, 0.2, 0.08, 0.04, 0.026, 0.008 mM). Sensitivity factors for the 
methyl esters of 12:1, 12:2, and 12:4 were calculated from the ratio of the slope for the 
standard curve of each analyte to that of the methyl ester of 15:0. 
The acyl-CoA concentrations were determined by the conversion of the CoA 
products to FAMES prior to GC/MS analysis. A 40 mM solution of 15:0 in hexanes was 
prepared as an internal standard. FAMES analysis was prepared by pipetting the CoA 
sample (10 µL) and 15:0 solution (37 µL) into a conical tube. Sulfuric acid (2%) in 
methanol (2 mL) was added and the solution was heated for 2 h at 80 °C. The solution 
was cooled and H2O (1 mL) and extracted with hexanes (2 x 1 mL). The hexanes were 
dried down and the sample was re-dissolved in hexanes (200 µL) and run on GC-MS.  
The following calculations were used to calculate the concentration of each CoA 
(X = 1, 2, and 4) and the percent yield from the acyl CoA synthesis. 
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Corrected area = (experimental area of 12:X) • (sensitivity factor)         (4) 
 𝜇𝑚𝑜𝑙 𝑜𝑓 12:𝑋 − 𝐶𝑜𝐴 =  !"##$%&$' !"#$ !" !":!!"#$%&%' !"#$ !" !":! •  𝜇𝑚𝑜𝑙 𝑜𝑓 15: 0                       (5) 
 12:𝑋 − 𝐶𝑜𝐴 =  !"#$ !" !":!!!"!!" !"•!"!       (6) 
 
3.3 Results and Discussion 
 Previously, to study biosynthetic pathways radiolabeled [14C] compounds were 
used due to their enhanced sensitivity. However, stable isotopic precursors like deuterium 
can be utilized to determine isotopomer patterns in GC/MS and LC/MS, potentially 
providing additional data. The most prevalent alkamide present in E. purpurea is BA8 
(NiBu/12:4Δ2E,4E,8Z,10E) followed by BA9 (NiBu/12:4Δ2E,4E,8Z,10Z) [1]. BA9 accumulates at 
1/5th the level of BA8 [1]. Both BA8 and BA9 were used for correlating incorporation of 
labeled compounds because they are the most abundant within E. purpurea seedlings. 
They both have similar retention times in GC/MS and LC/MS, and they also have a 
distinctive GC/MS fragmentation pattern. The dominant fragment produced has an m/z of 
167 that is thought to arise from a pericyclic fragmentation eliminating hexatriene (Figure 
39) [132]. This fragmentation contains the six carbonyl-proximate carbons within the 
acyl chain including the N-isobutylamide [132]. 
 
 
 
Figure 39: The dominant fragment m/z 167 comes from the pericyclic fragmentation and 
elimination of hexatriene [132]. 
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E. purpurea, grown as a field plant, collects alkamides in the roots, flowers, and 
seed coats [1, 132]. It had been determined from an earlier study that alkamides were 
actively produced late during seedling development [132]. The seedlings were 
characterized in five phenotypically distinct stages [132]. Stage 1 and stage 2 included 
the emergence from the seed coat and the appearance of the shoot apical meristem. In 
stage 3, the cotyledons were formed and emerged from the seed coat. Stage 4 
corresponded to the first true leaf being formed. Then, in stage 5, the first true leaf fully 
formed and begin to unfurl (Figure 40). Alkamide production increases in germination 
stages 3-5 [1, 132]. The use of stage 5 seedlings provides a faster way for alkamide 
analysis with less variables such as soil, humidity, and microorganisms [1, 132]. 
Production of alkamides could be amplified by the application of 10 µM of methyl 
jasmonate (MeJA) in the media. Over a 72-h period, E. purpurea treated with MeJA 
showed a 2-fold increase in accumulation of alkamides [1]. All seedlings in the current 
studies were stage 5 and were supplemented with MeJA via the liquid media and grown 
for three consecutive days for all feeding experiments.  
 
 
 
Figure 40: Example of a stage 5 of E. purpurea seedling used in feeding experiments 
 
3.3.1 Isotope labeling experiments of amino acids, Val and Ile 
 Our group has hypothesized that amino acids and fatty acids are associated with 
the biosynthesis of alkamides due to the two moieties that are present in alkamides, i.e. 
the amine moiety that seems to be acylated by a fatty-acid derivative. The Nikolau group 
has explored the accumulation pattern of fatty acids and amino acids in 13 plant tissues 
and organs [1]. After GC/MS and LC/MS analysis, 371 analytes were identified, Pearson 
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correlation coefficients were calculated, and the coefficients were clustered together if 
they had a correlation analysis value of greater than 0.7. This led the 371 compounds to 
be segregated into 21 separate clades labeled A-U [1]. 
 All eight alkamides measured in this study previously shown clustered in clade U. 
The branched-chain amino acids, valine and isoleucine, were clustered in clad N; this 
clade is statistically distant from clade U [1]. The fatty acids identified with 14-carbons 
atoms or longer were allocated among eight different clades (C, F, H, I, J, N, O, and P). 
There were no fatty acids with a 12-carbon acyl chain found in the alkamides-enriched 
clade U. Thus, metabolite-profiling studies did not support the starting hypothesis that 
there is a tissue-dependent metabolic correlation between the accumulated levels of the 
potential precursors, amino acids and fatty acids, and the alkamides produced [1]. 
 An experiment was designed to use isotopic tracers to test whether Val and Ile are 
precursors of the amine moiety and to identify the probable chemical transformations 
leading to that amine segment [1]. Initial studies were completed to identify the labeling 
patterns of Val and the alkamides. In order to complete this, seedlings were cultured in 
media containing uniformly labeled 13C6 glucose ([U-13C6]Glc) and the isotopic 
composition of the alkamides was then analyzed using LC-MS and GC-MS. Valine was 
shown to have extensive labeling by [U-13C6Glc], extending to an M + 5 peak with an 
abundance of 7.4%. Alkamides were analyzed using the GC-MS. The m/z peak at 167 for 
alkamides NiBu/12:4Δ2E,4E,8Z,10E revealed enhancement through a signal at M + 10. The M 
+ 10 peak arises from fully labeling the isobutylamine moiety plus the six carbon atoms 
for the acyl moiety of the alkamides. The incorporation of the labeled isobutylamine 
moiety provided initial evidence that valine is a precursor to alkamide biosynthesis. 
 To test the involvement of de novo branched chain amino acid (BCAA) 
biosynthesis, the same experiment was completed except chlorsulfuron was used. 
Chlorsulfron is a known as an inhibitor of acetolactate synthase, which catalyzes the first 
step of branched-chain amino acid (BCAA) synthesis. This resulted in a decrease in 
seedling growth by 50% over a 72 h period. Alkamide production and signals above the 
M + 6 ion of the m/z 167 ion were reduced. Also, [U-13C6]Glc showed minor 
incorporation into Val (≤1%) and alkamides. However seedling growth and alkamides 
production could be restored to wild type level if supplemented with 15 mM Val and 15 
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mM Ile. Both these experiments further suggested the amine moiety of this alkamides 
originates from Val biosynthesis. Furthermore, these experiments established an 
experimental system in which alkamides biosynthesis was dependent on externally 
proved BCAA precursors. 
 In order to determine the origin of the C1’-N bond of alkamides, [2-13C,15N]Val 
was fed to seedlings. LC-MS analysis of NiBu/12:4Δ2E,4E,8Z,10E revealed an M + 2 peak 
with an accumulated level of 4.2% enhancement above the control. This verified that the 
C-N bond from valine remains intact in alkamides (Figure 41A). The mechanism by 
which the isobutylamine moiety is generated can be probed by examining the fate of the 
hydrogen at C-2 of Val. Fully deuterated-Val, [2H8]Val, was feed to seedlings and 
alkamide NiBu/12:4Δ2E,4E,8Z,10E was examined by electrospray MS. The MS exhibited two 
new M + 7 and M + 8 peaks at a ratio of 1:1.1 (Figure 41C). The lower mass peak of M + 
7 can be attributed to background transamination of valine [1]. It may be noted that this is 
consistent with an increase in the M + 1 / M ion ratio (0.8%-1.7%) from the 13C-15N-Val 
labeling experiment, which had been ascribed to minor 15N scrambling due to amino acid 
transamination (Figure 41D). Because of the complete incorporation of the deuterium 
atoms from [2H8]Val, the most likely mechanism for generating the amine moiety was 
anticipated to be a pyridoxal phosphate (PLP)-dependent decarboxylation [1]. If 
decarboxylation requiring oxidation at C-2 had occurred, the incorporation of the 
deuteron at C-2 would not have been observed. The PLP-mediated mechanism would 
lead to isobutylamine as an intermediate, but isobutylamine is not observed to accumulate 
in Echinacea seedlings. However, when 0.25 mM [2H8]isobutylammonium chloride is 
used in the growth medium, there was the appearance of a peak 9 amu larger than the 
parent ion in the LC-MS spectrum of 12:4Δ2E,4E,8Z,10E. Of the accumulated alkamide, 
NiBu/12:4Δ2E,4E,8Z,10E, the labeling of M + 9 was 3.7% (Figure 43C) [1]. This established 
isobutylamine can function as an intermediate in the alkamide biosynthetic pathway. 
Finally, [2H10]Ile was fed to E. purpurea seedlings that provided parallel evidence to the 
[2H8]Val observations, thus confirming Ile as an intermediate in the synthesis of the 2-
methylbutylamide moiety of alkamides. 
   
139 
 
 
 
Figure 41: Enhanced isotopologue ratios in NiBu/12:4Δ2E,4E,8Z,10E resulting from feeding 
of E. purpurea seedlings with isotopically labeled precursors. (A, B) A. Feeding of [2-
13C/15N] valine significantly increased the abundance of M + 2 versus M + 1 species, 
indicating the retention of the C-N bond from the precursor, corrected for background 
Val transamination. MeJA and the presence of additional carbon sources, such as glucose 
(Glc), isoleucine (Ile), and chlorsulfuron (CS) had no significant effect on isotope 
incorporation. Isotopic envelope revealed by full-scan QqQ mass spectroscopy of 
NiBu/12:4Δ2E,4E,8Z,10E isolated from seedlings incubated with A. natural abundance valine 
and isoleucine and B. media supplemented with [2H8]valine, unlabeled isoleucine, and in 
the presence of chlorsulfuron. Ions with m/z 256 and 255 correspond to the M + 8 and M 
+ 7 ions resulting from incorporation of eight deuterium atoms from the decarboxylated 
form of [2H8]valine or the incorporation of seven deuterium atoms following the 
metabolic exchange of [2H8]valine with 2-ketoisopentanoate via transamination that 
results in the loss of one of the deuterium atoms. C.  Isotopic envelope from plants 
cultured in standard media (dashed line) or media supplemented with [2H9]isobutylamine 
hydrochloride (solid line); the M + 9 ion at m/z 257 indicates that this precursor is 
incorporated into the alkamide without loss of any deuterium atoms. 
 
 Due to the Val and Ile-labeling experiments and the amino acid decarboxylases 
that catalyze PLP-dependent reactions, the Nikolau group looked to identify an enzyme 
that generating the amine moiety of alkamides. They used two strategies to help identify 
this enzyme; one based on sequence homology among PLP-dependent amino acid 
decarboxylases and the other based on the expectation that the expression of the genetic 
elements responsible for alkamides biosynthesis should positively correlate with 
alkamide accumulation [1].  
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 First, the NCBI conserved-domain database for E. purpurea transcriptome data 
was searched for genes that encoded amino squences related to known PLP-dependent 
amino acid decarboxylases, and found 21 E. purpurea transcripts to encode such enzyme 
[1]. A homology-based phylogentetic tree was constructed that contained 595 PLP-
dependent enzymes, which were divided into 4 clades (Groups A-D) [1]. Group A 
contained seven of the E. purpurea sequences. Group B contained the biochemically 
characterized valine decarboxylase from S. viridifaciens (VlmD) and a single E. purpurea 
sequence (contig epa_952). Group C contained a single E. purpurea sequence (epa_3096). 
Group D did not contain PLP-dependent enzyme sequences from plants. 
 Second, the accumulation of the alkamide NiBu/12:42E,4E,8Z,10E among 20 tissues 
and organs was correlated with the expression patterns of the 21 E. purpurea transcripts 
[1]. This led to the identity of a single putative PLP-dependent amino acid decarboxylase 
(contig Epa_11279) with a correlation coefficient of 0.8 to the accumulation of alkamide 
NiBu/12:4Δ2E,4E,8Z,10E, whereas all other correlation coeficients were below 0.3.  
 From the homology and correlating expression patterns, Epa_952 and, Epa_11279 
were identified as a potential PLP-enzymes [1]. This led to the heterologous expression 
of Epa_952 and Epa_11279 ORFs in Escherichia coli and assaying for decarboxylation 
enzymatic activity in hopes to identify the BCAA decarboxylase. Epa_952 did not 
support enzymatic decrboxylation of either valine or isoleucine. Epa_11279 did catalyze 
the decarboxylation of both valine and isoleucine, and thus must encode the BCAA 
decarboxylase that can generate the amine moieties of alkamides. Further biochemical 
characterization identified that Epa_11279 encodes a type II BCAA decarboxylase 
because it is dependent on the PLP cofactor. The spatial expression pattern of the 
Echinacea BCAA decarboxylase was investigated at the mRNA and protein level. The 
roots were found to accumulate the largest concentration of alkamide 
NiBu/12:4Δ2E,4E,8Z,10E and have the highest expression of the BCAA decarboxylase at both 
the mRNA and protein levels [1]. The labeling experiments established that Val and Ile 
are direct precursors to the amine moiety of alkamides in Echinacea. This led to the 
discovery and characterization of a new BCAA decarboxylase. The BCAA converts the 
amino acids Val and Ile to isobutylamine and 2-methylbutylamine, respectively, which 
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we propose is then subsequently acylated with fatty acid derivatives to generate the 
alkamides found in Echinacea.  
 
3.3.2 Synthesis of deuterated aldehydes 
 It has yet to be definitively determined whether the alkamides themselves are 
being unsaturated or if the fatty acids undergo desaturation before amide bond formation. 
All eight alkamides previously shown in Figure 30 have α,β−unsaturation, and the 
majority of them have a trans configuration. To probe the biosynthetic pathway, 
α,β−unsaturated, d3-labeled fatty acids and alkamides needed to be synthesized. 
Alkamides and fatty acids with varying chain lengths of C12, C13, and C14 were prepared 
and tested. Routes were developed in order to incorporate a trans double bond at the C2 
position and d3 label at the end of the acyl chain in the biosynthetic probes. 
Retrosynthetically, it was expected that the two types of compounds could be synthesized 
in a similar manner (Figure 42). A Horner-Wadsworth-Emmons (HWE) reaction could be 
utilized for the trans double bond with a phosphonate and an aldehyde with d3-labeling at 
the end of the acyl chain. After the formation of the α, β-trans double bond, the ester 
would be hydrolyzed to the fatty acid, respectively. 
 
 
 
Figure 42: Retrosynthetic approach to synthesizing [d3]-labeled C12, C13, and C14 
α,β−unsaturated alkamides and fatty acids. 
 
First the aldehydes were synthesized to ensure that the labeling could be 
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and undecanal, starting materials underwent a zipper reaction to produce terminal alkynes 
28 and 29. For dodecenal, the starting carboxylic acid had a terminal alkyne and therefore 
the carboxylic acid was reduced to form alcohol 30.  With this reduction, the general 
procedures leading to all three aldehydes were then the same. The alcohol was protected 
with dihydropyran to form the tetrahydropyranyl ether. In testing the synthetic route, the 
protected alcohol was methylated with CH3 and carried through to the aldehyde. Once the 
unlabeled aldehyde was successfully made, the protected alcohols (31, 32, 33) were 
methylated with ICD3 to put the deuterium at the end of the acyl chain. Reduction of the 
alkyne was attempted under a hydrogen atmosphere with Wilkinson’s catalyst, but this 
catalyst caused deuterium scrambling. Therefore, the alkyne was reduced with H2 and 
Pd/C. The THP-protecting group was removed by alcoholysis with p-toluenesulfonic acid 
and methanol. Finally the alcohol was oxidized to the aldehyde by using Dess-Martin 
periodinane. 
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Figure 43: Synthesis of aldehydes with and without deuterium labeling at the ω-end of 
the acyl chain.  
 
3.3.3 Synthesis of α,β-unsaturated alkamides 
 Alkamides NiBu/12:1Δ2E, NiBu/13:1Δ2E, NiBu/14:1Δ2E were synthesized initially 
without the labeled aldehyde (Figure 44). Once the synthetic pathway was optimized 
without any labeling, the [2H3]-aldehydes were used. To synthesize each alkamide, ethyl 
2-bromoacetate was converted by an Arbuzov reaction to the alkyl phosphonate, 58, with 
triethylphosphite. The alkyl phosphonate was hydrolyzed to yield 2-
(diethyloxyphosphoryl)acetic acid 59. A carboxylic acid cannot be used directly to make 
an amide because amines are basic; activation of the acid to the acyl chloride normally 
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144 
 
circumvents this problem. Initially, we used SOCl2 to make the acid chloride before using 
isobutylamine to form the amide. However, this resulted in a low yield and side products; 
therefore, CDI was used to make an anhydride before being treated with isobutylamine to 
complete the isobutylamide moiety of the alkamides. Finally, 60 was deprotonated and 
either commercial aldehydes or synthetically derived deuterated aldehydes from Figure 
45 was used to complete HWE reaction and insert form the α,β-trans double bond with 
deuterium at the end of the acyl chain. 
 
 
 
Figure 44: Alkamide synthesis of NiBu/12:1Δ2E, NiBu/13:1Δ2E, NiBu/14:1Δ2E 
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3.3.4 Synthesis of α,β-unsaturated fatty acids 
 A synthetic pathway was designed to incorporated d3-labeling at the end of the 
acyl chain of 12:1, 13:1, and 14:1 (Figure 45). Phosphate 58 was deprotonated with NaH 
to form the carbanion and this underwent a HWE reaction with the respective aldehydes 
from Figure 45 to form the α,β−unsaturated ethyl esters 67 – 72. Each ester was 
hydrolyzed with 10% KOH and after workup with concentrated HCl afforded the 
α,β−unsaturated fatty acids 73-78.  
 
 
 
Figure 45: Synthesis of fatty acids 12:1, 13:1, 14:1, [d3]-12:1, [d3]-13:1, and [d3]-14:1. 
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3.3.5 Determination of isotope distribution patterns in alkamides isolated from plants 
provided deuterated α,β-unsaturated fatty acids and α,β-unsaturated alkamides 
 
Toxicity tests were completed with unlabeled synthesized compounds with the 
expectation that the d3-labeled compounds would behave similarly. Conditions for the 
media were prepared in a manner identical to that of the labeled amino acid feeding 
experiments. Initially, DMSO was used to make stock solutions, but the solvent was 
switched to 2-methyoxyethanol. When DMSO was placed on the leaf as an control it was 
found to be toxic to the leaves as evidenced by the leaf turning brown and wilting.  
In the initial toxicity results, the 14:0 fatty acid was toxic to the plant at all 
concentrations tested (5 – 100 mM, 2 µL application).  Further serial dilutions of the fatty 
acid were investigated and the fatty acid was found to be no longer toxic at 
concentrations of 0.5 mM or lower.  Contrastingly, the alkamide was not toxic to the 
plant at any of the concentrations tested (≤100 mM). However, at higher concentrations a 
white crystal was observed to accumulate on the leaves indicating that a significant 
amount of the alkamide was not absorbed into the leaf. The alkamide experiment presents 
a problem because if the synthesized material failed to enter the plant, labeling would not 
occur and a false negative could easily result. 
The Chapman group previously published a study in which they fed N-
acylethanolamines (NAEs) to plants at concentrations of 40 µM and 400 µM by adding 
the NAEs as DMSO stock solutions to the media [196]. In order to feed the plants the 
synthesized compounds through the media, glass plates were used without filter paper. 
Since the toxicity levels had already been tested on the leaves above the concentrations of 
the Chapman paper, the d3-labeled compounds were used to at a final concentration of 
500 µM in the liquid media.  
After growing for 3 days, the alkamides were extracted and analyzed by LC/MS. 
The media was also analyzed to determine if any of the synthetic probe was still present. 
A positive outcome would lead to an M + 3 peak in the isotopic envelope for the parent 
ions of BA 6 (NiBu/13:2Δ2E,7Z,10a,12a) and BA8 (NiBu/12:4Δ2E,4E,8Z,10E) / BA9 
(NiBu/12:4Δ2E,4E,8Z,10Z).  However, for [2H3]- NiBu/12:1Δ2E, NiBu/13:1Δ2E, and 
NiBu/14:1Δ2E the envelope of only extended to M + 2. When the media was tested 
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deuterated alkamide was found in the media.  Similar to the applications to leaves, no 
evidence was gained that alkamides entered the plant, thwarting any examination of 
whether less-unsaturated alkamides might intermediates on the pathway. Initial results 
showed no labeling, but future experiments to try and certify the plants take up the 
alkamides needs to be explored to confirm these results. For [2H3]-12:1, 13:1, 14:1, 
labeling of BA6 and BA 8/9 should have incorporated the d8-valine used as a control and 
labeling with the fatty acids would have resulted in a M + 11 envelope. However, M + 7 
and M + 8 peaks were visible as expected, but not M + 11. When the media was analyzed, 
there was no labeled fatty acid present. Unlike the alkamides, the roots do seem to be 
taking in the fatty acids, but they do not look to have intact incorporation into alkamide 
biosynthesis.  
 Though the synthesized [2H3] compounds did not show any labeling, additional 
work needs to be completed in order to insure the alkamides are entering the plant cell. 
Also, based on the media, the fatty acids do look to be taken up by the plant, but not 
incorporated into the alkamide pathway. However, if the plant is using the synthesized 
fatty acid it should be found in other pathways. For example, running FAMES analysis 
on the plant extract would allow us to see incorporation of the d3-fatty acids into the fatty 
acid biosynthesis pathway. Further studies need to be completed in order to uncover the 
origin of the α,β−double bond found in alkamides of E. purpurea. 
 
3.3.6 Synthesis of 12:1, 12:2, and 12:4 used for acyl-CoAs 
The same synthesis shown in Figure 45 was used to make (E)-dodeca-2-enoic 
acid (73). (2E,4E)-Dodeca-2,4-dienoic acid, (2E)-butenoic acid was esterified to methyl 
ester 78 (Figure 46). Allylic bromination of 78 was completed in excellent yield using N-
bromosuccinimide (NBS). Heating of methyl (E)-4-bromobut-2-enoate with 
triethylphosphite provided phosphonate, 80.  Horner-Wadsworth-Emmons (HWE) 
reaction was completed by deprotonating 80 with NaH followed by the addition of 
octanal in order to synthesize the second double bond in the acyl chain. Finally, the 
methyl ester (81) was hydrolyzed to yield 2E,4E-dodeca-2,4-dienoic acid, 82. 
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Figure 46: Synthesis of 2E,4E-dodeca-2,4-dienoic acid. 
 
For the synthesis of (2E,4E,8Z,10E)-dodeca-2,4,8,10-tetraenoic acid, ethyl 4-
bromobutanoate was first treated with triphenylphosphine to form phosphonium salt 83 
(Figure 47). Potassium tert-butoxide was used to deprotonate 83 and crotonaldehyde 
were coupled by a Wittig reaction to form 84. Ethyl (4Z,6E)-octa-4,6-dienoate was 
carefully reduced at -80 °C with a dropwise addition of DIBAL to yield the aldehyde 85. 
The phosphonate, 80, from the synthesis of 12:2 was deprotonated with sodium hydride 
and (4Z,6E)-octa-4,6-dienal was added. Though different conditions were tested, the 
yield for this HWE reaction was low to yield methyl (2E,4E,8Z,10E)-dodeca-2,4,8,10-
tetraenoate (86). Finally the methyl ester was hydrolyzed to (2E,4E,8Z,10E)-dodeca-
2,4,8,10-tetraenoic acid. 
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Figure 47: Synthesis of (2E,4E,8Z,10E)-dodeca-2,4,8,10-tetraenoic acid. 
 
 Acyl-CoAs are central metabolic intermediates in plants and are formed by 
several reactions including the condensation reaction of free fatty acids and CoA 
catalyzed by acyl CoA synthetase (ACS) and importantly in plants acyl 
CoA:lysophosphatidylcholine acyl transferase (LPCAT) coverts other glycerolipids to 
acyl CoAs [197, 198]. However, the non-enzymatic preparation of these acyl-CoAs was 
not trivial. Commercial 12:0 was used while the procedure was being optimized. Initial 
attempts to synthesize 12:0-CoA were completed with a procedure modified by Sanchez 
[199].  Extreme caution had to be taken during the neutralization and precipitation of the 
acyl-CoA. If an excess amount of 2 M HCl was added, the acyl-CoA was completely 
hydrolyzed. The highest percent yield achieved using this unmodified procedure was 
around 13%.  To optimize the yield, three key aspects of the procedure were examined; 
the formation of the mixed anhydride, formation of the acyl-CoA, and purification of the 
acyl-CoA.  
 To start, the extent of formation of the mixed anhydride was checked. After 
evaporation of the methylene chloride solvent, NMR analysis showed that free fatty acid 
was still present. In the procedure of Levoin, 2,6-lutidine is used instead of triethylamine 
[200]. When using this procedure, no mixed anhydride was seen via NMR. Therefore 
different conditions were tested using the Sanchez procedure as a starting point. The 
solvent was changed from DCM to THF. Triethylamine and ethylchloroformate were 
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added in direct succession instead of having a 30-minute stir in between the two. Finally, 
the amount of triethylamine and ethyl chloroformate was doubled to help drive the 
reaction to completion. All of these conditions slightly increased the percent yield, but 
further analysis was done on the formation of the acyl-CoA and purification.  
 The CoA was the limiting reagent to confirm all the CoA was being consumed, 
after neutralization, the supernatant was tested via UV-Vis for CoA absorption. Free CoA 
was found to be present in the supernatant. Therefore, the mixture of THF and CoA 
solution was mixed longer to ensure the mixed anhydride and CoA were interacting in the 
heterogeneous mixture. The reaction seemed to be optimized after 2 hours of vigorous 
stirring. After a few attempts where no product was produced, the conditions of the 
mixing the anhydride with the CoA solution were adjusted to that reported in the CRC 
Handbook of Chromatography [201]. The base was changed from KHCO3 to NaHCO3. It 
was noted that a homogenous solution of water:THF must be achieved in order for the 
reaction to mix properly. Collectively, changing the solvent to THF, doubling the amount 
of triethylamine and ethylchloroformate, changing the base to NaHCO3 for the CoA 
solution, and 2 h of vigorous stirring of the anhydride/CoA mixture, the yield improved 
to 32%.  
 After purification, the acyl-CoA was dissolved in 80 mM NaHCO3. Some of the 
solutions were cloudy meaning additional purification was needed. Solid-phase extraction 
with a C18 column was completed to eliminate unreacted starting materials. After loading 
the sample onto the column, the column was washed with H2O. The product was eluted 
with 50% MeOH. When free CoA was tested on the column, it eluted with the H2O 
washes. When free fatty acid was tested, it was not seen in any of the washes until the 
CoA concentration was tested. By UV-Vis the percent yield was around 50%, but when 
the concentration was determined by GC-MS the percent yield was over 200%. Therefore 
unreacted fatty acid was not being purified from the acyl-CoA sample via the C18 column. 
Finally, a new purification procedure from Al-Arif was followed using 5% HClO4 to 
precipitate acyl-CoA from solution followed by washes with 0.8% HClO4, acetone, and 
diethyl ether [202]. The yield was optimized at 39%. 
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3.3.7 Concentrations of acyl-CoAs  
Concentrations of each acyl-CoA were calculated using absorbance from the UV-
VIS and the correlations areas of the FAMES from GC-MS analysis. Previous studies 
have shown concentration analyses of acyl-CoAs by UV-Vis [195, 197]. Following the 
procedure by Merrill et. al., the stock solutions were diluted in a phosphate buffer and the 
absorbance was recorded at 260 nm. To test the procedure, commercial 16:0-CoA was 
used. A stock solution was made and absorbance was recorded in the phosphate buffer. 
The UV-Vis technique showed less than a 10% error with 16:0-CoA, which verified the 
use for our purposes. However, if the free-CoA was not entirely removed during the 
extraction process, the quantity of the acyl-CoA would be inflated. Therefore, gas 
chromatography was used as an independent technique to verify the acyl-CoA 
concentrations. For GC-MS analysis, the acyl-CoAs were derived to their methyl esters, 
using 15:0 as an internal standard.  The relative response for the GC/MS in the FAMES 
analysis was determined for the esters of 12:1 and 12:2, with respect to 15:0. The slopes 
from each concentration curve were used to determine the sensitivity of 12:X compared 
to the internal standard, 15:0 (Table 4). There was a limited amount of 12:4 free fatty acid 
available from our synthesis; therefore, the sensitivity of methyl 12:2 was used to 
calculate the concentrations of methyl 12:4. FAMES analysis was completed with each 
acyl-CoA and 15:0 as a standard. The correlation areas were determined and Equations 2-
4 were used to calculate the concentration of the acyl-CoAs (Table 5). 
 
Table 4: Calculated concentrations of acyl-CoAs (12:1, 12:2, and 12:4) determined by 
UV-Vis and GC-MS. 
 
 
UV-Vis GC-MS 
Acyl-CoA 
Concentration of 
Acyl-CoA (mM) 
Sensitivity 
Concentration of 
Acyl-CoA (mM) 
12:1CoA 2.7 mM 0.402599 3.2 mM 
12:2CoA 35.4 mM 0.1487589 11.2 mM 
12:4CoA 14.3 mM 0.1487589 10.5 mM 
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The concentrations between 12:1CoA and 12:4CoA were reasonable between the 
two analyses. The concentration for 12:2CoA was much higher from the UV-Vis than the 
GC-MS. Therefore, there must be excess CoA in the sample that was not washed away 
during purification. Because CoA exists in cells, the excess CoA was not expected to 
have deleterious effect on the assays and therefore the sample was still used for further 
analysis. The concentrations from the GC-MS were used for the enzymatic feedings.  
 
3.3.8 Activity assays of acyl-CoAs with EpLigase 
The Nikolau group isolated an enzyme, EpLigase, in the hope that it plays a key 
role in alkamide biosynthesis by catalyzing the reaction to form the amide bond. As 
previously discussed, the isolation of the BCAA decarboxylase Epa_11279 was shown to 
decarboxylate valine and isoleucine to form isobutylamine and 2-methylbutylamine 
providing the alkyl amide nitrogen in alkamides. EpLigase was tested using activity assay 
with fatty acid acyl-CoAs and isobutylamine for the formation of the amide bond. Initial 
activity of the protein was checked using each fatty acid CoAs chain-length from C3-C18; 
only C12-CoA showed any activity. The synthesized acyl-CoAs, 12:1-CoA, 12:2-CoA, 
and 12:4-CoA were also tested with the protein and 20 mM isobutylamine. The kcat and 
Vmax were compared to 12:0-CoA (Table 5).  
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Table 5: Enzyme activity of EpLigase with unsaturated CoAs. 
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Initially 12:2-CoA and 12:4-CoA showed almost no activity with the protein. 
When the higher concentrations were used, the enzymatic activity was detected. However, 
looking at the catalytic efficiency values, the kcat/Km values for 12:2-CoA and 12:4-CoA 
were significantly lower than 12:1-CoA. 12:1-CoA has a much higher kcat/Km, and the 
activity is comparable to that of 12:0-CoA.  
Finally, the products from the in vitro assays were confirmed by GC-MS. All 
three synthesized acyl-CoAs produced the respective alkamide. It has been determined 
that EpLigase shows activity with acyl-CoAs of 12 carbons. However, after one unit of 
unsaturation, the Km drastically increases showing the enzyme has low affinity for those 
substrates. It is still unknown whether the initial unsaturation in the acyl chain comes 
before or after the amide bond is formed, but these results may indicate that the majority 
of desaturation comes after the amide bond. As α,β-unsaturation occurs in all alkamides, 
there is a possibility the α,β-unsaturation may come before the amide bond is formed. 
 
3.4 Conclusion 
 Through experiments described in this chapter, further insight was gained into 
several aspects of alkamide biosynthesis in E. purpurea. It was determined that the amide 
moiety is synthesized from the decarboxylation of isoleucine and valine. Both [2H8]Val 
and [2H10]Ile were both fully labeled into NiBu/12:4Δ2E,4E,8Z,10E. The decarboxylation of 
valine leads to isobutylamine. Though isobutylamine does not seem to accumulate in 
Echinacea seedlings, [2H8]isobutylamine chloride does incorporate into 
NiBu/12:4Δ2E,4E,8Z,10E. Further proving the amide moiety is derived from valine and 
isoleucine. This contributed to our collaboration with the Nikolau group that discovered 
the branched-chain decarboxylase that catalyzes this reaction. Additionally, the Nikolau 
group isolated a ligase that potentially connects an acyl-CoA with isobutylamine to form 
the amide moiety. We synthesized three C12-CoAs with varying degrees of unsaturation. 
Along with standard 12:0CoA, 12:1CoA showed promise as the acyl intermediate in the 
alkamide pathway. Finally, in an attempt to better understand the modification of the 
unique acyl chain of alkamides, three fatty acids (12:1Δ2E, 13:1Δ2E, and 14:1Δ2E) and 
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three alkamides (NiBu/12:1Δ2E, NiBu/13:1Δ2E, NiBu/14:1Δ2E) were synthesized with d3-
labeling at the end of the acyl chain. Though initial studies showed no labeling in 
NiBu/12:4Δ2E,4E,8Z,10E from these six synthesized compounds, further studies are needed to 
ensure and optimize the internalization of the proposed intermediates by the seedlings. 
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CHAPTER 4. STRUCTURE ELUCIDATION OF PROPOSED 
INTERMEDIATES IN THE SAD2 PATHWAY 
4.1 Introduction 
Our goal was to identify the products of SAD2 mutants in order to give insight 
into the bifunctional character of AsCYP51H10 and thus providing further understanding 
of the biosynthetic pathway of avenacin A-1.  Subcloning of the SAD2 gene from A. 
strigora allowed for its transient co-expression with SAD1 in Nicotiana benthamiana 
leaves [203].  The design of site-directed mutants from SAD2 that were proposed to 
disrupt the binding of either beta-amyrin or 16β-hydroxy-beta-amyrin was undertaken.  
Co-expression of each mutants with SAD1, similar to that which had been carried out 
with the wild-type enzyme, made several products including monooxygenated and 
deoxygenated triterpenes and possibly a desmethylated product.  The goal of this portion 
of the project was to fully identify the mutant SAD2-derived metabolites and to further 
evaluate whether the 14-desmethyl product, suggested by GC-MS data, was present. The 
14-desmethyl product would be interesting because it would show the conserved 
mechanistic property of the CYP51 family (Figure 48). 
 
Figure 48: The possible14-desmethylation product from a SAD2 mutant that would show 
similar the same mechanistic function as other CYP51 enzymes. 
 
 Additionally, it was felt that if 12,13β-epoxy-β-amyrin and/or 16β-hydroxy-β-
amryin were identified and could be isolated, it would provide an opportunity to feed 
single oxidized products back to the wild-type enzyme to see whether 12,13β-epoxy-β-
amyrin can be converted to 16β-hydroxy-12,13β-epoxy-β-amryin or if 16β-hydroxy-β-
amryin is converted to 16β-hydroxy-12,13β-epoxy-β-amryin. This would aid in 
HO
O
OH
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determining the sequence of events to form 12,13β-epoxy-16β-hydroxy-β-amyrin. The 
structures of intermediates from the wild-type protein and two different mutant proteins 
were elucidated by several NMR experiments including 1H, 13C, DEPT, COSY, HSQC, 
HMBC, and NOESY. 
4.1.1 Evolution of enzymes in secondary metabolism 
Since the 1970s, knowledge of the enzymes involved in specialized metabolism 
has expanded. Like primary metabolic enzymes, most plant secondary metabolic 
enzymes display high substrate specificity for both core pathways and modifying 
reactions for structural diversity, and there is no evidence of unspecific side reactions [3]. 
Unlike enzymes from primary metabolism, generally, enzymes of secondary metabolism 
tend to lack feedback regulation [3]. Many enzymes in secondary pathways are 
multifunctional such as cytochrome P450s (CYPs) [3]. It is also recognized that enzymes 
of specialized metabolism are found in 3-5 fold lower concentrations than enzymes of 
primary metabolism [3], which can provide difficulty in identifying them and 
understanding their functions. 
Oxygenation is a common feature amongst a majority of secondary metabolites 
[10]. In plants, the cytochrome P450 (CYP) superfamily is the largest class of plant 
metabolic enzymes, and they most commonly catalyze a variety of monooxygenations, 
usually by inserting one oxygen molecule into an aliphatic position [203]. There are over 
5,100 sequences of plant CYPs that have been identified [204]. They have several 
important roles in plants such as signaling, defense, polymerization, and the development 
of complex anatomical and chemical structures [204]. They are excellent examples of the 
evolution of plant metabolic enzymes. 
CYPs share a catalytic center in which iron is coordinated to a thiolate of a 
conserved cysteine [205]. They are similar in topology and three-dimensional fold, but 
they vary at the amino acid level [206, 207]. Though CYPs play an important role in 
secondary metabolism, many of the founding members of the CYP families catalyze 
primary metabolic reactions [10]. Through gene duplication, members from primary or 
existing secondary pathways have led to multi-member gene families with a widened 
array of substrates and greater functional diversity to synthesize new secondary 
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metabolites [10]. Advances in sequencing technologies have led to an increase in 
sequencing of a diverse number of aquatic and land species resulting in new plant CYP 
families being identified [10]. By 1996, plants had already broken the nomenclature 
system established ten year earlier [208]. To date, there are 127 plant CYP450 families 
[10].  
Plant CYPs were originally divided into two different clades: A-type and non-A-
type [209]. It was thought that A-type enzymes participate in the biosynthesis of 
specialized metabolites; whereas, non-A-type function in lipid and hormone metabolism 
[209]. Non-A-type CYPs were thought to be more divergent than A-type [210]. Now it is 
known that non-A-type enzymes are involved in specialized metabolites and this 
simplified view is inaccurate [10]. Instead, CYP enzymes from land plants can be divided 
into 11 phylogenetically distinct clans, CYP51, 71, 72, 74, 85, 86, 97, 710, 711, 727 and 
746 [10]. The original A-type CYPs are now contained in the CYP71 clan, and non-A-
type are spread across the other 10 clans [10]. Either through gene duplication of general 
metabolic CYPs or divergence from pre-existing specialized pathways, clans have 
expanded over time [10]. The membership of some clans such as CYP71, CYP85, and 
CYP86 has expanded more than others like CYP51, CYP710, and CYP74 (Figure 49) 
[10]. One of the most highly conserved clans is CYP51. In all CYPs across animals, 
microbes, and plants sequences are less than 30% identical except within the CYP51 
family [205]. The CYP51 family is conserved across all phyla with a sequence identity in 
the range of 30-40% [205]. The CYP51 is the only family in the CYP51 clan and it 
catalyzes 14α-demethylation reaction for sterol biosynthesis. Through evolution within 
the family, changes in the CYP51 sequences have been seen, though less frequent then 
other families. However, even after changes to sequence, the catalytic function across all 
phyla is the same. The CYP51 continually remains an interesting family to study due to 
the preserved metabolic role across phyla and the possibility of diversification in new 
species [211]. 
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Figure 49: Graphical representation of the occurrence of plant CYP clans across plant 
phylogeny. CYP746 is not represented because it makes up less than 0.2% of the chart. 
Reproduced with permission from [10] 
 
One of the oldest and most structurally diverse classes of plant natural products is 
the terpenoids [10]. In fact, there are more than 43,000 known terpenoids, and most of 
them are oxygenated at one or more carbon positions (Table 6) [10]. CYPs are most often 
the enzyme involved in the oxygenation of terpenoids [10]. Oxygenation diversifies the 
products produced, increases their polarity, and decreases the metabolites volatility, 
which all can benefit a plant [10]. Currently, it is known that the CYPs used for terpenoid 
biosynthesis are distributed over 8 of the 11 clans [10]. In four of the clans, the CYPs 
from primary metabolism have started to proliferate to form specialized terpenoids [10]. 
This shows that a key feature in the evolution of CYPs is the recruitment from primary 
pathways [10].  
  
CYP51	
CYP71	
CYP72	
CYP74	
CYP85	
CYP86	
CYP97	
CYP710	
CYP711	
CYP727	
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Table 6: The fraction of terpenoids that are oxygenated per class. 
Class of Terpenoid Number of Terpenoids Percent Oxygenated 
C10 monoterpenoid 3,816 99.8% 
C15 sesquiterpenoid 13,211 96.7% 
C20 diterpenoid 11,609 98.8% 
C30 triterpenoid 14,505 95.2% 
 
Not only are CYPs involved in the synthesis of terpenoids, but also in the 
biosynthesis of other specialized metabolies such as phenylpropanoids and alkaloids [10]. 
Therefore they are a key component of specialized metabolism and essential in the 
evolution of natural product diversity. As herbivores and pathogens have evolved, plants 
have developed new defense-related molecules [10]. Oxygenation reactions are a driver 
of structurally diverse natural products, significantly modulating their physiochemical 
properties. CYPs have also shown to have catalytic flexibility, which makes them ideal 
for the evolution of new function. Because they are already a large fraction of plant genes, 
it is hypothesized these enzymes will continue to be important for plants to adapt to their 
environment.  
4.1.2 Triterpenes 
Isoprenoids, also known as terpenes, are compounds composed of isoprene (2-
methyl-1,3-butadiene) units (Figure 50). They are produced by plants, animals, and 
microorganisms and have recognized commercial pharmacological and agricultural value 
[212, 213]. In plants, isoprenoids are usually found in the essential oils and the C30 
carotenoids provide the orange, yellow, and red pigments found in plants [214]. They can 
range from small volatile oils with one isoprene unit to natural rubber containing about 
4,000 isoprene units [214]. Isoprenoids are broadly classified based on the number of 
isoprene units in the structure; monoterpenes (C10H16), sesquiterpenes (C15H24), 
diterpenes (C20H32), triterpenes (C30H48), tetraterpenes (C40H56), carotenoids (C40H56) and 
polyterpenes (C5H8)n designate some of the most prolific groups [214]. Furthermore 
within each class compounds can be classified into subclasses based on whether they are 
acyclic, monocyclic, or bicyclic, as examples [214]. 
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Figure 50: A. Structure of an isoprene unit. B. Acyclic assembly of head-to-tail linked 
isoprene units that form the backbone of terpenes. 
 
Triterpenes, C30H48, are formed from the linkage of 6 isoprene units and are 
produced by animals, plants and fungi. This large group is structurally diverse with over 
200 different skeleton structures known from natural sources or engineered enzymatic 
reactions [215]. Over 100 distinct skeleton structures are known in the realm of natural 
products. [215]. The most common structures are 6-6-6-5 tetracyclic, 6-6-6-6-5 
pentacyclic, or 6-6-6-6-6 pentacyclic fused rings [215]. However, a wide range of acyclic, 
monocyclic, bicyclic, tricyclic, and hexacyclic triterpenoids have been also been isolated 
[215].  
The most well known acyclic triterpene is squalene (Figure 51). Squalene is 
widely distributed in nature. For example, it is found in vegetable oils, in fungi, in human 
earwax, and it makes up more than half of liver oil is several shark species [214]. 
Squalene is also an important intermediate in the biosynthesis of cholesterol, an essential 
component to animal cells, and β-amyrin, a natural product isolated in a variety of plants 
(Figure 51) [216, 217].  
 
 
 
Figure 51: Structures of squalene, cholesterol, and β-amyrin. 
Although squalene is an acyclic triterpene, β-amyrin is a pentacyclic triterpene, 
and cholesterol is categorized as a sterol, they still share a biochemical relationship in 
their biosynthesis (Figure 52) [214]. The biosynthesis of β-amyrin and cholesterol share a 
A. B.
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H
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biosynthetic pathway until the cyclization of 3R-2,3-epoxy-2,3-dihydrosqualene where 
the pathway diverges into sterol biosynthesis and triterpene biosynthesis. Therefore, 
squalene is an important triterpene that provides a biochemical connection between 
structurally different compounds, cholesterol and β-amyrin, across kingdoms. 
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Figure 52: Sterol biosynthesis and triterpene biosynthesis share the squalene as a 
common intermediate in their biosynthetic pathways. The two pathways diverge with the 
cyclization of (3S)-2,3-epoxy-2,3-hydrosqualene. Multiple arrows indicate multiple steps 
previously occurred in order to synthesize squalene.  
 
4.1.3 Biosynthesis of the triterpene avenacin 
Triterpenes can be further subdivided based on the functional groups attached to 
the triterpene backbone. Triterpene saponins are glycosylated plant secondary metabolites, 
and they are the largest class of plant-derived natural products [203]. Triterpene saponins 
squalene
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are components of the cell membrane and are most well known for their antimicrobial 
properties [218]. They have uses in pharmaceuticals as foaming agents and in industry as 
agrochemicals and food additives [203, 219]. Lyonifolic acid A has shown to have 
antiviral activity against influenza A and pedunculoside has shown antifungal activity 
(Figure 53) [220, 221]. Triterpene saponins play important roles in plant defense and the 
fluidity of the cell membranes [218, 219]. 
 
 
 
Figure 53: Two examples of triterpene saponins that have biological functions, lyonifolic 
acid A (antiviral) and pedunculoside (antifungal). 
 
Cultivated oats (Avena sp.) are unique because they produce a family of defense-
related triterpenes known as the avenacins; no other cereal is known to contain these 
compounds [219, 222-224]. Four structurally similar compounds, avenacin A-1, A-2, B-1, 
and B-2, are found in the roots (Figure 54) [225, 226]. Avenacin A-1 is the most 
abundant metabolite though the relative proportions of the avenacins varies during 
development [225]. Avenacin A-1 is synthesized and stored in the epidermal cells of the 
roots providing protection against the soil-borne fungal pathogen Gaemannomyces 
graminis var tritici, a take-all disease of wheat [219]. All four of these triterpenes have a 
β-amyrin core and a branched sugar chain at C3 [225]. Nomenclature of the avenacins 
emphasizes structural variation at the C4 and C21 positions. “A” indicates a hydroxyl 
group at R1, whereas “B” denotes that R1 is a hydrogen [226].  The “1” indicates a N-
methylanthranilate group at C21 and “2” indicates a benzoate group [226]. 
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Figure 54: Avenacin A-1, A-2, B-1, and B-2 are structurally similar avenacins. All four 
triterpenes have a decorated β-amyrin backbone and C3 is a branched sugar chain, D-
glucose-D-glucose-D-arabinose [225]. The “A” is indicative of a hydroxyl group at R1 
and “B” means R1 is a hydrogen [226].  The “1” indicates a N-methylanthranilate group 
at C21 and “2” indicates a benzoate group [226]. 
 
Due to the highly fluorescent nature of avenacin A-1, saponin-deficient (SAD) 
mutants prepared by chemical mutagenesis could be identified by their lack of root 
fluorescence. This provided a ready entry to the study of the avenacin biosynthetic 
pathway. Currently, there are ten loci known for avenacin biosynthesis (SAD1-10) [219, 
227-229]. After a more thorough genetic analysis, a gene cluster was revealed; SAD1, 
SAD2, SAD7, SAD9 and SAD10 loci are linked to the SAD1 locus [229, 230]. It has 
been shown that SAD1 mutants result from non-synonomyous, premature termination, 
and splicing error mutations within the β-amyrin synthase gene (AsbAS1) causing an 
accumulation of 2,3-oxidosqualene and absence of β-amyrin [217, 231]. Other SAD 
mutants that have been identified through biochemical analysis have shown to 
accumulate putative intermediates. SAD2 mutants blocked hydroxylation, SAD7 and 
SAD10 mutants impaired acylation at the C21 position, SAD9 mutants inhibit N-
methylation, and SAD3 and SAD4 mutants prevented glucosylation [229-231]. Recent 
work done by the Osbourn group has provided insight into the triterpene cyclization of 
SAD1 [232]. In collaboration with our group, we hope to provide further insight into the 
function of SAD2. 
To date, triterpenoid saponins are synthesized from mevalonic acid (MVA) via 
the cytosolic isoprenoid pathway [217, 223, 230]. The chloroplastic methylerythritol 
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phosphate (MEP) gives rise to mono-, di- and tetraterpenes are synthesized by plants and 
cyanobacteria through a chemically independent route [223, 230]. The beginning of the 
avenacin pathway is shared with the sterol biosynthetic pathway. Subsequent to the 
production of 2,3-oxidosqualene, triterpenoid synthesis splits from the sterol pathway 
through enzymatically guided conformationally disparate transition states [223, 230].  In 
a sterol and cycloartenol cyclases, 2,3-oxidosqualene is cyclized via a chair-boat-chair 
transition state into a tetracyclic products in animals and plants, respectively.  For 
avenacin, 2,3-oxidosqualene is cyclized by the triterpene cyclase enzyme β-amyrin 
synthase, SAD1, through a chair-chair-chair-boat conformation to form pentacyclic β-
amyrin [217, 223]. The Osbourn group recently reported the characterization of the 
saponin-deficient 2, or SAD2, gene that is required for avenacin biosynthesis [233]. 
Plants with defective SAD2 alleles accumulated β-amyrin. Osbourn’s group was also able 
to show that SAD2, also referred to as AsCYP51H10, catalyzed the formation of 12,13β-
epoxy-16β-hydroxy-β-amyrin [203]. After the formation of the 12,13β-epoxy-16β-
hydroxy-β-amyrin, details concerning the progression of the pathway can only be 
speculated (Figure 55).  
167 
 
 
 
Figure 55: Proposed pathway for avenacin A-1 production. The dotted line indicates that 
several enzymatic transformations are anticipated. The sequence and chemistry from 
12,13β-epoxy-16β-hydroxy-β-amyrin to des-acyl avenacin A-1 has not been confirmed 
[217]. Recent work has provide insight into SAD7, SAD9, and SAD10 for the production 
of avenacin A-1 [232]. 
 
It has been proposed that a series of cytochrome P450 (CYP) monooxygenases 
hydroxylate several intermediates of the pathway after 12,13β-epoxy-16β-hydroxy-β-
amyrin [219]. Other steps that appear to occur include the formation of an N-
methylanthranilate group through a coordinated system of methylating anthranilate 
(SAD9), which is subsequently glucosylated (SAD10) and then transferred to the 
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triterpene backbone by an acyltransferase (SAD7) [229]. Also, the linking of a branched 
trisaccharide is most likely effected by three different glycosyltransferases [219]. It has 
been proposed that a dehydrogenase, has been seen in sesquiterpene synthesis, may add 
the aldehyde by a pair of successive oxidations [234]. Due to the complexity and low 
abundance of the intermediates and the lack of availability of commercial standards for 
intermediates after β-amyrin has provided a challenge for saponin research [219]. 
Advances in chromatographic and spectroscopic techniques have expanded metabolic 
profiling of complex structures and thus have overcome a majority of these difficulties 
[219, 235, 236].  An alternative way to understand the biosynthetic pathway of avenacin 
A-1 is to study the intermediates produced by different enzymes involved in the pathway. 
As previously stated, it has been proposed that hydroxylations to avenacin A-1 occur via 
a series of CYP monooxygenases [217, 219]. For our project, a method to access β-
amyrin derivatives could be beneficial in aiding to the understanding of the function of 
SAD2. 
The cytochrome P450 (CYP) superfamily has been identified in all domains of 
life: animals, plants, fungi, bacteria, and viruses; it is the largest class of plant metabolic 
enzymes [203]. They catalyze a vast array of oxidation reactions, referred to by Coon et 
al. as a “diversosome”, most commonly inserting one oxygen atom into an aliphatic 
position in their substructures [203, 237]. There are thousands of CYP sequences known 
[208]. Due to large number of CYPs, and to help unify the enzymes across kingdoms a 
system of nomenclature has been developed [208]. For example, CYP51H10, CYP stands 
for cytochrome P450, 51 represents the family, H is the subfamily, and it was the 10th 
gene discovered in this subfamily. For genes to be categorized in the same family, the 
amino acid sequence identity must be at least 40% a cut off of 55% identity is applied for 
each subfamily [208]. During the modern practice of classifying a new sequence into an 
existing group, clustering takes priority. Use an agglomerative clustering algorithm rather 
than emphasizing the absolute % identity given [208]. Due the number of enzymes and 
that the names are assigned in historic order, the original capacity of the nomenclature 
system has been periodically extended and quite possibly will have to be further 
expanded. The CYP51 family is one of the most conserved enzyme families and is the 
only family in the CYP51 clan. The subfamily CYP51G catalyzes 14α-demethylation 
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reaction for sterol biosynthesis. The discovery of CYP51H10 was unique because it was a 
CYP51 enzyme that mechanistically behaved differently than most members in this 
family.  
The exceptional diversity among CYP enzymes is believed to have originated 
from a small number of ancestral CYP enzymes that duplicated and diverged to accept a 
broad range of substrates, but the cytochrome P450 14α-sterol demethylase (CYP51) is 
unique because the structure of it’s active site has been maintained and the primary 
function of the enzyme has remained conserved across the living world [203, 238, 239].  
CYP51 is one of the most ancient of the P450 families and can be found in all biological 
kingdoms including plants and fungi [186, 211]. The primary function of CYP51 resides 
in the critical conversion of lanosterol, eburicol, and obtusifoliol into membrane sterols 
such as cholesterol in humans, ergosterol in fungi, and sitosterol/brassinosteroids in 
plants, respectively [211]. The sterol substrate can vary but the sequence of oxidative 
conversions remains the same. Initially, the methyl at C14 is oxidized to an alcohol that is 
subsequently oxidized to the aldehyde. Finally, the aldehyde is oxidatively cleaved as 
formic acid with the concomitant of a double bond at C14-C15 (Figure 56) [211]. 
 
 
 
Figure 56: The prototypical CYP51 reaction, where lanosterol is converted to 4,4-
dimethylcholesta-8(9),14,24-trien-3-β-ol  [211]. 
 
For plants, the obtusifoliol 14-demethylase falls into the clan CYP51G [233]. The 
Osbourn group cloned and characterized a new CYP enzyme belonging to the CYP51 
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sterol demethylase family, SAD2 [203, 233]. However, this enzyme was unable to be 
expressed in yeast using the standard system for CYP51G enzymes [233]. SAD2 had a 46% 
amino acid sequence identity with CYP51G, but only 32% identity in the active site 
residues [203, 233]. Phytogenetic analysis showed SAD2 belonged to a newly defined, 
but functionally uncharacterized subfamily, CYP51H, thus designated AsCYP51H10 
[233]. When comparing the amino acid sequences of CYP51 enzymes from bacteria, 
fungi, protozoa, plants, and animals, 34 amino acids were fully conserved [233].  
However, in AsCYP51H10, six of these residues were not conserved. Using 3D modeling, 
the structure of AsCYP51H10 and an oat 14α-demethylase, AsCYP51G1 were compared 
to the crystal structure of MtCYP51B1 (Mycobacterium tuberculosis) [233]. A major 
difference in AsCYP51H10 compared to AsCYP51G1 was in the active site size. The 
volume of AsCYP51H10 was 568 ± 96 Å compared to MtCYP51B1was 343 ± 62 Å and 
AsCYP51G1 was 346 ± 108 Å [233].  The ballooning of the active site correlates with 
the different functionality of AsCYP51H10 and thus makes it an inaugural member of the 
CYP51H subfamily [233].  Previous work done by Aoyama’s group suggested that 
AsCYP51H10 expressed in yeast was able to oxygenate β-amyrin at two positions, one of 
which was the epoxidation of the 12-alkene [240]. Though the full structure was not 
determined, the MS spectrum from Osbourn’s group and yeast expression were in 
agreement [203, 240]. AsCYP51H10 was coexpressed in Nicotiana plants with AsbAS1 
to investigate its biochemical function [203].  The complete identification of the product 
from the coexpression of AsbAS1 and CYP51H10 was determined by NMR analysis to 
yield 12,13β-epoxy-16β-hydroxy-β-amyrin [203].  
The compound β-amyrin does not seem to possess antifungal properties [227]. 
Therefore, the other functional groups of avenacin A-1 must play an important role in its 
antimicrobial activity. The function groups instilled into the product from SAD2 both 
appear in avenacin A-1. Currently, there are no standards available of avenacin A-1 
lacking the epoxy or 16-hydroxyl function group [203]. However, the Osbourn group was 
able to generate and purify 12-oxo-avenacin A-1 (OA) [203]. Disk assays were used to 
study the antifungal activity of the epoxide moiety [203]. Gaeumannomyces graminis var. 
tritic is a fungus known to be sensitive to avenacin (45). As the concentration increased, 
avenacin A-1 inhibited growth of the fungus, but 12-oxo-avenacin did not (Figure 57). 
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This indicates that the C12-C13 epoxide is critical for the antifungal activity, and thus the 
enzyme AsCYP51H10 plays an important role in the antimicrobial properties of avenacin 
A-1. 
 
 
 
Figure 57: Disk assays testing the antifungal activity of avenacin A-1 (A1) and 12-oxo-
avenacin A-1 (OA) against Gaeumannomyces graminis var. tritic, where the loading of 
the applied triterpene increases from left to right.  Control discs were loaded with equal 
volumes of 75% methanol Reproduced with permission from [203]. 
 
It was recognized from the identified product of Sad2 oxidation that the pathway 
to the epoxidized triterpene diol likely proceeds through two different intermediates, 
12,13β-epoxy-β-amryin or 16β-hydroxy-β-amyrin (Figure 58A) [203]. Other microbial 
multifunctional P450s have been shown to both epoxidize and hydroxylate substrates. 
There are examples of both possible reaction mechanisms. GfsF found in Streptomyces 
synthesize the antibiotic FD-891. It first catalyzes the epoxidation of 25-O-methyl FD-
892 and then hydroxylates (Figure 58B), whereas MycG from Micromonspora 
griseorubida hydroxylates mycinamycin IV (M-IV) before epoxidation of M-V (Figure 
58B) [203, 241, 242].  
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Figure 58: Multifunctional CYP enzymes that perform epoxidization reactions. A. Two 
hypothetical pathways for the formation of 12,13β-epoxy-16β-hydroxy-β-amyrin from β-
amyrin. It is not known whether Sad2 oxidizes intermediates 12,13β-epoxy-β-amyrin or 
16β-hydroxy-β-amyrin.  Both pathways could be active. B.  MycG is a multifunctional 
CYP enzyme that hydroxylates before it epoxidizes the dienone C. GfsF is an example of 
a multifunctional CYP enzyme that epoxidizes a trans-alkene before hydroxylation [203]. 
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Geisler et. al. used a sequence alignment from other CYP51 enzymes and 
molecular modeling experiments to predict the order of the reactions carried out by 
AsCYP51H10 [203].  For molecular modeling the crystal structure of human CYP51 
complexed with the fungal CYP inhibitor ketoconazole was used as a template. 
Representative members of the CYP51 subfamilies were used for sequence alignment 
substrate recognition sites (SRSs) were highlighted as shown in Figure 59A [203]. Of the 
five-substrate recognition sites, SRS5 looks to be key determinant for the size of the 
active site. At residues 353 and 354 all the sterol demethylase subfamilies have either 
proline or leucine residue, whereas AsCYP51H10 contains an alanine [203]. In addition, 
previous works has shown that the regiospecificity and selectivity can be altered by 
substitutions in SRS5 in a range of families including CYP51 [212, 243-246]. 
Molecular modeling was used to gain insight into the shape and binding 
orientation of the triterpene at the active site. Previous work investigated the molecular 
modeling of a CYP to predict the insertion sites discovering the average distance of the 
oxidation of the carbon atoms ad the heme iron was 4.14 Å and all were within 6 Å [247]. 
Again, the crystal structure of human CYP51 complexed with the fungal CYP inhibitor 
ketoconazole was used as a template. The precatalytic binding complexes were identified 
by minimizing the binding energy of beta-amyrin or its epoxidized or 16β-hydroxylated 
form and examining those enzyme-substrate complexes that had an average distance of 
the heme iron distal oxygen ligand (atom O1) to the hydroxylation site (C16) or to the 
epoxidation sites (C12, C13) that was 5 Å or less [203, 247]. This resulted in identifying 
precatalytic binding modes for 16β-hydroxy-β-amyrin and β-amyrin, but not for 12,13β-
epoxy-β-amyrin suggesting that 16β-hydroxy-β-amyrin is formed first [203]. The SRSs 
that appear to have the most significant interaction in the precatalytic complex with β-
amyrin include SRS1, SRS2, SRS4, SRS5, and SRS6, and those that might participate in 
the binding of 16β-hydroxy-β-amyrin include SRS1, SRS4, and SRS5 (Figure 59B/C) 
[203]. This further suggests that AsCYP51H could act as a multifunctional enzyme that is 
capable of two different oxidative reactions [203]. 
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Figure 59: A. Representative members of the CYP51 subfamilies used for sequence 
alignment include human lanosterol (HsCYP51A1), Mycobacterium tuberculosis 
(MtCYP51B1), Trypanosoma brucei lanosterol 14α-demethylase (TbCYP51E1), 
Saccharomyces cerevisiae lanosterol 14α-demethylase (ScCYP51F1),  Avena strigosa 
(AsCYP51G1), and Avena strigosa (AsCYP51H10). Substrate recognition sites are 
indicated in the black boxes. Black triangles represent residues modeled in the active site 
and that may interact with either or both β-amyrin or 16β-hydroxy-β-amyrin. Red 
triangles represent sites identified in sad2 mutants where non-synonymous substitutions 
prevent the synthesis of avenacin; #1027 was a A124V mutation and #791 was the 
mutation P463S. B. Modelled precatalytic binding modes of β-amyrin and C. 16β-
hydroxy-β-amyrin. Reproduced with permission from [203]. 
4.2 Method and Materials 
1H, 13C, DEPT, COSY, HSQC, HMBC, and NOESY NMR spectra were recorded 
on a Bruker Avance-II NMR spectrometer using pyrdine-d5 solvent; the most downfield 
peak from residual C5HD4N (1H, δ 8.74; 500 MHz) and C5D5N (13C, δ 150.35; 125 MHz) 
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were used as internal chemical shift references. Temperature was adjusted to 298 K for 
all spectra collected. Pulse programs were adjusted as follows: DEPT NS = 256; COSY 
TD = 512, SW = 6680 Hz; HSQC NS = 8, TD = 512, SW = F1 = 20.7 MHz F2 = 2940 
Hz; HMBC NS = 16, TD = 512, SW = F1 = 27.9 MHz F2 = 6493 Hz, J filter = 10 Hz; 
NOESY TD = 512, SW = 4995 Hz, TIME = 19.40. Peak multiplicities and shapes were 
annotated as follows: s, singlet; d, doublet; t, triplet; q, quartet; qn, quintet; m, multiplet; 
br, broad. Initially carbons were numbered in an increasing fashion from downfield to 
upfield chemical shifts. All correlations were originally made using this numbering 
system. Once the product was fully assigned, the carbon-shift based numbers were re-
assigned IUPAC numbers to compare chemical shifts between identified products and 
other triterpenes. The labeling of diastereotopic hydrogens denotes the most downfield 
number as “a” and upfield as “b.” Infrared spectra were recorded in KBr pellets with a 
Fourier-transform infrared spectrophotometer (Nicolet Avatar 33).  Mass spectra were 
collected with an Agilent 6520 Q-TOF mass spectrometer or GC/MS. 
 
4.2.1 GC/MS and Q-TOF protocols for triterpene analysis 
GC/MS analyses were performed using an Agilent 7890A GC/5975C MS.  
Samples were dissolved in ACN, silylated with BSTFA + 2% TMSCl, and the triterpenes 
were separated with a HP-5 (30 m x 250 µm x 0.25 µm) column. 
 
 
 
 
 
170 °C, 2 min 6 °C/min 
290 °C, 4 min 
10 °C/min  
325 °C, 10 min 
GC 1: Triterpene 
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GC/MS parameters were as follows:  
• Split-Splitless Inlet: Splitless; Inlet temperature: 280 °C; Pressure: 17.222 
psi; Septum purge flow: 3 mL/min  
• He flow rate: 15 mL/min for 2 min  
The scan parameters were as follows: 
• Solvent delay: 6 min 
• Scan speed: Normal  
• Start mass: 58.00 amu; Stop mass: 800.00 amu  
• Threshold: 150; Scans/sec: 1.99 
Triterpene high-resolution mass spectrum was obtained for each compound using 
Q-ToF LC/MS analysis. Q-ToF analyses were performed using an Agilent 6520 
Quadruple Time-of-Flight MS.   
 
 
 
The source parameters were set as follows: 
• MS2 full scan method 
• ESI positive mode 
• Fragmentation: 135 V 
• Gas temp: 315 °C 
• Gas flow: 10 L/min 
• Nebulizer: 50 psi 
80% B 
1 min 
100% B; 5 min 
Q-ToF LC/MS: Triterpene 
 
1 min 
80% B, 1 min 
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• Capillary: +/- 3500 V 
For the product from mutants I471M-2 and I471M-3, and the triterpene standard β-
amyrin, the parameters for the chromatograph were: 
• Solvent A: H2O + 0.1% formic acid. Solvent B: MeOH + 0.1% formic acid 
• Flow rate: 1 mL/min; 80% to 100% B over 1 min with a 5-min hold and then 
ramped back to 80% B over 1 min 
• Run time: 6 min 
• Post time: 1 min 
For the product from wild-type CYP51H10 and mutant CYPs A345L and I471M-1, the 
parameters for the chromatograph were: 
• Solvent A: H2O + 0.1% NH4OAc. Solvent B: MeOH + 0.1% NH4OAc 
• Flow rate: 1 mL/min; 50% to 100% B over 1 min with a 5-min hold and then 
ramped back to 50% B over 1 min 
• Run time: 6 min 
• Post time: 1 min 
4.2.2 Triterpene isolation from SAD2 mutant expression in N. benthamiana 
James Reed and Michael Stephenson at the John Innes Centre isolated the 
triterpene products using the procedures that follow. We collected IR, GC/MS and HR-
MS after receiving the samples to ensure that they were not degraded during transport 
prior to the NMR analysis. 
 
CYP51H10 wild-type product: For the isolation of the major product of wild-type Sad2, 
about 70 N. benthamiana plants were vacuum infiltrated with constructs that led to the 
coexpression of three enzymes, tHMGR, AsbAS1, and CYP51H10.  Leaves were 
harvested from the plants after 5 days and lyophilized. Using a mortar and pestle, the leaf 
material was pulverized in liquid N2 and then a mixture of ethanol/H2O/KOH 9:1:1 
(v:v:w) was added (6.5 mL/g of dry tissue) to disrupt the tissue and release acyl lipids as 
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carboxylate salts. The leaves were saponified for 2 hours at 65 °C. The ethanol was 
removed by rotary evaporation and the remaining mixture was extracted several times 
with ethyl acetate. The combined organic fractions were pooled together and 
concentrated to an oil by rotary evaporation. The crude product was suspended in toluene 
and loaded on a SNAP KP-Sil 25-g silica gel column (Biotage). Using an Isolera One 
flash chromatograph and a step gradient of hexane:ethyl acetate ranging from 6% ethyl 
acetate to 100% ethyl acetate, 9-mL fractions were collected. After the analysis by TLC 
and GC-MS, fractions containing product 88 were combined and the solvent was 
removed. A second purification was performed using a SNAP Ultra 10-g column (Biotage) 
again with a gradient of hexane:ethyl acetate from 0 to 50% ethyl acetate. After TLC and 
GC-MS analysis, the 12,13β-epoxy-16β-hydroxy-containing fractions deemed pure were 
concentrated to yield a yellow solid. The solid was furthered purified by decolorization 
with charcoal; and recrystallized from an ethanol:water mixture to give the final product. 
IR (KBr pellet): 3493, 2996, 2985, 2957, 2861, 1458, 1389, 1368, 1357, 1106, 1061, 
1052, 1035, 1024, 1001 cm-1; HRMS (ESI) m/z calc for [M + H]+ C30H51O3 459.3834, 
found 459.3833. 
 
CYP51H10-A354L product: Approximately 45 N. benthamiana plants were vacuum 
infiltrated with constructs that led to the coexpression of three enzymes, tHMGR, 
AsbAS1, and CYP51H10-A354L.  Leaves were harvested from the plants after 5 days 
and lyophilized. Using a mortar and pestle, the leaf material was pulverized in liquid N2 
and then a mixture of ethanol/H2O/KOH 9:1:1 (v:v:w) was added (6.5 mL/g of dry tissue) 
to disrupt the tissue and hydrolyze acyl lipids to their carboxylate salt constituents.  The 
leaves were saponified for 2 hours at 65 °C. The ethanol was removed by rotary 
evaporation and the remaining mixture was extracted several times with ethyl acetate. 
The combined organic fractions were pooled together and concentrated to an oil by rotary 
evaporation. The crude product was suspended in toluene and loaded on a SNAP Ultra 
50-g silica gel column (Biotage). A step-wise gradient of hexane:ethyl acetate ranging 
from 6% ethyl acetate to 100% ethyl acetate was used; 9-mL fractions were collected. 
After the analysis by TLC and GC-MS, fractions containing M2 product were combined 
and solvent was removed to yield an orange solid. The solid was dissolved in toluene and 
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a second purification was performed using a SNAP Ultra 10-g column (Biotage) with a 
gradient of hexane:ethyl acetate from 7% to 70% ethyl acetate. After TLC and GC-MS 
analysis, the M2-containing fractions deemed pure were concentrated. The orange 
material was dissolved in methanol purified further by reverse-phase semi-preparative 
HPLC was used with a Phenomenex Luma column (C18, 5 µm, 100 Å, 250x10 mm). A 
methanol:H2O gradient was run from 85% methanol for 3 minutes to 98% over 20 
minutes at 3 mL/min and held for 9 additional minutes. Dionex charged-aerosol detector 
monitored fractions and M2 were collected at around 24 minutes. IR (KBr pellet): 3340, 
2950, 2876, 1458, 1385, 1360, 1060, 1030, 998, 907, 737 cm-1; HRMS (ESI) m/z calc for 
[M + H]+ C30H51O2 443.3889, found 443.3850. 
 
CYP51H10-I471M product 1: For I471M mutant, 144 N. benthamiana plants were 
vacuum infiltrated with constructs that led to the coexpression of three enzymes, tHMGR, 
AsbAS1, and CYP51H10-I471M.  Leaves were harvested from the plants after 5 days 
and lyophilized. Crude material was extracted using Büchi SpeedExtractor in ethanol at 
100 °C and 150 bar. The ethanol was dried down by rotary evaporation to give a green 
material for saponification. A mixture of ethanol/H2O/KOH 9:1:1 (v:v:w) was added (6.5 
mL/g of dry tissue) to disrupt the tissue and hydrolyze acyl lipids to their carboxylate 
salts. The leaves were saponified for 2 hours at 65 °C. The ethanol was removed by 
rotary evaporation. The remaining mixture was dissolved in ethyl acetate and washed 
several times with H2O. The ethyl acetate was removed to yield an orange-brown solid. 
The material was dissolved in dichloromethane and absorbed onto silica gel 60 (Material 
Harvest UK), which was loaded onto a KP Sil 25-g column (Biotage). Flash column 
chromatography was completed using a step gradient of hexane:ethyl acetate from 0% to 
100% ethyl acetate collecting 9-mL fractions. After the analysis by TLC and GC-MS, 
fractions 40-50 were combined and the solvent was removed. The residue was dissolved 
in dichloromethane and loaded onto a 10-g SNAP Ultra column (Biotage) prior to eluting 
with a step gradient of hexane:ethyl acetate ranging from 0% to 100% ethyl acetate was 
used. After GC-MS analysis, the 90-containing fractions of highest purity were 
concentrated to yield a red solid. This material was further purified by decolorization 
with charcoal to yield a yellow solid before trituation in methanol gave the final product 
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as a white solid. IR (KBr pellet): 3452, 2933, 2863, 1465, 1375, 1101, 1065, 974, 719 
cm-1; HRMS (ESI) m/z calc for [M + H]+ C30H51O2 443.3889, found 443.3797. 
 
CYP51H10-I471M product 2: N. benthamiana plants were vacuum infiltrated with 
constructs that led to the coexpression of three enzymes, tHMGR, AsbAS1, and 
CYP51H10-I471M.  Leaves were harvested from the plants after 5 days and lyophilized. 
Crude material was extracted using Büchi SpeedExtractor in ethanol at 100 °C and 150 
bar. The ethanol was dried down by rotary evaporation to give a green material. A 
mixture of ethanol/H2O/KOH 9:1:1 (v:v:w) was added (6.5 mL/g of dry tissue) to disrupt 
the tissue and hydrolyze acyl lipids to carboxylate salts. The leaves were saponified for 2 
hours at 65 °C. The ethanol was removed by rotary evaporation. The remaining mixture 
was dissolved in ethyl acetate and washed several times with H2O. The ethyl acetate was 
removed to yield an orange-brown solid. The material was dissolved in dichloromethane 
and absorbed onto silica gel 60 (Material Harvest UK), which was loaded onto a KP Sil 
25-g column (Biotage). Flash column chromatography was completed using a step 
gradient of hexane:ethyl acetate from 0% to 100% ethyl acetate collecting 9-mL fractions. 
After the analysis by TLC and GC-MS, fractions 51-60 were combined and the solvent 
was removed. The residue was dissolved in dichloromethane and loaded onto a 10-g 
SNAP Ultra column (Biotage) prior to eluting with a step gradient of hexane:ethyl acetate 
ranging from 0% to 5% before ramping to 100% ethyl acetate. Fractions containing the 
product were purified again by SNAP 10-g Ultra column (Biotage) using a step gradient 
of hexane:ethyl acetate from 0% to 30% and 30% to 100% ethyl acetate. Fractions 
containing 91 combine and absorbed onto silica gel 60 (Material Harvest UK) and then 
loaded onto a SNAP 10-g Ultrage (Biotage). Flash column chromatography was 
preformed using hexane:ethyl acetate ranging from 5% to 25% before ramping to 100% 
ethyl acetate. Fractions of higher purity were combined, concentrated, and decolorized 
with charcoal to yield a yellow sold. The yellow solid was triturated using ethanol to give 
the final product as a crystalline solid. IR (KBr pellet): 3453, 2967, 2945, 2852, 1698, 
1468, 1385, 1368, 1083, 1045, 1035, 992 cm-1; HRMS (ESI) m/z calc for [M + H]+ 
C30H51O2 443.3889, found 443.3899. 
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CYP51H10-I471M product 3: N. benthamiana plants were vacuum infiltrated with 
constructs that led to the coexpression of three enzymes, tHMGR, AsbAS1, and 
CYP51H10-I471M.  Leaves were harvested from the plants after 5 days and lyophilized. 
The leaf material was pulverized in liquid N2 using a mortar and pestle, and then a 
mixture of ethanol/H2O/KOH 9:1:1 (v:v:w) was added (6.5 mL/g of dry tissue) to disrupt 
the tissue and saponify acyl lipids to their constituent carboxylate salts. The leaves were 
saponified for 3 hours at 65 °C. The mixture was filtered through an 8 cm x 10 cm 
column of diatomaceous earth (celite – Sigma) and the solvent was removed. The leaf 
material was reextracted with ethyl acetate (250 mL) overnight. The ethanol and ethyl 
acetate fractions were combine and dried. The crude material was dissolved in H2O (500 
mL) and extracted with hexane (4 x 500 mL). The hexane fractions were combined, 
washed with brine (500 mL), and the solvent was then removed by rotary evaporation to 
give an orange solid. The crude solid was loaded on a SNAP Ultra 50-g column (Biotage). 
The material was purified using flash column chromatography with 15% ethyl 
acetate:hexane. After analysis by GC-MS, the fractions containing 93 were combined and 
the solvent was removed. The solid was furthered purified by dissolving the triterpene in 
dichloromethane and decolorizing with charcoal; the final sample was recrystallized from 
methanol to give the final product. IR (KBr pellet): 3312, 2928, 2850, 1471, 1389, 1368, 
1047, 1033, 1000, 964 cm-1; HRMS (ESI) m/z calc for [M + H]+ C30H51O2 443.3889, 
found 443.3907. 
4.3 Results and Discussion  
4.3.1 Mutants 
Previous work showed that mutants of AsCYP51H10 were defective in avenacin 
synthesis but accumulated β-amyrin [227, 233]. AsCYP51H10 was coexpressed in 
Nicotiana plants with AsbAS1 and the product was identified by NMR analysis in CDCl3 
to be 12,13β-epoxy-16β-hydroxy-β-amyrin (Figure 61) [203]. When β-amyrin is oxidized, 
key chemical shift changes in the 13C spectra are observed at C12 and C13, where 
resonances at δ 121.7 and 145.2 ppm are replaced by peaks at δ 54.1 ppm and 66.9 ppm 
indicative of an epoxy moiety. Also, in the 1H spectrum, a new signal is observed 
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downfield at δ 4.16 ppm reflecting the presence of a new carbon-oxygen bond. Through 
heteronuclear multiple bond correlation and NOE experiments, the new hydroxyl group 
was determined to be on the β-face at C16, thus defining the intermediate as 12,13β-
epoxy-16β-hydroxy-β-amyrin (88).  Both modifications are maintained in the final 
product of avenacin A-1 [203].  
 
 
 
Figure 61: The structure of 12,13β-epoxy-16β-hydroxy-β-amyrin collected in CDCl3 with 
IUPAC numbering.  Tabulated are 1H and 13C chemical shifts, carbon type, proton 
coupling constants and multiplicity. The key chemical shift changes versus β-amyrin are 
indicated in red boxes [203]. 
 
It is known that AsCYP51H10 synthesizes 12,13β-epoxy-16β-hydroxy-β-amyrin, 
but the order of the oxidation events in which the enzyme functions is unknown. Mutants 
of SAD2 have been studied by computational modeling help understand the function of 
AsCYP51H10 [203]. The Osbourn group identified the location of seven SAD2 mutants. 
Of those seven, four have single mutations on residues that are critical to the heme 
binding or play roles in maintaining the three-dimensional structure of the CYP enzyme, 
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IUPAC	# δ	13C	
Carbon	
Type δ	1H (m),	JHH	(Hz)
1 38.03 CH2 1.52,	0.88
2 27.12 CH2 1.59,	1.54
3 78.89 CH 3.17 dd,	J	=	11.2,	4.4	Hz
4 38.81 C -
5 55.42 CH 0.66 dd,	J	=	11.2,	4.4	Hz
6 17.76 CH2 1.51
7 34.17 CH2 1.39,	1.19
8 41.38 C -
9 45.72 CH 1.33
10 37.19 C -
11 21.59 CH2 1.86,	1.70
12 54.13 CH 2.76 d,	J	=	4.6	Hz
13 66.90 C -
14 42.35 C -
15 34.17 CH2 1.82,	1.44
16 67.15 CH 4.16 dd,	J	=	11.1,	4.8	Hz
17 38.47 C -
18 49.55 CH 1.16
19 41.25 CH2 1.69,	1.14
20 30.73 C -
21 34.17 CH2 1.34,	1.15
22 30.70 CH2 1.81,	1.24
23 28.00 CH3 0.77 s
24 15.35 CH3 0.97 s
25 15.04 CH3 0.86 s
26 20.36 CH3 1.11 s
27 23.40 CH3 1.22 s
28 21.34 CH3 1.03 s
29 33.17 CH3 0.81 s
30 23.69 CH3 0.91 s
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and therefore they were discarded [203]. The three remaining, A124V, P463S, T113I, 
were tested individually by computational modeling in hope one of these mutants would 
accumulate the 12,13β-epoxy- or 16β-hydroxy intermediates [203]. Unfortunately not 
one of the mutants were predicted from computational modeling to be able to form pre-
catalytic complexes [203]. Consistent with this, the seven mutants accumulated β-amyrin, 
but did not accumulate either potential intermediate [203, 233]. New mutants needed to 
be made in order to try and isolate 16β-hydroxy-β-amyrin and/or 12,13β-epoxy-β-amyrin. 
As previously stated, at positions A353 and A354, the presence of small residues 
appear to be relevant for the alcohol binding. Therefore a series of mutants were made for 
the residues at 353 and 354. The other amino acids found in CYP51 enzymes at 353 and 
354 were threonine (T), leucine (L), valine (V), isoleucine (I), alanine (A), proline (P), 
and serine (S). Seven different amino acids at two different residues resulted in a possible 
49 mutants. Due to the strategy used to produce the variant proteins, only 28 of the 49 
mutants were analyzed (Table 7).  
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Table 7: The 28 mutants that were analyzed. 
Indels Amino Acids at 353 and 354 
ACTCTT TL 
ACTGTT TV 
ATTACT IT 
ATTATT II 
ATTGCT IA 
CCTATT PI 
CCTCCT PP 
CCTCTT PL 
CCTGCT PA 
CCTTCA PS 
CTTCCT LP 
CTTCTT LL 
CTTGCT LA 
CTTGTT LV 
CTTTCA LS 
GCAGCG AA 
GCTGCT AA 
GCTCTT AL 
GCTGTT AV 
GCTTCA AS 
GTTATT VI 
GTTCCT VP 
GTTCTT VL 
GTTGCT VA 
GTTTCA VS 
TCACCT SP 
TCACTT SL 
TCAGTT SV 
 
 
The mutants were infiltrated in Nicotiana benthamiana with SAD1 and the 
products were extracted and analyzed by GC/MS. The series of mutants of sad2 from 
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Table 7 were observed to make a range of monooxidized β-amryin products (initially 
designated M1-4), several dioxidized β-amyrin products (D1-3), a 14-demethylation 
product, and a minor compound with m/z 440. Through agglomerative hierarchical 
clustering and principal component analysis, the mutants that make these products were 
divided into five different groups. Group 1 was best described as wild-type group 
producing D1 as the main triterpene. Group 2 was comprised of inactive mutants. Group 
3 predominately made M2. Group 4 mutants made a mixture of products that included 
M1, M3, the demethylation product, and m/z 440. Finally group 5, produced a variety of 
oxidation products in addition to the WT products was M4, D2, and D3. 
The mutants that were most interesting were I471M and A353X-A354X’ mutants 
X’ = I, L, or V. I471M appears to produce a distinctive group of monooxygenated 
products and, through the apparent product of a demthylation triterpene, shifts the 
enzyme substantially back to the CYP51G. Mutant I471M was present in group 4 
producing M1, M3, the demethylation product, and m/z 440.  Mass vacuum infiltration of 
N. benthamiana leaves was used to scale-up this screening hit, where products of the 
coexpression were separated, purified, and identified. A354X’ with either I or L made 
exclusively the M2 product and very little wild type products. A354V mutants are 
intermediates between WT and A3354L/I mutants. With the goal of requiring different 
binding of β-amyrin in order for the enzymatic reactivity to produce the epoxidation 
product, mutant A353A-A354L was used in large-scale vacuum infiltrations of Nicotiana 
benthamiana leaves and the product, M2 was isolated. The rigorous elucidation of the 
wild-type, A354L, and I471M products was the prime goal of our effort. Additionally, 
mutants of sad2 could provide alternative oxidation patterns for making avenacin 
derivatives. Semi-synthetic derivatives of triterpene saponins and their biosynthetic 
intermediates are currently being explored for possible applications in the pharmaceutical, 
cosmetic, and/or food industries [248-251]. 
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4.3.2 Structure elucidation of the products from SAD2 mutants 
1H, 13C, DEPT, COSY, HSQC, HMBC, and NOESY NMR spectra were recorded. 
The following structure elucidation is described using IUPAC numbering. All of the 1J 
CH correlations that assisted in assigning the structure were assigned from the HSQC 
spectrum. For all products isolated, each of the eight methyl signals was a singlet 
consistent with the β-amyrin skeleton. For the HMBC, the majority of the assignable 
cross-peaks were attributable to carbons that coupled to hydrogens on the eight well-
resolved methyl groups. As a result, most of the connectivity of the structure could be 
characterized from these correlations.  
 
4.3.3 Structure elucidation of the product from wild-type SAD2  
The structure of the epoxydiol from wild-type Sad2 had been identified earlier by 
the Osbourn lab, partially through NMR data collected in deuterochloroform [203].  After 
many unsuccessful efforts during the current project were made to purify the oxygenated 
triterpenes, it was found that the extreme acid sensitivity of the epoxidized triterpenes 
required that all spectra were collected in pyridine-d5. Employing a reliable consistent 
NMR solvent allowed for the comparison of the chemical shifts from the product of wild-
type Sad2 with the products produced by the mutants.  
The structural elucidation of compounds from the mutant SAD2 enzymes relied, 
in part, on the detailed evaluation of a data set believed to be attributable to the 12,13-
epoxy-16-β-hydroxy-β-amyrin, initially dubbed compound 88.   
After isolation, compound 88 was derivatized with TMS and analyzed by GC-MS; 
under these conditions, it had a distinctive ion with to give an m/z of 602. This indicated 
the presence of two derivatizable hydroxyl groups and suggested the further addition of a 
non-hydroxylic oxygen to β-amyrin, an observation that was supported by 1H NMR, 13C 
NMR, and IR data. The full set of NMR experiments used to determine the structure of 
88 included 1H, 13C, DEPT-135, DEPT-90, HSQC, HMBC, COSY, and NOESY; all 
spectra were collected in pyridine-d5 solvent.  Based on the overall similarity of mass 
spectrum of 88 with known derivatives of β-amyrin, compound 88 was expected to have 
a β-amyrin skeleton.  According to data from the 13C spectrum, DEPT-135, and DEPT-90 
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experiments, there were thirty unique carbons including eight methyls, nine methylenes, 
six methines and seven quaternary carbons. The double bond of β-amyrin was 
conspicuously no longer present. Based on 13C peaks observed at 67.4 ppm and 54.5 ppm 
and HSQC data correlating the more upfield 13C to a proton at 2.89 ppm, the alkene 
appeared to have been oxidized to an epoxide. Tabulated spectral data is found in Table 8. 
The detailed assignment of the carbon-13 and proton NMR data is as follows.  
The secondary carbons attached to the hydroxyl groups provided the most easily 
identifiable entry point. They are both attached the most electronegative atoms in the 
structure leading to their downfield resonance in the range of 60-85 ppm in the 13C NMR 
and will have a scalar coupling to a exchangeable hydrogen that is downfield the 1H 
NMR spectrum. Two carbons met this criteria; the carbon at 78.3 ppm (C3) correlating to 
the hydrogen at 3.44 ppm and the carbon at 66.0 ppm (C16) correlating to the hydrogen 
at 4.57 ppm. Only two pairs of methyl groups were observed to correlate to each other in 
the HMBC spectrum. There are two geminal dimethyl groups on the β-amyrin framework; 
one pair was anticipated to be C23 and C23 and the other set was C29 and C30. C3 had 
cross peaks to the geminal dimethyl groups H23 and H24 revealing a segment of ring A 
(Figure 62A); collectively, this defined several strategic starting points for the remaining 
assignments. Continuing on ring A, the quaternary carbon C4 and methine carbon C5 
showed coupling to H23 and H24.  C5 correlated to the methyl group H25 at the ring 
fusion; C10 and C1 were also located with HMBC correlations to Me25.  Finally, the 
COSY showed a cross peak between protons H3 and H2, completing ring A. 
Proceeding from the bridgehead atoms at the A/B fusion, C5 and C10, an HMBC 
crosspeak was observed that linked C5 to H6 (Figure 62B). C9 additionally correlated 
back to H25, the methyl group attached to C10. Also, C9 showed long-range coupling to 
H26, tentatively assigning C26 as the methyl group at the bridgehead from ring B to ring 
C. There were two nearly chemically equivalent signals at 35.0 ppm in the 13C spectrum 
that displayed a correlation to H26; this assigned the chemical shift of C7 (the 
overlapping carbon resonance is assigned to C21 vide infra). Finally the substructure 
containing quaternary carbons C8 and C14 was identifiable from C4 cross-peaks to H26 
as well as to H27.  C8 and C14 could be distinguished because the HMBC showed weak 
coupling from C8 to H7.  
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 Going from ring B to ring C, the quaternary carbon C13 at 67.4 ppm correlated to 
H27 allowing it to be the other bridgehead carbon between ring C and ring D (Figure 
62C).  C13 was most likely attached to the non-hydroxylic oxygen based on its chemical 
shift. This was confirmed by C12 at 54.2 ppm in 13C spectrum correlating to a proton at 
2.89 ppm in the HSQC indicative of the presence of an epoxide. The proton resonance is 
a doublet with a small 4 Hz coupling constant that supports the assignment of an epoxide. 
The doublet represents H12α coupling to the H11α, the coupling constant to H11β is 
expected to be zero. Finally, the COSY had a cross peak from H12 to H11 and thus 
completed ring C.  
 C15 was correlated by the HMBC spectrum to the methyl at the ring fusion of 
C/D (H27) (Figure 62D). For the product from wild-type SAD2 the second hydroxyl 
group was found on ring D.  The oxymethine hydrogen at 4.57 ppm showed a 1J 
correlation to the carbon at 66.0 ppm (C16) in the HSQC spectrum. C16 has an HMBC 
cross-peak to H28 and could be extended via the COSY data to both H15a and H15b.  
The remaining correlations from methyl H328 to carbon C17 and methine C18 were 
located, thus completing ring D. 
Starting at C18 between ring D and ring E, the COSY showed a crosspeak from 
H18 to H19a (Figure 62E). The HMBC connected C19 to the geminal dimethyl groups, 
H29 and H30. The quaternary carbon, C20, and two methylenes, C22 and C21, all 
correlated to H29 and H30. The methyl groups were distinguishable because C22 
possessed a defining crosspeak to H28.  
The NOESY confirmed the relative stereochemical arrangements. The hydroxyl 
group at C3 is in the beta-position (equatorial) making the hydrogen axial, which is 
confirmed by the axial-axial coupling constant to C2β of 11 Hz. It can only have a 3Jaa = 
7-12 if the hydroxyl is beta [252]. The axial hydrogen at H3 correlated to H23 indicating 
it is on the same side of the ring as H3. Since the chair conformation is the most stable 
arrangement for the ring, H23 must be in the equatorial position. The 1,3-diaxial methyl 
groups on ring A, B, and C correlate to across the trans-fused rings, H24 to H25 and H25 
to H26. H16 had a cross-peak to axial H27, thus making hydroxyl group equatorial/beta. 
Again this can be further confirmed by the vicinal 3Jaa = 8.3 Hz. The NOE from H16 and 
H27 supports ring D occupying predominantly a chair or near-chair conformation. H12 
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correlated to H18, but also to H19b at 1.25 ppm. Axial protons are upfield to their 
equatorial proton. Therefore H12 correlating to the axial proton, H19b, places the epoxy 
group on the beta face of the triterpene. Because of the cis-ring fusion of rings D/E, there 
is some flexibility in the conformation of the two rings. Rings A, B, and C are locked in a 
chair conformation because of the trans-ring fusion. As stated previously ring D, must be 
in a chair conformation based on the NOEs present. On ring E, the NOE from H30 to 
H22b and H30 to H18 means it is also in a chair conformation. This completed the 
assignment of the wild-type product as 12,13β-epoxy-16β-hydroxy-β-amyrin, 88. 
 
 
 
Figure 62: The oxidized triterpene, 12,13β-epoxy-16β-hydroxy-β-amyrin (88), was 
identified as the main product from N. benthamiana co-expressing wild-type CYP51H 
with SAD1. Numbering is based on IUPAC. Substructures based on NMR correlations 
and coupling data. A-E Nuclei on the five rings were assigned using 1H-1H COSY 
(dashed arrows) and HMBC heteronuclear correlations (solid arrows) in Table 8 resulting 
in the final structure E. 
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Table 8: Tabulated NMR data for 12,13β-epoxy-16β-hydroxy-β-amyrin.  Data was 
collected in pyridine-d5. 
 
 
 
* denotes the overlapping resonance of C7 and C21 and therefore the protons are 
indistinguishable. 
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4.3.4 Structure elucidation from mutant A354L 
Mutant A354L was identified through the DNA sequencing of constructs for the 
AHC-derived cluster “Group 3,” which produced only M2. Compound M2 was 
derivatived with TMS and analyzed by GC-MS displaying an m/z of 586. This parent ion 
indicated the mass of compound M2 was equal to β-amryin plus another hydroxylic 
oxygen derivatized with two TMS group. The presence of two hydroxyl groups was 
confirmed in the 1H NMR spectrum by the presence of two signals at 3.47 ppm and 4.57 
ppm that each integrated for one hydrogen and a broad IR stretch at 3340 cm-1. As was 
determined by the 13C, DEPT-135, and DEPT-90 spectra, there were thirty unique 
carbons, eight methyls, nine methylenes, six methines, and seven quaternary carbons. The 
unmodified trisubstituted alkene was confirmed by the downfield chemical shifts in 1H 
and 13C NMRs. Tabulated spectral data can be found in Table 9. Original data was 
collected in CDCl3 before needing to switch NMR solvents to pyridine-d5 for consistency. 
The data described below is from pyridine-d5.  
The detailed assignment of the carbon-13 and proton NMR data is as follows. 
Rings A/B were assembled via an analogous set of HMBC and COSY correlations as 
were found for compound 88 (Figure 63A/B).  
Similar to 88, the quaternary carbons C14 and C8 both correlated to the methyl 
groups H26 and H27. However, additional long-range connectivity between C8 and H9 
as well as C14 to H12 bolstered ring C.  
Ring C retained the C12-C13 alkene of β-amyrin with 13C peaks at 145.0 ppm and 
122.9 ppm with the methine C12 (122.9 ppm) coupling to the triplet found in the 1H 
NMR spectrum at 5.37 ppm (Figure 63C). In the HMBC, C12 coupled with H11. 
Furthermore, C11 showed weak correlation to H9 and H12 confirming C11 was the 
allylic methylene. The quaternary carbon at 145.0 ppm, C13, coupled to the H27 methyl 
hydrogens at the C/D bridgehead, and thus completing ring C. 
Progressing from ring C, C12 and C13 both correlated to the methine H18 on ring 
D (Figure 63D). The quaternary carbon, C17 coupled to H18 as well as the methyl group 
H28. Critically, the hydroxylated carbon, C16, showed a cross-peak to H28. This 
pinpointed the second hydroxyl group on compound M2. Finally, C16 correlated to H15 
and H15 coupled back H27, the methyl group at the ring junction C/D closing ring D.  
192 
 
 The correlations on ring E are very similar to 88, where the HMBC data 
supported the coupling of C19 to the methine H18 and methyls H29 and H30. Due to 
correlations to each other on the HMBC, the geminal dimethyl group on ring E was H29 
and H30. The quaternary carbon C20 and methylene C21 also couple to H29 and H30. 
Finally, the last methylene C22 correlated to H28 completing ring E. 
The NOESY provided sufficient relaxation data to assign the stereochemistry.  H3, 
assigned to the axial, alpha position consistent with the substrate provided by SAD1, 
correlated to H23 and H5, placing H23 in the equatorial position and H5 in the axial 
positions both on the alpha face. The absence of a crosspeak linking H3 to Me25 aligns 
with the trans A/B ring fusion provided by β-amyrin. H16 did not correlate to H28, but 
did correlate to H27 therefore the stereochemistry of hydroxyl group at C16 was 
determined to be beta. Lastly, for the geminal dimethyl group with H29 and H30, H18 
correlated to H30 revealing their diaxial syn-facial relationship. The conformations of 
rings D and E were both confirmed to be in chair conformations from the NOEs similar 
to those found in 88. Therefore, the identity of M2 was 16β-hydroxy-β-amyrin, 89 
(Figure 63E). 16β-Hydroxy-β-amyrin, also known as maniladiol, has been previous 
reported in literature [253, 254]. 1H and 13C NMR data was similar to that reported by 
[254] in CDCl3 and by [253] pyridine-d5. 
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Figure 63: Structure elucidation of compound M2 isolated from N. benthamiana plants 
coexpressing the mutant SAD2, A354L, and the triterpene SAD1. IUPAC numbered. 
Substructures are based on NMR correlations and coupling data. A-E Nuclei were 
assigned and located on the five rings through the use of 1H-1H COSY (dashed arrows), 
HMBC heteronuclear correlations (solid arrows), and 1H-1H NOESY (red arrows) in 
Table 9 resulting in the final structure E.  
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Table 9: Tabulated NMR data for 16β-hydroxy-β-amyrin.  Data was collected in 
pyridine-d5. 
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4.3.5 Structure elucidation from mutant I471M 
AsbAS1, tHMGR, and CYP51H10-I471M were coexpressed in N. benthamiana 
leaves, and after purification, characterization of the sample was attempted. I471M, a 
single point mutation in CYP51H had been determined through screening to accumulate 
M1, M3, and two additional products. Initial NMR spectra in deuterochloroform showed 
that the initial I471M sample which had been expected to be the purified epoxide, was 
likely a mixture of triterpenes, even though the chromatography (HPLC, TLC) had only 
indicated one component. Over a couple of hours in CDCl3, 1H NMR analysis revealed 
four components in a ratio of approximately 3.6, 53, 39, and 4.5. Based on a cursory 
analysis, the compounds seemed to be the likely epoxide, epoxide isomer 1, epoxide 
isomer 2, and a fourth compound, respectively. Data collected over a week showed 
epoxide isomer 1 and the epoxide to be decaying overtime primarily to epoxide isomer 2. 
By 9 days the epoxide and epoxide isomer 1 were completely transformed to the more 
stable product. A second purification was completed using material from a second plant 
infiltration experiment and two compounds were isolated I471M-1 and I471M-2 avoiding 
any contact with acidic solvent. For NMR analysis, the solvent was switched to pyridine-
d5 and the components no longer decayed. 
 
4.3.6 Structure elucidation of product 1 from mutant I471M 
Compound I471M-1 was believed to be a β-amyrin derivative. After isolation, the 
compound was derivitized with TMS and analyzed by GC-MS to give an m/z of 514. 
Initially based on the mass spectra, isolate I471M-1 was thought to be β-amyrin with one 
oxygen that could be silylated and one additional non-hydroxylic oxygen. However, the 
1H NMR presented two signals at 3.48 and 3.98 ppm suggesting the presence of two 
hydroxyl groups. The structural elucidation of the mutant relied on complete evaluation 
of the data set in order to resolve whether the additional oxygen present is non-hydroxylic 
or non-TMS derivatized hydroxyl group. 
According to the 13C, DEPT 135, and DEPT 90 there were twenty-nine unique 
carbons, eight methyls, nine methylenes, six methines, and six quaternary carbons. 
However, since this compound was believed to be a β-amyrin derivative, there was a 
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concern that insufficient signal dispersion or accidental by chemical shift equivalent 
carbons might be present. The 13C NMR confirmed that an alkenyl functionality similar 
to that of β-amyrin was present in the structure of I471M-1 with two 13C shifts at 158.6 
ppm and 118.8 ppm. In addition, the HSQC showed a CH coupling between C12 at 118.8 
ppm to hydrogen at 5.79 ppm indicative of an sp2. Tabulated spectral data can be found in 
Table 10. 
The detailed assignment of the carbon-13 and proton NMR data is as follows. 
Starting at C3, a network of correlations equivalent to those used in the structure 
elucidation of 88 uncovered the molecular framework of ring A; the HMBC and COSY 
correlations are shown in Figure 61A. Ring B also showed similar correlations as 88, but 
the methyl group at C26 had a proton shift significantly more downfield, moving from 
1.35 ppm to 1.74 ppm in the 1H NMR spectrum (Figure 64B). This was presumably due 
to the presence of a proximate oxygenated functionality.  
The quaternary carbon at C14 also coupled to H26 and H27, but C14 had a weak 
cross-peak to H26 and a stronger cross-peak to H27. This allowed the quaternary carbons 
C8 and C14 to be distinguished from one another; therefore C8 connected ring B to ring 
C and C14 was at the bridgehead of rings C/D (Figure 64C). It also helped to confirm the 
presence of the alkene from β-amyrin was still intact.  C13, the quaternary carbon at 
158.6 ppm correlated to H26 and H27. The other double bonded carbon, C12 showed 
weak coupling to H11b in the HMBC and was further confirmed from the cross-peak 
between the allylic and vinylic hydrogens in the COSY. 
The key correlation came from cross-peak between the carbon at 70.2 ppm (C15) 
and to the methyl at the bridgehead between ring C/D, H27 (Figure 64D). This methine 
carbon must be attached to an oxygen due to its downfield chemical shift in the 13C 
spectrum. HSQC data linked this carbon to the methine hydrogen at 3.98 ppm, leading us 
to surmise there was a hydroxyl group attached to C15 that was not silylated during 
analysis for GC-MS. H15 coupled to H16a in the COSY. At the D/E fusion, C17 and C18 
at the D/E ring fusion coupled to the H28.  
At the ring fusion of D/E, the COSY spectrum showed the correlation H18 to 
H19a. C19 then coupled to C29 and C30 therefore identifying the other geminal dimethyl 
group. They also displayed cross-peaks to each other. The last methylene group was C22 
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showed a cross-peak to H28. The quaternary carbon, C20, of the geminal dimethyl group 
was hidden underneath another carbon peak and was identified by the HMBC. Methyl 
carbon C28 correlated to the geminal dimethyl, but that would be a coupling of 6JCH  
which too far for our parameters to have coupled. There for the quaternary carbon C20 
must be directly underneath the C28 at 29.9 ppm. 
The NOESY experiment was central to the stereochemical analysis (Figure 64E). 
Assuming this compound is a β-amyrin derivative means the hydroxyl group at C3 is in 
the beta-position (equatorial). Again, the 3Jaa coupling constant of 10.7 Hz further 
confirms that hydrogen occupies the axial position. The axial hydrogen at H3 correlated 
to H23 indicating it is on the same face of the ring as H3. Since the ring is in a chair 
conformation, H23 must be in the equitorial position. There was a cross-peak between 
H15 to H27, H27 is axial leading to the conclusion that the β-hydroxyl group axial. 
Finally H18 had discernable cross-peaks to H28 and H30, in accord with the expected cis 
ring junction at ring D/E. Therefore, the final structure elucidation for the first compound 
isolated from I471M is 15β-hydroxy-β-amyrin, 90. 
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Figure 64: Deduction of the structure of compound 90 produced by the coexpression of 
SAD2 mutant M471I with SAD1 in N. benthamiana. The elucidation molecule is the 
oxidized triterpene derivative,15β-hydroxy-β-amyrin. IUPAC numbered. Substructures 
are based on NMR correlations and coupling data A-E Nuclei were assigned and located 
on the five rings through the use of 1H-1H COSY COSY (dashed arrows), HMBC 
heteronuclear correlations (solid arrows), and 1H-1H NOESY (red arrows) in Table 10 
resulting in the final structure E. 
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Table 10: Tabulated NMR data for 15β-hydroxy-13β-β-amyrin.  Data was collected in 
pyridine-d5. 
 
 
 
 
  
IU
PA
C
 #
δ 
13
C
 
δ 
1 H
(m
)
J H
H
 (H
z)
D
EP
T
1 H
-1
H
 C
O
SY
C
or
re
la
tio
ns
13
C
-1
H
 H
M
B
C
C
or
re
la
tio
ns
1 H
-1
H
 N
O
ES
Y
C
or
re
la
tio
ns
1
38
.9
1.
56
 m
, 0
.9
4 
m
-
C
H
2
25
2
28
.6
1.
86
 m
-
C
H
2
1b
3
78
.6
3.
48
 d
t
 1
0.
7,
 5
.4
C
H
2
23
, 2
4
5,
 2
3
4
40
.0
-
-
C
23
, 2
4
5
56
.8
0.
9 
m
-
C
H
6b
23
, 2
4,
 2
5
6
20
.0
1.
72
 m
, 1
.6
4 
m
-
C
H
2
7
43
.8
2.
23
 m
, 1
.4
6 
m
-
C
H
2
26
8
39
.9
-
-
C
26
9
50
.4
1.
7 
m
-
C
H
25
, 2
6
10
38
.6
-
-
C
25
11
38
.4
2.
11
 m
, 1
.7
7 
m
-
C
H
2
12
11
8.
8
5.
79
 d
12
C
H
11
a,
 1
1b
11
b
13
15
8.
6
-
-
C
26
, 2
7 
11
b 
w
14
43
.2
-
-
C
26
 w
, 2
7
15
70
.2
3.
98
 d
d
4.
5,
 7
.5
C
H
16
a
27
 1
6a
, 1
6b
w
 2
7
16
30
.2
2.
26
 m
, 1
.9
8 
m
-
C
H
2
17
35
.9
-
-
C
28
18
39
.2
2.
57
 d
d
3,
 1
4
C
H
19
a
30
19
36
.9
1.
42
 m
, 1
.1
4 
m
-
C
H
2
29
, 3
0
20
-
-
-
C
21
34
.1
1.
47
 m
, 1
.3
0 
m
-
C
H
2
29
, 3
0
22
36
.1
1.
50
 m
, 1
.1
6 
m
-
C
H
2
28
23
29
.1
1.
27
 s
-
C
H
3
24
24
16
.8
1.
10
 s
-
C
H
3
23
25
25
16
.7
1.
07
 s
-
C
H
3
24
, 2
6
26
26
.4
1.
74
 s
-
C
H
3
25
27
22
.2
1.
08
 s
-
C
H
3
28
29
.9
1.
09
 s
-
C
H
3
29
33
.6
1.
03
 s
-
C
H
3
30
30
30
.7
1.
04
 s
-
C
H
3
29
200 
 
4.3.7 Structure elucidation of product 2 from I471M 
Mutant I471M-2 was also believed to be a β-amyrin derivative. After isolation, 
the compound was derivitized with TMS and analyzed by GC-MS to give a m/z of 514. 
This indicated the presence of one hydroxyl group from β-amryin and one additional non-
hydroxylic oxygen. 1H NMR and IR confirmed the hydroxyl group. Mutant I471M-2 
provided a quasimolecular ion [M + H]+ with an m/z of 443.3899 consistent with the 
molecular formula C30H51O2 (calcd m/z 443.3889).   The structural elucidation of the 
mutant relied on complete evaluation of the data set in order to determine the location 
and form of the oxygen. 
According to the 13C, DEPT 135, and DEPT 90 there were thirty unique carbons 
consistent with a triterpene, eight methyls, ten methylenes, five methines, and seven 
quaternary carbons. The beta-hydroxy group at C3 of ring A presented signals for an 
oxygenated carbon at 78.1 ppm in the 13C spectrum and 3.42 ppm in the 1H spectrum. 
The 13C spectrum revealed a carbonyl group at 212.2 ppm. According to the HSQC, the 
carbonyl carbon does not correlate to any hydrogens so therefore must be a ketone. 
Tabulated spectral data can be found in Table 11. 
The detailed assignment of the carbon-13 and proton NMR data is as follows. 
Ring A and ring B displayed the same COSY and HMBC correlations as 88 (Figure 
65A/B). The most noticeable change from 88 was the hydrogens at the methyl group C23 
became the most downfield methyl group.  
Both quaternary carbons C8 and C14 correlated to the hydrogens on methyl 
groups H26 and H27 (Figure 65C). However, C8 correlated back to H7 thus 
distinguishing the two carbons from one another. There was no longer an alkene present 
from β-amryrin as seen from the lack of peaks from 120-145 ppm in the 13C spectrum 
and no hydrogen peak around 5.25. Instead C13 had become a methine as seen in the 
DEPT90. This methine at 2.85 ppm in the 1H spectrum split into a doublet and in the 
HMBC coupled to H27. C12 was then identified as the carbonyl that correlated to H13 
and H11. This pointed to the oxidation of the double bond of β-amyrin to the ring C 
ketone. 
According to the HMBC, C18 correlated to H13, which was confirmed in the 
COSY with H18 coupling to H13. The HMBC showed C15 to H27, which gave initial 
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insights to ring D (Figure 65D).  C18 coupled to the methyl group H28. The methyl 
group became a key component of ring D because it has had cross-peaks with C16, C17, 
and C22. To complete ring D, in the COSY H16b correlated H15a. The remaining ring E 
correlations are the same as the previous structures. 
The NOESY completed all the stereochemistry specifications including H23 in 
the equatorial position because it had a correlation to H3 in the axial position (Figure 
65E). The 3Jaa coupling constant of 10.7 Hz for H3 confirms that it is in the alpha 
position. H13 correlated H18, H28, and H26 indicating that H13 was axial in the 
thermodynamically most favorable trans C/D fusion. Last H18 had a cross-peak to H30 
and H28 making it equatorial in keeping with the chair conformations of ring D/E. Thus 
the second compound isolated from I471M is the compound 12-keto-13β-β-amyrin, 91. 
 
 
Figure 65: Deduction of the structure of compound 91, a second compound produced by 
the coexpression of SAD2 mutant M471I with SAD1 in N. benthamiana. The elucidated 
molecule is the oxidized triterpene derivative, 12-keto-13β-β-amyrin. IUPAC numbered. 
Substructures are based on NMR correlations and coupling data. A-E Assigned nuclei on 
the five rings were constructed using 1H-1H COSY (dashed arrows) and  HMBC 
heteronuclear correlations (solid arrows), and 1H-1H NOESY (red arrows) in Table 11 
resulting in the final structure E. 
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Table 11: Tabulated NMR data for 12-keto-13β-β-amyrin.  Data was collected in 
pyridine-d5. 
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4.3.8 Structure elucidation of product 3 from I471M 
In the initial attempts to analyze the products of the SAD2 I471M mutant, it 
decomposed, apparently from small amounts of HCl present in CDCl3. After the second 
purification, two products were identified I471M-1 and I471M-2, but neither were the 
epoxide. The epoxide seemed to be degrading through the purification process and so the 
conditions were simplified to avoid elevated temperatures and only one isocratic flash 
column with pH neutral solvents was performed. This allowed the presumptive epoxide, 
I471M-3, to be isolated in about 70% purity which could be further purified by 
crystallization with hot methanol. 
Compound I471M-3 was derivitized with TMS and analyzed by GC-MS to give 
an m/z of 514. Similar to compound I471M-2, this MS data indicated the presence of one 
hydroxyl group from β-amryin and one additional non-hydroxylic oxygen, confirmed by 
1H NMR and IR. Mutant I471M-3 provided a quasimolecular ion [M + H]+ with an m/z 
of 443.3907 consistent with the molecular formula C30H51O2 (calcd m/z 443.3889).  The 
structural elucidation of the mutant relied on complete evaluation of the data set in order 
to determine the location and identity of the oxygen functionality. 
According to the 13C, DEPT 135, and DEPT 90 experiments, there were thirty 
unique carbons consistent with a triterpene, eight methyls, ten methylenes, five methines 
and seven quaternary carbons. Based on the 13C spectrum, the 3β-hydroxyl group on the 
A ring was still present due to the 13C peak at 78.3 ppm bearing a proton at δ 3.45 ppm. 
The alkene present in β-amryin appeared to be the modification site due to the lack of 
signals at 145 and 122 ppm. Tabulated spectral data can be found in Table 12. 
The detailed assignment of the carbon-13 and proton NMR data is as follows. 
Ring A and ring B displayed the same correlations as 88. All of the HMBC and COSY 
correlations are shown in Figure 66A/B.  
When assigning rings C and D, quaternary carbons C8 and C14 both correlated to 
the methyl groups H26 and H27, and no other cross-peaks were present to distinguish the 
two apart (Figure 66C). Spectroscopic data is consistent with the oxidization of the 
alkene to the epoxide, which has peaks at 67.4 ppm and 55.0 ppm with the relatively 
upfield 13C peak correlating to a hydrogen at δ 2.79 ppm. The COSY showed a 
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correlation between H12 and allylic H11b. To finalize ring C, the HMBC revealed C13 
coupled to H27.  
On ring D, C15 correlated to back H27 and was further confirmed by the COSY 
spectrum that showed a cross-peak from H27 to H15a (Figure 66D). The last methine to 
be assigned was C18. It is notable because of its downfield shift in the 13C spectrum (48.9 
ppm) and upfield shift in the 1H (1.11 ppm) is characteristic of a hydrogen at the cis-
fused D/E rings. C18 was linked through the HMBC to the methyl H28. The quaternary 
carbon C17 and the methylene C16 was also coupled to H28. 
Finally on ring E, the COSY yielded a strong 3J correlation between H18 and the 
likely axial H19a, which was extended by the correlation of C19 to H29 and H30. The 
last quaternary carbon C20 and methylene C21 both coupled to H29 and H30. Finally 
C22 correlated back to the methyl group at the ring D/E bridgehead, H28. 
Similar to compound 88, the NOESY was central to the stereochemistry 
specifications and gave similar correlations (Figure 66E). Assuming this compound is a 
β-amyrin derivative, the hydroxyl group at C3 is in the beta-position (equatorial). The 
NOESY confirmed that H23 is in the equatorial position because it had a correlation to 
H3 in the axial position and H30 is axial due to its correlation to H18. Critically, H12 
correlated to H18 and H19b.  Due to the cis-fusion of rings D/E and both rings are in a 
chair conformation, H12 must be alpha in order to correlate to axial H19b. With the 
improvements to the purification conditions and a different NMR solvent, it could finally 
be shown that one of the products of the I471M mutant, I471M-3 was in fact 12,13β-
epoxy-β-amyrin, 92. 
205 
 
 
Figure 66: Structure elucidation of 12,13β-epoxy-β-amyrin, 92. This compound was 
isolated as M471I-3 from SAD2 mutant M471I. Substructures numbered according to 
IUPAC. Substructures are based on NMR correlations and coupling data. A-E Assigned 
nuclei on the five rings were constructed using 1H-1H COSY (dashed arrows) and HMBC 
heteronuclear correlations (solid arrows), and 1H-1H NOESY (red arrows) in Table 12 
resulting in the final structure E. 
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Table 12: Tabulated NMR data for 12-keto-13β-β-amyrin.  Data was collected in 
pyridine-d5. *C-7 and C-14 could not be distinguished from one another. 
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4.3.9 Deciphering the products produced by mutant I471M 
From the first sample, 1H NMR analysis revealed four components: the likely 
epoxide, isomer 1, isomer 2, and a fourth compound corresponding to approximately 3.6, 
53, 39, and 4.5% of the sample, respectively. A subsequent transient expression of I471M 
provided new leaf material, from which two compounds were purified collected that both 
gave an m/z of 514 upon silylation indicating the two compounds had m/z equivalent to β-
amyrin plus oxygen, but also that the oxygen was not a hydroxyl group. The compound 
I471M-2 was easily identified as 12-keto-13β-β-amyrin and was also identified as isomer 
1 from the initial sample. It was concluded that the initial sample, believed to be the 
epoxide, was rapidly opened by acid catalysis to 12α-keto-13β-β-amyrin 93 (isomer 2), 
which then slowly isomerized to 12-keto-13β-β-amyrin, 91 (I471M-2) (Figure 67) [225]. 
From the original sample, this explained the presence of three of the four compounds. 
The fourth component was never fully identified.  
 
 
 
Figure 67: Acid-catalyzed epoxide opening to 12α-keto-13β-β-amyrin and 
tautomerization to 12β-keto-13β-β-amyrin. 
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 However, I471M-1 was not as easily identified mainly because the compound 
contained a hydroxyl group, which should have been indicated in the mass spectrum by 
the doubly silylated m/z 586 ion. Initially, I471M-1 gave a parent ion with an m/z of 514 
(Figure 68). Due to the hindered position of the 15β-hydroxy group, the second hydroxyl 
group was not readily silylated. The non-silylated hydroxyl group is consistent with the 
mass spectrum. The base peak of m/z 234 is consistent with a fragment containing a 
portion of ring C + D/E plus an oxygen and a small peak of 280 for rings A/B. It was 
determined that in the crude data, there were two components at 24.4 min from GC/MS, 
at 24.33 min was the epoxide (I471M-3) and 24.45 was the 15β-hydroxy compound 
(I471M-1). The loss of the methyl to give m/z 219 was only seen in 12-keto and 12,13β-
epoxy triterpenes. 
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Figure 68: Crude mass spectrum with epoxide and 15β-hydroxy-β-amyrin. A. The front 
half of the peak at 24 min looked to be the epoxide B. The tail of the peak at 24 min 
looked to be 15β-hydroxy-β-amyrin with only one hydroxyl group silylated.  
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Figure 68 continued 
 
From the second sample collected, the higher temperature during purification 
destroyed the epoxide to the ketone (I471M-2), revealing the 15β-hydroxy-β-amyrin that 
could subsequently be extracted. Had the epoxide never been destroyed, 15β-hydroxy-β-
amyrin would probably not have been found. 15β-Hydroxy-β-amyrin is an interesting 
product; it is the thermodynamically less stable alcohol. Positioning of the substrate in the 
enzyme active site seems to be relatively flexible in order to produce this compound 
along with 16β-hydroxy-β-amyrin and the β-epoxide. 15β-Hydroxy-β-amyrin appears to 
come from oxygen insertion by the CYP450 to the same face of β-amyrin. To check the 
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stability of the compounds, both I471M-1 and I47M-2 were dissolved in CDCl3; neither 
triterpene decayed over time as monitored by 1H NMR spectroscopy.  
 
4.3.10 Analysis of mass spectra of SAD2 mutants 
The Osbourn group collected original mass spectra data after infiltration and 
isolation of the compounds. Initially, the 15β-hydroxy position did not silylated and this 
precluded the assignment. We wanted to replicate the GC/MS results completed by the 
Osbourn group with the isolated compounds. For the 15β-hydroxy-β-amyrin, we were 
able to silylate the 15-hydroxy position as seen in Figure 69. However the mass spectrum 
was still quite different than the other mass spectra collected. All products were 
derivatized with TMS before GC/MS analysis. The mass spectra for 12,13β-epoxy-16β-
hydroxy-β-amyrin, 12,13β-epoxy-β-amyrin, and 12-keto-β-amyrin can all be found in the 
Appendix.  
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Figure 69: Mass spectra collected for I471M-1 and A354L. A. Mass spectrum of 16β-
hydroxy-β-amyrin, the product from plants expressing SAD1 and the A354L mutant of 
SAD2 B. Mass spectrum of 15β-hydroxy-β-amyrin. 
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Figure 69 continued. 
 
In all the samples, there is a loss of TMSOH from the parent ion thought to be 
from the 3-position of β-amyrin. The main product of the wild-type enzyme and 16β-
hydroxy-β-amyrin undergo a retro Diels-Alder cleavage to give an m/z of 279 
representing rings A/B + TMS less H (Figure 70). In a retro Diels-Alder reaction of the 
parent radical cation, the charge can be localized to either fragment; for 16β-hydroxy-β-
amyrin, we see predominantly the other fragment m/z 306. A McLafferty rearrangement 
of 12-keto-13β-β-amyrin leads to the m/z 279 ion and the C/D/E fragment with an m/z of 
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12-keto-13β-β-amyrin and the m/z 279 and 234 ions. Interestingly, 15β-hydroxy-β-
amyrin does not undergo the retro Diels-Alder as seen by the lack of m/z of 279.  
 
 
 
Figure 70: Key fragmentations from the mass spectra of the isolated products. A. The loss 
of m/z 279 is visible in the mass spectra for all products except 15β-hydroxy-β-amyrin. B. 
The C/D/E ring fragment released from the retro Diels-Alder reaction fragmentation of 
16β-hydroxy-β-amyrin. C. The other fragment from 12-keto and 12,13β-epoxy seen from 
the loss of m/z 279. 
 
Although 15β-hydroxy-β-amyrin and 16β-hydroxy-β-amyrin are both 
hydroxylated on ring D, even when both are silylated, their fragmentation patterns are 
very different. As stated previously, for 16β-hydroxy-β-amyrin, the loss of TMSOH is 
seen, as in all β-amyrin derivatives, with a small peak at 496. The pentacyclic ring is 
cleaved at rings A/B + TMS – H2 to give an m/z of 279. When the A/B ring is cleaved, 
there is a larger peak for C/D/E + TMSO at 306 and the subsequent loss of TMSOH 
giving the base peak of m/z 216. For 15β-hydroxy-β-amyrin the same fragmentation 
pattern is not observed. Instead, the loss of the ring D TMSOH is much faster in 15β-
hydroxy-β-amyrin than 16β-hydroxy-β-amyrin due to the 1,3-diaxial interaction between 
the methyl CH3 at C8 and the OTMS at C15. The retro Diels-Alder fragmentation is not 
observed in 15β-OH.  
 
 
  
HTMSO
Chemical Formula: C17H31OSi+
Exact Mass: 279.2139
A. B. C. OH
Chemical Formula: C16H26O
Exact Mass: 234.1984
H
OTMS
Chemical Formula: C19H34OSi
Exact Mass: 306.2379
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4.3.11 Effects of NMR solvent on 13C chemical shifts 
We wanted to compare the chemical shifts from the isolated triterpenes to 
understand how new moieties effect the chemical shifts of neighboring groups and 
facilitate future spectral analysis of oleanane natural products. Most data sets for β-
amyrin and its derivatives are collected in CDCl3 [255-257]. The original data set for the 
16β product from A354L, were collected in CDCl3 as well. A previous study by Agrawal 
reported that, general, 13C shifts were not very sensitive to different solvents, but there 
was a noticeable difference in the use of chloroform to pyridine [258]. Their study was 
conducted with steroids and they noticed an upfield shift (0.6-0.9 ppm) for C3 and 
downfield shift up to 0.9 ppm for the remaining carbons on a monohydroxylated steroid 
[258]. For our experiments, for 16β-hydroxy-β-amyrin, was assigned anew in pyridine-d5 
and data was acquired and analyzed for the reference compound β-amyrin in pyridine-d5 
as well (full assignment in Appendix). The chemical shifts were compared between 
CDCl3 and pyridine-d5 (Table 13). The solvent effects that Agrawal reported for sterols 
were similar to the effects observed with triterpenes. Both 16β-hydroxy-β-amyrin and β-
amyrin had an upfield shift of 0.6 ppm for C3 and a downfield shift for the other twenty-
nine carbons. An upfield shift of 1.2 ppm was also observed for the second oxygen-
bearing carbon in 16β-hydroxy-β-amyrin. Most shifts were less than 1 ppm difference, 
but there were a few exceptions in both 16β-hydroxy-β-amyrin and β-amyrin (highlighted 
in Table 13). The biggest effects are closest to the oxygen, where the Δδ was 1 to 1.4. For 
example, in 16β-hydroxy-β-amyrin samples there was a downfield shift of 1.4 ppm 
observed at C13. Also, for β-amyrin, there was a shift difference of 1.7 ppm at C8. Since 
the solvent does affect the carbon chemical shifts, collecting a broader data set of 
triterpenes in pyridine-d5 was undertaken in order to compare chemical shifts. 
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Table 13: Comparing the chemical shifts from pyridine-d5 and CDCl3. 
 
 
 
4.3.12 Comparison of 13C shifts of oleanene triterpene in pyridine-d5 
When comparing the chemical shifts, each chemical shift was compared to β-
amyrin using the following formula. 
Δppm = corresponding product (ppm) - β-amyrin (ppm) 
Shifts that had a significant downfield shift are highlighted in red and significant upfield 
shifts are highlighted in green with difference ± 10 shaded darker and differences that 
were ±5 shaded lighter (Table 14). 
 Looking across the table, the largest chemical shift differences correspond to the 
sites directly perturbed addition of oxygen(s). The addition of the hydroxyl group occurs 
from the products of A354L (Δ37.7 ppm), I471M-1 (Δ43.7), and wild-type (Δ38.8). The 
IUPAC δ 13C CDCl3 δ  13C pyr d5 Δδ 
13C IUPAC # δ 13C CDCl3 δ  13C pyr d5 Δδ 
13C 
1 38.7 39.6 0.9 1 38.7 39.5 0.8
2 27.3 28.6 1.3 2 27.3 28.5 1.2
3 79.1 78.5 -0.6 3 79 78.4 -0.6
4 38.9 39.9 1 4 38.8 39.7 0.9
5 55.3 56.2 0.9 5 55.3 56.1 0.8
6 18.4 19.3 0.9 6 18.5 19.1 0.6
7 32.7 33.5 0.8 7 32.8 33.4 0.6
8 40 40.7 0.7 8 38.8 40.5 1.7
9 46.9 47.8 0.9 9 47.7 48.4 0.7
10 37 37.7 0.7 10 37 37.6 0.6
11 23.6 24.4 0.8 11 23.6 24.2 0.6
12 122.5 122.9 0.4 12 121.8 122.7 0.9
13 143.6 145.0 1.4 13 145.1 145.6 0.5
14 43.9 44.4 0.5 14 41.8 42.3 0.5
15 35.7 37.0 1.3 15 26.2 26.5 0.3
16 66.1 64.9 -1.2 16 27 27.2 0.2
17 37.4 38.5 1.1 17 32.5 33.1 0.6
18 49.2 50.1 0.9 18 47.4 47.9 0.5
19 46.6 47.6 1 19 46.9 47.4 0.5
20 31 31.7 0.7 20 31.1 31.5 0.4
21 34.3 35.2 0.9 21 34.8 35.3 0.5
22 30.7 31.6 0.9 22 37.2 37.8 0.6
23 28.2 29.2 1 23 28.2 29.1 0.9
24 15.7 17.0 1.3 24 15.5 16.9 1.4
25 15.6 16.3 0.7 25 15.6 16.1 0.5
26 16.9 17.7 0.8 26 16.9 17.4 0.5
27 27.2 27.8 0.6 27 26 26.2 0.2
28 21.6 23.0 1.4 28 28.4 28.9 0.5
29 33.3 33.9 0.6 29 33.3 33.8 0.5
30 24.1 24.6 0.5 30 23.7 24.1 0.4
16β-Hydroxy-β-amyrin β-Amyrin
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addition of the electronegative group caused the attached carbon to be deshielded, which 
is seen by the positive change versus the unmodified alicyclic carbon. In olean-12-enes, 
like β-amyrin, the C12 and C13 alkene resonances are characteristically at 122 and 144 
ppm, respectively [259]. There was a large increase in shielding at C12 and C13 when the 
double bond was oxidized to the epoxide in wild type product and I471M-3. Although 
oxygen is electronegative it does not deshield the carbon atoms compared to alkene so the 
chemical shift difference is large in the negative direction because of the hybridization 
change of the carbon from sp2 to sp3. Also, the oxirane is similar to cyclopropane in that 
the planar three-membered ring creates an even greater shielding effect through magnetic 
anisotropy [260]. 
A large change also occurred when the alkene was oxidized to a ketone I471M-2. 
Though in this case, C12 has a large positive change (Δ+89.5 ppm) because the electrons 
are now in a polarized pi system from the sp2 hybridized carbon and now there are 
effectively two electron-withdrawing groups; therefore, the carbonyl group deshields C12. 
Magnetic anisotropy from the pi system from the carbonyl group creates shielding cones 
above and below the plane, which causes shielding at C18 and C19. However, C13 has a 
large negative change (Δ-95 ppm) from β-amyrin due to the change of hybridization state. 
An inductive effect is seen by the addition of a 16β-hydroxy group in the products 
from the A354L mutant and the wild-type enzyme. C15 and C17 alpha to C16 are shifted 
downfield by 5.4 to 10.5 ppm due to the deshielding by the electron-withdrawing group, -
OH.  When C16 is hydroxylated, there are noticeable upfield shifts at γ-C22 and γ-C28. 
In a previous study, Lambert studied the shielding effects the relationship between the 
gamma carbon and the shielding effect from the dihedral angle [261]. The γ effect is 
important because it is the simplest shielding effect that is dependent on the dihedral 
angle and it usually as the opposite sign from the α and β effects [261]. We observe the 
opposite effect at γ-C22 and γ-C28 compared to α-C16 or β-C15 and β-C17. In the report 
by Lambert, they reported that substituting a hydroxyl group at the equatorial position on 
a cyclohexane would cause the γ-carbons with a φ =60-90° to be shielded by -4.10 and -
6.31 ppm. Our results for C22 and C28 follow a similar pattern and are shielded by -6.2 
ppm and -5.9 ppm. 
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15β-Hydroxy-β-amryin and 16β-hydroxy-12,13β-epoxy-β-amyrin had the largest 
number of carbons affected relative to unmodified β-amyrin, even though 16β-hydroxy-
12,13β-epoxy-β-amyrin had an addition of two functional groups and 15β-hydroxy-β-
amryin only had one. For 15β-hydroxy-β-amryin, C7, C11, C13, C15, C26, C30 had a >5 
shift downfield and C18 and C19 had a >5 effect upfield.  For the wild-type product, had 
a >5 shift difference downfield at C15, C16, and, C17 and a >5 effect upfield at C12, C13, 
C19, C22, and C28.  One of the reasons for the number of carbons effected in 15β-
hydroxy-β-amryin could be due to the fact the hydroxyl group is in an axial position 
potentially destabilizing the chair conformation of ring D, leading to unexpected 
shielding effects. There are additional interactions attributable to the axial OH group. The 
hydroxyl group at C15 has an 1,3-diaxial interaction with methyl C26, a significant effect 
in conformationally restricted cyclohexanes, appears to cause steric deshielding of the 13C 
registered by a downfield shift of 9 ppm at methyl C26 [259]. Another effect, shifts C7 
downfield with the addition of the axial hydroxyl group at C15 because the gauche 
interaction betweeb C15 and C7 [259]. 
The 1,3-diaxial interaction between the OH at C15 and C28 would be expected to 
cause a significant downfield shift of methyl C28. However, the lack of this influence 
gives insight into the D/E ring fusion for 15β-hydroxy-β-amyrin.  C28 appears not to be 
in an axial position due to the lack of deshielding from a 1,3-diaxial interaction. The cis-
ring fusion of ring D/E allows for some flexibility in the molecular configuration. The 
flip of ring E also explains the shift differences at C18 (Δ-8.7 ppm), C19 (Δ-10.5 ppm), 
and C30 (Δ6.6 ppm). C18 and C19 become more shielded from the magnetic anisotropy-
shielding cone of the alkene [260]. C30 flips from equatorial to an axial position where it 
experiences a 1,3-diaxial interaction from H22 that deshields C30 causing a downfield 
shifts [260]. Product 90 was the only product to undergo a ring flip at ring E. 
Another interesting observation is the carbons with the largest shift difference in 
16β-hydroxy-12,13β-epoxy-β-amyrin were the same compared to 16β-hydroxy-β-amyrin 
and 12,13β-epoxy-β-amyrin. The epoxide compound has upfield shifts at C12 (-67.7 
ppm), C13 (-78.2 ppm), and C19 (-5.7 ppm).  In epoxy-diol compound there are upfield 
shifts observed for C12 (-68.2 ppm), C13 (-78.2 ppm), and C19 (-5.5). For 16β-hydroxy-
β-amyrin, downfield shifts occur at C15 (10.5 ppm), C16 (37.7 ppm), and C17 (5.4 ppm). 
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There are upfield shifts at C22 (-6.2 ppm) and C28 (-5.9 ppm). For the epoxy-diol, the 
effects at those same carbons were downfield for C15 (8.7 ppm), C16 (38.8 ppm), and 
C17 (6.5 ppm) and upfield C22 (-6.0) and C28 (-5.9 ppm). The effects from 16β-
hydroxy-β-amyrin and 12,13β-epoxy-β-amyrin are additive effects in 16β-hydroxy-
12,13β-epoxy-β-amyrin. 
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Table 14: Comparative table of chemical shifts of β-amyrin derivatives relative to β-
amyrin. All data collected in pyridine-d5. Downfield shifts greater than 10 ppm are 
denoted in dark red and downfield shifts of  0.1-5 are printed in light red. Upfield shifts 
greater than 10 ppm are shown in dark green and upfield shifts of 0.1-5 ppm are printed 
in light green. 
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Table 14 continued’  
 
py
r-
d5
β-
am
yr
in
IU
PA
C
 c
ar
bo
n
δ 
13
C
 
δ 
13
C
 
ΔI
47
1M
-1
δ 
13
C
 
ΔI
47
1M
-2
δ 
13
C
 
ΔI
47
1M
-3
D
ow
nf
ie
ld
 S
hi
ft 
Δ 
> 
|1
0|
1
39
.5
38
.9
-0
.6
38
.7
-0
.8
38
.8
-0
.7
D
ow
nf
ie
ld
 S
hi
ft 
Δ 
> 
|5
|
2
28
.5
28
.6
0.
1
28
.3
-0
.2
28
.3
-0
.2
U
pf
ie
ld
 S
hi
ft 
Δ 
> 
|1
0|
3
78
.4
78
.6
0.
2
78
.1
-0
.3
78
.3
-0
.1
U
pf
ie
ld
 S
hi
ft 
Δ 
> 
|5
|
4
39
.7
40
.0
0.
3
39
.8
0.
1
39
.7
0
5
56
.1
56
.8
0.
7
55
.8
-0
.3
56
.2
0.
1
6
19
.1
20
.0
0.
9
19
.1
0
18
.6
-0
.5
7
33
.4
43
.8
10
.4
32
.5
-0
.9
34
.8
1.
4
8
40
.5
39
.9
-0
.6
42
.2
1.
7
41
.8
*
1.
3
9
48
.4
50
.4
2
50
.4
2
47
.1
-1
.3
10
37
.6
38
.6
1
37
.5
-0
.1
37
.9
0.
3
11
24
.2
38
.4
14
.2
39
.2
15
22
.3
-1
.9
12
12
2.
7
11
8.
8
-3
.9
21
2.
2
89
.5
55
.0
-6
7.
7
13
14
5.
6
15
8.
6
13
50
.6
-9
5
67
.4
-7
8.
2
14
42
.3
43
.2
0.
9
42
.7
0.
4
40
.9
*
-1
.4
15
26
.5
70
.2
43
.7
26
.6
0.
1
25
.1
-1
.4
16
27
.2
30
.2
3
27
.0
-0
.2
28
.3
1.
1
17
33
.1
35
.9
2.
8
33
.2
0.
1
34
.0
0.
9
18
47
.9
39
.2
-8
.7
37
.8
-1
0.
1
48
.9
1
19
47
.4
36
.9
-1
0.
5
35
.5
-1
1.
9
41
.7
-5
.7
20
31
.5
-
-
31
.6
0.
1
31
.2
-0
.3
21
35
.3
34
.1
-1
.2
37
.7
2.
4
35
.1
-0
.2
22
37
.8
36
.1
-1
.7
38
.3
0.
5
37
.7
-0
.1
23
29
.1
29
.1
0
28
.9
-0
.2
28
.9
-0
.2
24
16
.9
16
.8
-0
.1
16
.6
-0
.3
16
.6
-0
.3
25
16
.1
16
.7
0.
6
15
.8
-0
.3
15
.7
-0
.4
26
17
.4
26
.4
9
16
.4
-1
21
.1
3.
7
27
26
.2
22
.2
-4
21
.4
-4
.8
22
.4
-3
.8
28
28
.9
29
.9
1
27
.7
-1
.2
29
.1
0.
2
29
33
.8
33
.6
-0
.2
34
.2
0.
4
33
.6
-0
.2
30
24
.1
30
.7
6.
6
23
.8
-0
.3
23
.7
-0
.4
15
β-
H
yd
ro
xy
-β
-a
m
ry
in
 
12
, 1
3β
-e
po
xy
-β
-a
m
ry
in
 
12
-k
et
o-
13
β-
β-
am
yr
in
222 
 
4.3.13 Correlation of methyl groups 
Pentacyclic triterpenes contain 8 methyl groups, which are distinctive in the 
proton spectrum by the intense singlet peaks. Establishing the identity of methyl groups 
could be beneficial and useful for studying new triterpenes. Several have tried to make 
this correlation, but assumptions were always made for methyls C23, C24, and C25 until 
a study by Ito that analyzed the regular changes that occur when 3β-hydroxy oleanenes 
are converted to 3β-acetoxy derivatives [262-265]. The areas they saw the most 
difference was from 0.78-0.99 ppm [265]. In order to unambiguously assign these three 
groups, 3β-hydroxyoleanenes, in the camelliagenin and barringtogenol families were 
selectively dideuterated at either C23 or C24. They observed the methyl 1H NMR signal 
intensity at 0.99-1.01 decreased for C23-d2 and signals at 0.80 ppm became less 
pronounced for C24-d2, thereby deducing the signal at 0.91-0.94 to be C25.  
Looking at the assigned methyl groups for β-amyrin and the five products in 
Table 15, the trend for our data is the same as Ito, but the range is bigger. For C23, the 
average methyl peak was around 1.26 ppm ranging from 1.23-1.28 ppm. For C24, the 
average methyl peak was found at 1.08 ppm ranging from 1.05-1.10. For C25, the 
average methyl peak was found at 0.97 ppm ranging from 0.88 – 1.07 ppm. Therefore, 
with Ito’s results one might be able to apply their results to derivatives of camelliagenin 
and barringtogenol, but not across all pentacyclic triterpenes. Further, when new 
functionality is added to rings C and D, methyl groups at carbons 23, 24, 25, and 29 had 
<0.1 ppm change, except for the 12-keto-13β-β-amyrin effected methyl-25 with an 
upfield shift of 0.12 ppm.  
The other four methyls -26, -27, -28, and -30 were affected to different degrees 
depending on the substitution. Both hydroxylated compounds 15β-hydroxy-β-amyrin and 
16β-hydroxy-β-amyrin remove electron density from and thus deshielded the C26, C27, 
and C28 methyl groups. 16β-Hydroxy-β-amyrin had a <0.1 ppm effect on C26 whereas 
15β-hydroxy-β-amyrin had a large chemical shift difference of 0.70 ppm for C26. This 
can be attributed to the 1,3-diaxial interaction discussed previously. Superimposing the 
effects of 16β-hydroxy-β-amyrin on the NMR chemical shift data for 12,13-β-epoxy-β-
amyrin allows the prediction of the methyls -26, -27, and -28 chemical shifts observed in 
the wild-type product. For example, the addition of the effects from 16β-hydroxy-β-
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amyrin to those of 12,13β-epoxy-β-amyrin, C26 = 0.36, C27 = 0.14, and C28 = 0.54 ppm 
gives almost the exact shift differences from β-amyrin for 16β-hydroxy-12,13β-epoxy-β-
amyrin C26 = 0.31, C27 = 0.11, and C28 = 0.55 ppm. This additivity effect could be 
useful in predicting chemical shifts with more than one substitution on β-amyrin 
derivative. Though correlations can be made from the different β-amyrin derivatives, the 
methyl groups alone can only aid in determining an unknown structure. Full assignment 
must be completed using several NMR experiments, IR, and GC-MS analysis to achieve 
a high confidence structure.  
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Table 15: Methyl shifts of five oleanane triterpene derivatives compared to β-amyrin in 
pyridine-d5. Downfield shifts > 0.1 ppm are in highlighted in yellow and upfield shifts > 
0.1 ppm are highlighted in purple. 
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4.3.14 Future Work 
Both proposed Sad2 intermediates, 12,13β-epoxy-β-amyrin and 16β-hydroxy-β-
amyrin, were isolated from two different mutants. 16β-Hydroxy-β-amyrin was isolated 
from the mutant A354L from the substrate recognition site SRS5 and 12,13β-epoxy-β-
amyrin was isolated from I471M from the substrate recognition site SRS6. Both substrate 
recognition sites were predicted from computational modeling to play a catalytic role in 
the conversion of β-amyrin to 12,13β-epoxy-16β-hydroxy-β-amyrin. The compounds will 
need to be fed to the wild type enzyme in yeast in order to determine if 12,13β-epoxy -β-
amyrin can be converted to 12,13β-epoxy-16β-hydroxy-β-amyrin or if 16β-hydroxy-β-
amyrin can be converted to 12,13β-epoxy-16β-hydroxy-β-amyrin. This part of the project 
is still in progress. Lastly, the desmethylation product was never identified. At this time, 
we do not have further evidence to support this hypothesis. The identification of the 
desmethylation product would give concrete evidence that the divergent enzyme 
AspCyp51H10 retained a native a plant CYP51G activity. 
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APPENDIX 
Assignment of β-amyrin in pyridine d5 
There is no published NMR data of β-amyrin collected in pyridine-d5 solvent. For 
the full investigation of the chemical shift differences in the oleanane family of 
triterpenes, the assignments of β-amyrin in pyridine d5 was undertaken. This gave a valid 
standard with which to compare the chemical shifts of the four mutant Sad2 products and 
wild-type Sad2 product. Again, initial identification was numbered based on 13C NMR 
but then switched to IUPAC once the structural was fully elucidated. 
The same set of NMR experiments used for the wild-type product and mutant 
products were also use to collected data for β-amyrin in pyridine-d5. The hydroxyl group 
was confirmed on the HSQC with 13C peaks at 78.7 ppm correlating to a proton at 3.47 
ppm. The double bond of beta-amyrin was present at 145.6 and 122.7 ppm in the 13C 
spectrum with the correlating proton at 5.25 ppm. Tabulated spectral data can be found in 
Table 16. 
Starting with ring A, the hydroxyl-bearing C3 correlated to H23 and H24 making 
H23 and H24 the geminal dimethyl group on ring A (Figure 71A). The quaternary carbon 
C4 along with the methine C5 were identified through their coupling to H23 and H24. 
Additionally, C5 correlated to methyl H25. The quaternary carbon C10 and the methine 
C1 also coupled to H25. Finally, in the COSY, H3 showed a cross-peak to H2a/b making 
C2 the methylene alpha to the hydroxylated carbon. 
 On ring B, methine group C9 correlated to the methyl H25 at the bridgehead 
between ring A/B and the methyl H26 leading to the bridgehead of rings B/C (Figure 
71B). Methylene H7 was coupled to H26. Quaternary carbons C14 and C8 both had 
correlation peaks to the methyl groups H27 and H26; through the correlation between C8 
and H9, the two quaternary carbons could be distinguished from one another. The COSY 
showed a cross-peak from H5 to H6a/b.  
On ring C, the double bond was easily identified by the 13C resonances at 122.7 
(C13) and 145.6 ppm (C12), similar to the standards reported for 12-oleanenes in other 
solvents (Figure 71C). C12 correlated to the hydrogen at 5.25 ppm in the HSQC making 
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it the methine. In the HMBC spectrum, C12 coupled to the allylic hydrogens H11a/b.  
Finally, C13 showed an important cross peak to H27 confirming assigning the methyl 
group C27 alpha to C14 and the methyl C26 alpha to C8. 
 On ring D, the methylene C15 correlated to H27 (Figure 74D).  In the COSY, 
there was a cross peak between H16b and H15. In the HMBC C16 correlated to the 
methyl H28. The last methine to be assigned was C18, which coupled to H28. 
Additionally, the showed the quartenary carbon C17 was attached to the methyl, H28. 
Finally on ring E, the COSY coupled H18 to H19a (Figure 74E). C19 correlated 
to H29 and H30, which made C29 and C30 the other geminal dimethyl groups. The last 
quaternary carbon must be C20 confirmed by correlation to H29 and H30. C21 had two 
cross-peaks, linking it to H29 and H30. To finish ring E, it was observed that C22 
coupled to H28. The NOESY confirmed the stereospecific groups; H3 correlated the 
axial hydroxgen H5 and methyl H23. Since H5 is axial in β-amyrin, this makes H3 axial 
and C23 equatorial. Critically, H18 correlated to H30 making it beta and H29 alpha. This 
allowed beta-amyrin to be fully assigned in pyridine-d5 and used to compare to the 
chemical shifts of other beta-amyrin derivatives. IR (KBr pellet): br 3276, 2945, 2867, 
2852, 1463, 1387, 1359, 1036 cm-1; HRMS (Dual ESI) m/z calc for [M + H]+ C30H51O 
427.3940, found 427.3939. 
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Figure 71: Structure elucidation of β-amyrin in pyridine-d5. IUPAC numbered. 
Substructures based on NMR correlations and coupling data. A-E Assigned nuclei on the 
five rings were constructed using 1H-1H COSY (dashed arrows) and HMBC 
heteronuclear correlations (solid arrows), and 1H-1H NOESY (red arrows) in Table 16 
resulting in the final structure E. 
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Table 16: Tabulated NMR data for β-amyrin.  Data was collected in pyridine-d5. 
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Figure 72: TMS-16β-hydroxy-12, 13-epoxy-β-amyrin 
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Figure 73: TMS-12-keto-13β-β-amyrin 
 
  
4
3
2
1
0
Ab
un
da
nc
e 
(x
10
5 )
 
600500400300200100
m/z
73.1
109.1
135.1
189.2 234.2
279.1
341.0
385.4424.4
457.4
499.4
514.5
293.2
219.2
193.2
165.2
409.4
HTMSO
H
O H
248 
 
 
 
Figure 74: TMS-12, 13β-epoxy-β-amyrin 
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